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ABSTRACT
To communicate with their environment, living cells feature recep-
tors that provide a bridge across the enclosing membrane. The preva-
lent G protein-coupled receptors (GPCR) receive outside information
through the binding of a ligand, which activates the receptor. During
activation, an open intracellular crevice forms, to which a G protein
(Gαβγ, G) can couple with its Gα C-terminus. Binding to GPCRs
triggers GDP/GTP exchange in the Gα subunit of Gαβγ, necessary
for further signal transfer within the cell. The coupling between re-
ceptor and Gαβγ involves a series of dynamic structural changes that
govern speed and specificity of the interaction. Here we used molec-
ular dynamics (MD) simulations to elucidate molecular details of the
GPCR Gαβγ coupling process before and during GPCR Gαβγ com-
plex formation up to the GDP/GTP exchange.
The photoreceptor rhodopsin is tuned to provide fast and precise
signal transfer. We investigated the role of its third intracellular loop
in enabling signaling specificity and speed. Employing MD simula-
tions, we find that the third intracellular loop is an intrinsically un-
structured region, that — like the Gα C-terminus — adopts a struc-
tured conformation upon complex formation. These findings corrobo-
rate a Fourier transform infrared spectroscopy study and allow struc-
tural interpretation of the spectroscopic data. Based on these data,
we propose a stepwise mutual structuring scheme, that explains fast
signal transfer by an increased likelihood of complex formation. The
high signal fidelity is realized by the stepwise structuring allowing
precise interrogation of a large interaction surface.
The β2-adrenoceptor can couple to the G protein families Gs and
Gi. However, agonists can bias the receptor to prefer coupling to
one family. Here we utilized MD simulations and umbrella sampling
calculations to determine structural differences in the binding modes
of active β2-adrenoceptor with Gs or Gi. Using peptides derived
from the far C-terminus of the Gα-subunit, we find that Gi can sta-
bilize active β2-adrenoceptor in a conformation very similar to active
rhodopsin binding to Gt, a close homologue of Gi. A comparison of
the observed Gi binding mode with crystal structures of Gs in com-
plex with active β2-adrenoceptor suggests that the specific outward
tilt of transmembrane helix 6 allows the receptor to distinguish be-
tween Gs and Gi. One hypothesis is that biased agonists control that
tilt to realize their biasing ability.
Signal transfer from GPCR to Gαβγ has to bridge the distance of
30Å that separates the receptor binding crevice and the GDP/GTP
binding pocket. The α5-helix in Gα connects the binding pocket to
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the receptor and its rotation has been directly linked to GDP release,
but it is unclear how the rotation is induced. The intermediary com-
plex between GPCR and Gαβγ leading to GDP/GTP exchange still
has GDP bound. For rhodopsin and the β2-adrenoceptor, our MD
simulations of the α5-helix show a rotation of the α5-helix resulting
only from interactions with the receptor interface. We propose that
the α5-helix rotates at the coupling interface of GPCR and Gαβγ dur-
ing the transition from the intermediary complex to the GDP-free
complex of receptor and Gαβγ. Thereby the intermediate complex
provides a structural scaffold in which the α5-helix can rotate, while
the receptor and the Gαβγ stay fixed, so that the rotation maximally
effects the GDP binding pocket thus triggering GDP release.
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ZUSAMMENFASSUNG
Ummit ihrer Umgebung zu kommunizieren verfügen lebende Zellen
über Rezeptoren, welche die umschließende Membran überbrücken.
Die vorherrschende G-Protein-gekoppelte Rezeptoren (GPCR) erhal-
ten Informationen von Außerhalb durch Bindung eines Liganden, wo-
durch der Rezeptor aktiviert wird. Während der Aktivierung bildet
sich innerzellulär ein offener Spalt, in den ein G-Protein (Gαβγ, G)
mit seinem C-terminalen Ende koppeln kann. Die Bindung an einen
GPCR führt in der Gα-Untereinheit vom Gαβγ zu einen GDP/GTP-
Austausch, welcher für die weitere Signalübertragung ins Zellinnere
notwendig ist. Die Kopplung von Rezeptor und Gαβγ umfasst ei-
ne Reihe von dynamischen strukturellen Änderungen, die Geschwin-
digkeit und Spezifität der Interaktion regeln. Hier haben wir MD-
Simulationen (Molekulardynamik) verwendet, um die molekularen
Details der GPCR Gαβγ Kopplung vor und während der GPCR-
Gαβγ-Komplexbildung bis hin zum GDP/GTP-Austausch zu unter-
suchen.
Der Photorezeptor Rhodopsin ist auf schnelle und präzise Signal-
übertragung abgestimmt. Wir haben untersucht, welche Rolle seine
dritte intrazelluläre Schleife für das Zustandekommen dieser Eigen-
schaften spielt. In MD-Simulationen beobachten wir, dass die drit-
te intrazelluläre Schleife an sich unstrukturiert ist, aber — wie der
Gα C-Terminus — bei Komplexbildung eine strukturierte Konforma-
tion einnimmt. Diese Ergebnisse bestätigen eine FTIR-Studie (Fourier-
Transformation-Infrarotspektroskopie) und ermöglichen die struktu-
relle Interpretation der spektroskopischen Daten. Basierend auf die-
sen Daten schlagen wir ein schrittweises, gegenseitiges Strukturie-
rungsschema vor, welches eine schnelle Signalübertragung durch ei-
ne erhöhte Wahrscheinlichkeit der Komplexbildung erklärt. Die hohe
Signaltreue wird durch die präzise Abfrage einer großen Interaktions-
fläche während der stufenweisen Strukturierung realisiert.
Der β2-Adrenozeptor kann an die G-Protein-Familien Gs und Gi
koppeln. Allerdings gibt es steuernde Agonisten (sogenannte bia-
sed agonists), die den Rezeptor eine Familie bevorzugen lassen. Hier
haben wir MD-Simulationen und Umbrella-Sampling-Berechnungen
durchgeführt, um die strukturellen Unterschiede der Bindung aktiver
β2-Adrenozeptor mit Gs oder Gi zu bestimmen. Bei Verwendung von
aus dem C-Terminus der Gα-Untereinheit abgeleiteten Peptiden fan-
den wir, dass Gi eine aktive Konformation des β2-Adrenozeptors sta-
bilisiert, die ähnlich zu aktivem, mit Gt gebundenem Rhodopsin ist,
einem nahen Verwandten von Gi. Ausgehend vom Vergleich des be-
obachteten Gi-Bindungsmodus mit Kristallstrukturen von einem mit
Gs komplexierten, aktiven β2-Adrenozeptor schlagen wir vor, dass
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die spezifische Auswärtsneigung von Transmembranhelix 6 es dem
Rezeptor ermöglicht, zwischen Gs und Gi zu unterscheiden. Eine
Hypothese ist, dass steuernde Agonisten diese Auswärtsneigungnei-
gung nutzen, um ihre steuernde Fähigkeit zu realisieren.
Signalübertragung von GPCR zu Gαβγ muss die Distanz von
30Å überbrücken, welche den Bindungsspalt im Rezeptor und die
GDP/GTP-Bindungstasche trennt. Die α5-Helix in Gα verbindet die
Bindungstasche mit dem Rezeptor und deren Drehung steht in di-
rektem Zusammenhang mit der GDP-Freisetzung, aber es ist unklar
wie die Drehung hervorgerufen wird. Den GDP/GTP-Austausch ein-
leitend, hat der Zwischenkomplex von GPCR und Gαβγ noch GDP
gebunden. Für Rhodopsin und den β2-Adrenozeptor zeigen unse-
re MD-Simulationen eine Drehung der α5-Helix als Resultat allein
von Interaktionen mit der Kopplungsfläche des Rezeptors. Wir schla-
gen daher vor, dass die Drehung der α5-Helix in der Kopplungs-
/Interaktionsfläche von GPCR und Gαβγ während des Übergangs
vom Zwischenkomplexes zum GDP-freien Rezeptor-Gαβγ-Komplex
geschieht. Dadurch bietet der Zwischenkomplex ein Strukturgerüst,
in welchem sich die α5-Helix drehen kann, während Rezeptor und
Gαβγ fixiert sind, sodass die Rotation maximale Wirkung auf die
GDP-Bindungstasche hat und so die Freisetzung des GDP auszulö-
sen vermag.
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INTRODUCT ION
1.1 biological background
1.1.1 Overview of signal transduction by GPCRs
Living cells must communicate with their environment to receive sen-
sory stimuli and to cooperate with other cells, especially in multicel-
lular organisms. To perform these functions, cells utilize proteins that
are embedded in the cell membrane thus bridging the inside of the
cell (or cellular compartment) with the outside. A widely deployed
class of proteins are G protein-coupled receptors (GPCRs) stretching
with seven transmembrane helices (7-TM) across the lipid bilayer that
surrounds the cell [1, 2, 3]. One side of these receptors sticks out
into the extracellular medium, while the other is in contact with the
cell interior. Given this topology, GPCRs can transmit signals into
the cell by responding to extracellular signals. This is for most sys-
tems a small ligand molecule that approaches the receptor (R) from
the outside and by binding activates the receptor. The so activated
receptor changes at its intracellular side, allowing receptor binding
proteins like G proteins or arrestins to couple to the receptor and re-
lay the signal to effectors, eventually leading to a cellular response
(Figure 1). For example, the β2-adrenoceptor (β2AR), responsible for
smooth muscle relaxation by adrenaline, is activated by diffusible lig-
ands and couples to two different heterotrimeric G proteins (Gαβγ,
families Gi, Gs, Gq, G12/13): Gs and Gi [4]. Rhodopsin from the
visual system on the other hand features a covalently bound ligand
that activates upon light absorption [1].
Signal transduction. Generally, different GPCRs can receive a large
variety of extracellular signals in the form of various ligands and
transduce them into the cell, for example to G proteins. Ligands
can be distinguished by their effect on receptor activation and sub-
sequent signal transduction through G protein coupling. Agonists
have an activating effect, whereas inverse agonists stabilize the in-
active receptor. The agonist-induced active state of GPCRs can cou-
ple to G proteins and catalyze the nucleotide exchange of GDP for
GTP in the α-subunit of the heterotrimeric G protein [12]. After GTP-
binding the Gαβγ holoprotein dissociates from the receptor. Even-
tually, the Gα-subunit and the Gβγ-complex separate and trigger
various signaling pathways by coupling to a downstream intracellu-
lar effector (Figure 1). More specifically, a single receptor type can
activate distinct intracellular downstream signaling proteins, includ-
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Figure 1: GPCR signaling pathways. Signaling starts with a receptor (green,
R) being activated (R*) by a ligand (L). A heterotrimeric G protein (orange,
Gαβγ) may then be activated by GDP to GTP nucleotide exchange upon
binding to R* [5]. Eventually the G protein dissociates and in its GTP bound
state, the α-subunit further transmits the signal, depending on its type [6].
Transducin (Gαt) activates cGMP phosphdiesterase (PDE), resulting in ris-
ing cyclic guanosine monophosphate (cGMP) levels [7]. Membrane bound
adenylate cyclase sub types (AC) can be activated by Gαs and inhibited
by Gαi, resulting in respective changes of cyclic adenosine monophosphate
(cAMP) levels [8]. Arrestin (Arr) generally shuts down the G protein depen-
dent pathway and targets receptors for internalization but can also trigger
its own signaling pathway [9, 10]. The remaining Gq pathway via phospho-
lipase C (PLC) is not shown [11].
ing the heterotrimeric G proteins and arrestins (arrestin 1–4). This
binding promiscuity results in different cellular and physiological re-
sponses [13].
Pharmacological side effects. The central role of GPCR in signal
transduction across the cell membrane makes them a prime target for
pharmaceuticals [14, 15]. GPCRs are one of the main mechanisms
by which cells are regulated in a multicellular organism. Pharmaceu-
tical molecules can act similar to endogenous ligands, with the aim
to positively influence cells exhibiting pathological behavior. A main
challenge in the approach are the multifaceted properties of GPCRs.
The receptors bind to different ligands, whose effects fill the whole
spectrum from complete deactivation to full or even over-activation
of the receptor [16, 17, 18, 19]. Besides ligands, other factors that
influence receptor activation and G protein coupling include recep-
tor dimerization [20], cellular localization [21], sodium ions [22], pH
value [23] or lipid composition [24]. Therefore, influenced by the
environment, the complex relationship between ligand (pharmaceuti-
cal) and cellular effect (i. e. between stimulus and response) is likely
a source for (mostly unintended) side effects of pharmaceuticals.
Coupling promiscuity mechanism. Elucidating the structural de-
tails of receptor G protein coupling may help to entangle some of the
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intricacies governing stimulus and response in GPCR signaling. Espe-
cially the molecular mechanism that underlies the coupling promis-
cuity observed for various receptors is a current focus of receptor
research. The ability of ligands to bias either towards arrestin- or
to G protein-specific signaling has been linked to different conforma-
tions observed for the active receptor (R*) [25, 26]. Specifically, it has
been suggested that there exist different R* conformations that exhibit
distinct G protein and arrestin binding properties. For the human
β2-adrenoceptor some structural details of how different ligands can
bias β2AR toward the arrestin or G protein signaling pathway have
recently been elucidated [27]. Even less is known about the structural
mechanism utilized by receptors to distinguish between different G
proteins for coupling, by which the receptor can selectively activate
distinct downstream effector pathways. For example, β2AR can ac-
tivate both the stimulatory Gs or the inhibitory Gi protein signaling
pathway [4], but the structural details by which the receptor achieves
this are unknown.
1.1.2 Activation of GPCRs
Before G protein or arrestin can bind to a GPCR, the receptor needs
to be activated, a process involving major structural changes. A hall-
mark of receptor activation is the outward tilt of transmembrane helix
6 (TM6). First identified by pioneering EPR work on the retinal pho-
toreceptor rhodopsin [28, 29], the TM6 movement has been confirmed
by an array of R* structures, obtained by X-ray crystallography for
rhodopsin [30, 31], the β2-adrenoceptor [32] and the muscarinic M2
receptor [33]. These R* structures have undergone significant struc-
tural changes compared to the inactive R structures and bind ago-
nistic ligands, G protein, fragments of the Gα-subunit or nanobodies
(see ref [34]). In addition to the TM6 movement, changes to TM5, com-
prising helix elongation and rigid body movements, are observed in
the crystal structures of R* in complex with Gα or parts thereof [31,
32]. Together, these major structural rearrangements result in the for-
mation of a open intracellular binding crevice. The helix movements
involve a number of microswitches of highly conserved residues and
motifs [1]. One of them is the arginine from the conserved E(D)R3.50Y
motif1, which is buried in the inactive receptor state but gets exposed
in the active state where it forms the floor of the created binding
crevice (Figure 2). Stabilization of the inactive receptor is facilitated
by the hydrogen bond network of deprotonated E3.49, R3.50 and E6.30
tethering TM3 and TM6 together [36, 37, 38]. Upon receptor activa-
1 R135 in rhodopsin or generally R3.50, utilizing the Ballesteros-Weinstein scheme
where the most conserved residue in each TM among GPCRs is designated x.50,
where x is the TM number and .50 is used for reference. Other residues on the same
TM are numbered relative to the x.50 residue [35].
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Figure 2: GPCR activation requires major structural changes and a series
of microswitches involving conserved residues. (A) Comparison of inactive
rhodopsin (blue) and active rhodopsin (red). Upon activation, TM6 tilts
outwards and the hydrogen bond network involving E134, R135 and E247
is broken, resulting in an open intracellular crevice at the receptor surface.
Side-view showing the major structural changes in the helical bundle of
rhodopsin (B) and β2-adrenoceptor (C) crystal structures upon activation.
Note the large outward tilt of TM6 by a rigid body movement of the helix
(yellow arrow), distinguishing the inactive and active receptor states. The
crystal structures shown are RhR [39] (blue), RhR* [30](red), β2AR [40] (dark
green) and β2AR* [32] (light green).
tion, proton uptake by E3.49 disrupts this network allowing the new
R3.50 conformation.
Rhodopsin, while an archetype of class A GPCRs, is also a spe-
cial case as it features a covalently bound light-sensitive ligand reti-
nal, attached via a Schiff base linkage. Retinal tightly controls the
transition/switch from inactive (RhR) to active (RhR*) rhodopsin. In
contrast to the diffusible ligands employed by other GPCRs, retinal
serves a dual role. In its 11-cis form it acts as a strong inverse agonist
but the absorption of a photon induces the isomerization of retinal
into its all-trans form, which is a potent agonist for rhodopsin. This
isomerization puts structural stress on the retinal binding pocket to
which the receptor reacts by relaxing into (photo)intermediate states
(batho-, lumirhodopsin), which eventually lead to receptor activa-
tion [41, 42]. By light activation, the receptor leaves its inactive dark
state and enters an equilibrium of so-called metarhodopsin states (MI,
MIIa, MIIb, MIIbH+, Scheme 1), of which the last (MIIbH+) can cou-
ple productively to G. Formation of the active MIIbH+ state is ac-
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companied by the protonation of D134 (D3.49) [36]. Already during
the transition to MIIb, the hydrogen bond network between R135 and
D247 is disturbed, severing the ties between TM3 (R135) and TM6
(D247), a prerequisite for TM6 outward movement [43]. Once acti-
vated, rhodopsin can in turn activate up to 103 G proteins per second
and more under optimal conditions [44]. Eventually, the Schiff base
linking retinal to rhodopsin is hydrolyzed and all-trans retinal leaves
through a hydrophobic channel [45, 46]. This newly formed apopro-
tein opsin exists in an equilibrium of active (Ops*) and inactive (Ops)
states.
RhR
⇝
v
Ñ bathoÑ lumiÑMIéMIIaéMIIbéMIIbH+
Scheme 1: Rhodopsin activation scheme. After RhR absorbs light (⇝ v), the
photointermediates batho- and lumirhodopsin (batho, lumi) are transiently
traversed to culminate in the coupled equilibria of metarhodopsin states (MI,
MIIa, MIIb, MIIbH+)
In contrast to rhodopsin, most other GPCRs like the β2-adrenocep-
tor show considerable constitutive activity [47] and the process that
leads to receptor activation is not known in the detail to which the
metarhodopsin states have been elucidated. However, experimental
data suggests that non-rhodopsin GPCRs have structural equivalents
to the metarhodopsin and opsin states [1, 48, 49]. Thus, after the
photoactivation of rhodopsin is completed, retinal acts similar to the
more common diffusible ligands that bind to other GPCRs for exam-
ple to the β2-adrenoceptor. The crucial protonation event of D3.49,
known from rhodopsin, has also been shown for the β2-adrenocep-
tor [50] as well as for the α1B-adrenergic receptor [51]. This proto-
nated species constitutes the active receptor: MIIbH+ in the context
of metarhodopsin states but generally referred to as R* or specifically
as RhR* and β2AR* for active rhodopsin and β2-adrenoceptor, re-
spectively.
It is important to note that the active receptor R* at the end of the
activation process by no means exhibits a globally fixed or rigid struc-
ture, as being an endpoint may suggest or as one might be inclined
to deduce from the respective crystal structures. For example, loop
motions generally can happen within nanoseconds and larger collec-
tive motions can already occur on the microsecond timescale [52].
So, while the rigid body movement of TM6 is a major distinguishing
feature of the inactive and active receptor states, it does not imply
that TM6 (or specifically its intracellular extension) remains at a sin-
gle position in the active state. There are additional changes at the
conserved NP7.50xxY motif and TM5 observed during the activation
process that are crucial for the conformational change of TM6 [1, 53,
54]. Thus the TM6 outward tilt is not the sole determinant for acti-
vation nor does TM6 exhibit a purely switch-like behavior. But TM6
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seems to exist in a spectrum of outward tilts even after activation.
X-ray crystallography and spectroscopic studies suggest that an intra-
cellular binding partner is required to restrict the TM6 ensemble to a
single conformation [31, 32, 33, 27, 55, 56].
1.1.3 Coupling interface between GPCR and G protein
Upon receptor activation, an open intracellular crevice is formed
when TM6 tilts outward. This crevice is lined by the intracellular
ends of the TM helices comprising the 7-TM bundle, their connect-
ing intracellular loops (ICL1–3) and helix 8, which lies with its axis
parallel on the lipid bilayer. The floor of the crevice is formed by
the highly conserved R3.50 from the E(D)R3.50Y motif. Crystal struc-
tures of active rhodopsin in complex with a peptide derived from
the C-terminus of the G protein α-subunit (RhR*•GαtCT) and of
agonist-bound β2-adrenoceptor in complex with the Gαsβγ holopro-
tein (β2AR*•Gαsβγ) reveal atomic details of the coupling interface
between receptor and G protein [31, 32] (Figure 3). On the recep-
tor side, the ICL3 loop connection TM5 with TM6 and the conserved
R3.50 are major determinants of G protein binding to the receptor. Ad-
ditionally, contacts to the ICL2 and the NP7.50xxY(x)5,6F region are
observed in the RhR*•GαtCT and β2AR*•Gαsβγ crystal structures.
A major role in coupling of receptor and G protein is played by the
third intracellular loop (ICL3), which is located adjacent to the con-
served E(D)R3.50Y motif and connects TM5 with TM6 [57, 58, 31, 32].
For most GPCRs, crystallographic studies indicate, that ICL3 is likely
a long, unstructured protein segment: High temperature factors (or
B factors) or a lack of electron density for atoms within ICL3 indi-
cate a high flexibility of ICL3 and the in the intracellular ends TM5
and TM6. Moreover, many GPCRs could so far not be crystallized
and resolved with their native ICL3 intact. To circumvent ICL3 flex-
ibility, truncation of ICL3 or substitution by fusion proteins (like the
T4-lysozyme) to minimize flexibility and to enhance crystallographic
contacts have proven successful [59]. This picture changes for crystal
structures that depict an active GPCR in complex with an intracellu-
lar binding partner like G proteins, mimicking proteins or fragments.
There, no fusion proteins are attached to ICL3 as they would likely
interfere with G protein binding. As a result, the intracellular ends
of TM5 and TM6 exhibit helical extensions, leaving only outer ICL3
segment unresolved, for example in the β2-adrenoceptor [60, 32] or
in the M2 muscarinic receptor [33]. Such an ordering is supported by
spectroscopic studies [27, 55, 56]. In the rhodopsin case ICL3 is com-
paratively short and stabilized by contacts in the crystal lattice, which
leads to very similar structures of RhR* and RhR*•GαtCT, both ex-
hibiting a well-ordered ICL3 [39, 30].
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Figure 3: GPCR coupling interface between R* and GαCT as seen in the
crystal structures of β2AR*•Gs (green) and RhR*•GαtCT (red) complexes.
(A) The Y391 at the tip of GαsCT forms a cation-π interaction with R1313.50
of β2AR*. (B) In RhR*•GαtCT, a hydrogen bond between the carbonyl
oxygen of V347 at the tip of GαtCT and R1353.50 is formed. Note how
TM5/6 form a large contact area between R* and GαCT in both complexes,
the hydrophobic patch. (C) Overview of the complexes showing the location
(gray box) of the coupling interfaces which are magnified in (A) and (B).
The findings of crystallographic and spectroscopic studies on ICL3
and the adjacent TM6 make ICL3 a strong candidate for an intrinsi-
cally disordered protein region. Such regions are characterized by a
lack of intrinsic order but upon binding to an interaction partner they
may transition to an ordered state. The ICL3 shows this characteris-
tic and is thus likely to represent an intrinsically disordered region
within GPCRs [61, 62]. Such regions have been shown to be of high
functional relevance for the binding and regulation of protein-protein
interactions in many different biological systems [63]. However, for
the coupling of receptor and G protein it remains to be elucidated
to what extent the ICL3 flexibility and eventual ordering is exploited.
The intrinsically disordered characteristic of ICL3 may play a role in
binding as well as in signal transduction (i. e. G protein activation).
Gα C-terminus
The C-terminus of the G protein α-subunit (GαCT) has repeatedly
been shown to be a main interaction site with the GPCR govern-
ing coupling fidelity and specificity [70, 71, 72, 73, 74]. Determina-
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Figure 4: GαCT structure. (A) Crystal structures of a GDP-bound Gαi/tβγ
chimera (orange) [64] or of GTPγS bound Gs (olive) [65] leave the GαCT
unresolved (gray box). But in the β2AR*•Gs complex (green) [32] GαsCT
is well-ordered. Moreover, the α5-helix, which ends in the GαCT, is rotated
and translated along its axis (black arrows) as indicated by the movement
of D337/381 (Note that to adequately compare the α5-helices the Gα Ras
domains where superposed on their β-sheets). Upon binding to R* GαCT is
structured forming a continuous α-helix capped by a reverse turn motif as
shown in numerous structures: (B) high affinity GαtCT from RhR*•GαtCT
crystal structure (red) [31, 66, 67], (C) GαtCT NMR structure while bound
to RhR* (blue) [68], (D) GαsCT from the β2AR*•GαsCT crystal structure
(green) [32], (E) another GαtCT NMR structure while bound to RhR* (light
blue) [69].
tion of the crystal structures of the RhR*•GαtCT [31] and β2AR*•
Gαsβγ [32] complex then showed the coupling interface between re-
ceptor and GPCR in atomic detail. A key feature was thereby the spe-
cific interaction between the tip of GαCT and the conserved arginine
R3.50. Another articulate feature of the complexes is the hydrophobic
patch between GαCT and ICL3, providing another hint at the impor-
tance of ICL3 (Figure 3). Additional contacts are observed from ICL2
to the αN-β1 and β2-β3 loops, both from the Gα Ras domain [32].
Thus GαCT interacts directly with the receptor binding crevice in a
well-ordered conformation. But in its unbound state GαCT is un-
structured. Only upon binding to a receptor, a continuous α-helix
forms, which is capped by a reverse turn motif, and numerous NMR
and X-ray structures of different Gα C-termini revealed a remark-
able preservation of that capping motif (Figure 4) [68, 69, 31, 66, 67,
32]. Also, as shown for the rhodopsin system, peptides of this motif
can stabilize the active receptor conformation, serving as a surrogate
of complete G proteins [31, 66]. Comparing the C-termini of Gαs
and Gαt shows that they share the same structure despite a different
amino acid sequence, for example a tyrosine at the tip of Gαs instead
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of a glycine. Moreover, for another GPCR binding partner, arrestin,
the so-called “finger loop” is considered to directly interact with the
receptor binding crevice. A recent crystallographic study shows a
peptide derived from the arrestin “finger loop” (ArrFL) bound to the
same intracellular receptor crevice employed by GαCT. They further
suggest a fundamental connection between the sequences of GαCT
and ArrFl segments: a common binding motif characterized by simi-
lar residues at key positions [75].
So far only crystal structures of RhR*•GαtCT and β2AR*•Gαsβγ
have been determined, raising as many questions as they answered.
The β2AR*•Gs complex structure provides a view at the nucleotide-
free state of the GPCR G protein complex after GDP release and be-
fore GTP uptake and complex dissociation, two processes that still
require structural elucidation. While β2AR* is known to couple to
Gs and Gi, no complex depicting the Gi binding mode is available.
But there is the structure of active rhodopsin in complex with a Gt
C-terminal peptide, which is a close homologue of Gi. Comparison
of these complex structures shows that the Gα C-termini bind to the
same binding crevice of the respective receptor. However, the TM6
tilt in the RhR*•GαtCT and β2AR*•Gαsβγ structures differ consid-
erably. It is not clear what the source of this differences is exactly as
the structures show two different receptors with two different G pro-
teins (or fragments thereof) obtained under unique crystallographic
conditions. The distinct TM6 tilts may originate from the use of pep-
tide versus holoprotein but they may also characterize two receptor
conformations utilized to distinguish between Gs and Gαi/t which
β2AR* must accommodate both.
1.1.4 Mechanistic aspects of signal transduction
For signal transduction of GPCRs to G proteins, a signaling complex
consisting of the receptor and the heterotrimeric G protein needs to be
formed. The dynamic assembly and activation of such GPCR signal-
ing complexes requires a complex series of conformational changes in
both receptor and G protein [76, 77] (Figure 5). Generally, signal trans-
duction from receptor to G protein is performed by the receptor trig-
gering nucleotide exchange, GDP for GTP, in the G protein. Thereby
GDP is released and GTP taken up. Thus activated, the G protein
sends the signal further down the signaling cascade (Figure 1).
Upon formation of the nucleotide-free R*•G complex, a number of
changes are known to occur within the G protein. First, this “Empty
Pocket” state was found to have a conformationally dynamic Gα sub-
unit [79]. Using site-directed spin labeling (SDSL) and electron para-
magnetic resonance (EPR), the C-terminal α5-helix of Gα was found
to undergo a rigid body movement in form of a rotation and a trans-
lation with respect to its helix axis (Figure 4A) [80]. A similar rigid
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Figure 5: Sequence of complex conformations/states during GPCR G pro-
tein signaling, including intermediary states [76, 78]. An inactive receptor
(R) is activated by an agonistic ligand, yielding an active receptor (R*), that
presents a flexible binding crevice to a GDP-bound G protein (Gαβγ[GDP])
featuring an unstructured α5 C-terminus (α5). Upon formation of the R*•
Gαβγ[GDP] intermediate and the following transition to the nucleotide-free
R*•Gαβγ[empty] complex, the coupling interface becomes structured and
α5 is displaced (see running text for details). During formation of R*•
Gαβγ[empty], GDP is released and replaced by GTP, resulting in a disso-
ciated Gαβγ[GTP] separated from R*.
body movement and, additionally, a mechanistic role of the GPCR
coupling interface were suggested by a molecular docking and mod-
eling study combining the Ops*•GαtCT [31] and Gαi/tβγ [64] crystal
structures [78]. By applying SDSL and EPR, a large movement of the
all-helical domain was observed opening an interdomain interface in
the Gα subunit upon interaction with R* [81]. Similar movements are
suggested by low resolution electron microscopy (EM) structures [82].
These earlier observations were confirmed by the X-ray structure of
β2AR* in complex with a nucleotide-free Gαsβγ [32] and accompa-
nying hydrogen-deuterium exchange (HDX) measurements [83]. An
increase in hydrogen deuterium exchange for nucleotide-free Gt in
complex with RhR* has been suggested to allow GTP uptake and
mediation of complex dissociation [84].
Molecular dynamics studies and in silico energetic analysis were
used to shed light on the receptor G protein interaction for systems
where other structural information is rare. The crystal structure of the
β2AR*•Gαsβγ complex provides a starting position for MD simula-
tions of the coupling interface between receptor and G protein. Using
homology modeling to create an initial model, coupling of Gi to the
cannabinoid CB1 [85] and CB2 [86] receptor was investigated with
MD simulations. The work with CB1 used mutagenesis experiments
and MD simulations to identify a number of residues in α5 contact-
ing intra-cellular loop (ICL) 2 and 3, that reduce coupling when mu-
tated to alanine. The latter study with CB2 observes a reorientation
of Gαiβγ, more precisely a tilting of the α5-helix and an outward
movement of trans-membrane helix (TM) 5, both of which are com-
patible with the cross-link sites found in the same work. In silico
energetic analysis of a β2RhR*•Gαiβγ complex based on the β2AR*•
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Gαsβγ crystal structure finds energetic (and quantitatively describes)
changes upon α5 R* interaction [87].
α5-helix
The role of the α5-helix in G protein activation is only partially
understood despite the determination of important conformational
states, in particular the solvated GDP-bound and the nucleotide-free
receptor-bound state. Extensive mutational studies on residues in
the α5-helix have underlined the role of the α5-helix in allosterically
connecting receptor and nucleotide. The T329A mutation in α5 of
Gαi allosterically changes the switch I region, moving away from the
nucleotide presumably destabilizing it [88]. Perturbation of the hy-
drophobic patch created by the conserved phenylalanine F336 in the
α5-helix (e. g. F336Y mutant), suggests F336 acts as a relay between
the α5-helix and the GDP binding region of heterotrimeric Gi protein
α-subunit [89]. Also in Gαi, a K345L mutation within α5 reduces
nucleotide exchange rates, hinting at a transient interaction between
the adjacent P-loop and the switch I region that contributes to the al-
losteric network between receptor and nucleotide binding pocket [90].
The importance of α5 in GDP release is undisputed, and rotation of
α5 has been identified as a crucial structural change. Understanding
the role of the active receptor in inducing the structural changes of
α5 is complicated by the lack of structural data on intermediate R*
G interactions. The existence of R*•G[GDP] intermediate was exper-
imentally shown by a study on the kinetics of Gt activation by RhR*
in disc membranes [44, 78]. Generally, the R*•G[GDP] intermediate’s
defining feature is that GDP is still bound in the nucleotide binding
site of the Gα subunit after complex formation with the active recep-
tor. Recently, HDX experiments with the β2AR* Gs system suggest
that GDP-bound Gαs couples to β2AR* mainly through GαsCT but
weaker than in the nucleotide-free complex [83]. The intermediary
R*•G[GDP] is the first stable/specific complex of receptor and G pro-
tein in the sequence of events during receptor triggered G protein
activation (Figure 5). A possible mechanistic role for the intermedi-
ary R*•G[GDP] is that α5-helix rotation starts with the intermediary
R*•G[GDP] complex but not before, thus separating initial R* and
G complex formation and nucleotide release [78]. The dynamic and
structural details of such a transition are, however, not known.
1.1.5 Peptides as G protein surrogates
Cellular processes often rely on small peptides, including in gene
regulation [91], immune response [92], cell signaling or signal trans-
duction [93, 94]. Following their endogenous models, synthetic pep-
tides, their derivatives and peptide mimetics are used for example
as antibiotics [95]. However, they have also been found a useful tool
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for studying protein-protein interactions by modulating or inhibiting
them [96, 97, 98]. Especially research on signal transduction through
GPCRs has profited from the use of synthetic peptides. The signal
transmission from activated receptors to their signaling proteins has
been studied by synthetic peptides derived from GPCRs [99], G pro-
teins (Gαβγ, G) [100, 74, 68, 69, 101, 31] and arrestin [102, 75]. These
peptides were first derived from regions all over the holoprotein to
identify regions crucial for complex formation. In case of rhodopsin,
GαtCT stabilizes the same active MIIbH+ receptor conformation as
Gt [100]. Intrinsically unstructured regions were identified as crucial,
because they change their conformation upon complex formation (i. e.
become structured) [103]. The so identified peptides therefore mimic
the binding of an interaction partner and are as such used to investi-
gate dynamic and mechanistic aspects of signal transmission that rely
on complex formation.
In the context of molecular dynamics simulations, utilizing pep-
tides opens up new opportunities when they are used to replace a
(large) holoprotein. Biologically relevant processes involving confor-
mational changes of the protein structure mostly occur on timescales
ranging from microseconds to minutes, that only begin to become
accessible to molecular dynamics simulations. By using a peptide,
any constraints depending on the larger holoprotein from which the
peptide is derived become obsolete. In a complex of an active re-
ceptor and a GαCT peptide this lowers the number of interactions
in the complex and thus also the interaction energy allowing easier
transitions between different states of the complex. Additionally, a
derived peptide is automatically much smaller, resulting in a simu-
lation system with less atoms. So, using peptides as surrogates in
MD simulations potentially requires smaller timescales due to lower
transition barriers and allows longer simulations as less atoms need
to be simulated.
1.2 md simulations
While static structures are determined for more and more proteins, in
the end, conformational dynamics determine the protein’s functions.
MD simulations provide dynamic information at angstrom and pi-
cosecond resolution at the same time, which is outside the scope of
any experimental method. Just now, with continuing advances in
computational and experimental methods, it becomes possible to di-
rectly compare computational results to experiments [52, 104]. For
example, a combination of temperature jump and fluorescence ex-
periments can detect conversion rates and the existence of intermedi-
ate states of fast folding proteins in the microsecond timescale [105].
These observations can then be compared with data from MD sim-
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ulations of fast-folding proteins, simulated for several hundred mi-
croseconds [106].
Since the first biologically relevant simulations of the bovine pan-
creatic trypsin inhibitor (PTI) [107], the field has made remarkable
progress. It is now possible to simulate large biomolecules in explicit
solvents and lipids, e. g. membrane proteins [108], do computational
electrophysiology [109] or perform folding simulations for millisec-
onds [110].
1.2.1 Augmenting static structures
Protein structure determination methods like X-ray crystallography
can only provide static snapshots of well-ordered proteins (or parts
thereof). The resulting protein structures are often preceded and
then augmented by spectroscopic methods like nuclear magnetic
resonance (NMR) labeling, EPR or Fourier transform infrared spec-
troscopy (FTIR), to which intermediate or even transient states are eas-
ier accessible than to crystallography. Moreover, these methods can
obtain more data on the dynamics of unstructured regions, for exam-
ple provide inter-label distance measurement with double electron-
electron resonance (DEER) or contact probes using florescent label-
ing techniques. But they mostly lack atomic resolution or provide
no detailed structural information. To overcome these limitations, ex-
perimentally obtained information is often refined or extended using
MD simulations [111]. Partial or fragmented structural data can be
assembled into a coherent structural model by applying force-fields
and energy minimization techniques [112] that in turn draw from
structurally relevant data like inter-label distances [29]. Starting MD
simulations based on crystal structures of well-defined states, yields
dynamic structural data that can help to interpret experimental data
that has lower time- and/or spatial resolution.
1.2.2 Simulating GPCRs
For GPCRs, solved structures are available for inactive and active re-
ceptor states of various GPCR types and classes [34]. However, inter-
mediate and transition states connecting the inactive and active struc-
tures are lacking, hence several approaches employing state of the
art MD techniques were used to elucidate the activation mechanism
of GPCRs. Adiabatic biased MD (ABMD) simulations suggested pu-
tative active states of RhR, including a stabilizing role of K231 [113]
and explored the effect of ligand on conformational receptor stabil-
ity [114]. Specialized computer hardware allowed observing the de-
activation pathway of β2AR, thus probing the G protein-coupled re-
ceptor (GPCR) activation mechanism [54]. Using accelerated MD sim-
ulations, the activation of muscarinic acetylcholine receptor M2 could
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be directly observed [115], predicting some features of the later crys-
tallographically determined M2 structure [33]. Markov state model
analysis of two milliseconds of β2AR dynamics yielded multiple acti-
vation pathways which are differentially used by agonists and inverse
agonists [116]. Simulations employing a structure-based force-field
investigated and compared the activation and deactivation process in
β2AR and RhR [117].
The coupling interface between receptor and G protein in itself has,
however, not received the focused attention maintained for the recep-
tor activation process.
1.3 study aims
The coupling interface between GPCR and G protein or arrestin
is comprised of the interactions created during complex formation.
Complex formation requires structural changes in both binding part-
ners, the receptor and the signaling protein. On the receptor side
this includes the outward movement and structuring of TM6 to-
gether with structural changes to the highly conserved E(D)R3.50Y
and NP7.50xxY motifs, that result in the formation of the open intra-
cellular crevice to which G protein or arrestin can bind [1, 2, 3]. The G
proteins contain intrinsically unstructured regions that become struc-
tured when interacting with receptor binding crevice. Experimental
data shows that the coupling interface is highly dynamic on both
sides, until complex formation results in the adoption of specific con-
formations. On the receptor side, TM6 and ICL3 are the involved
structural elements [61, 62]. In the G protein, the C-terminus of the
α-subunit becomes structured [68, 31, 32].
Here we investigate the mutual, dynamic relationship between the
structured and unstructured elements of the receptor binding crevice
and the intrinsically unstructured regions of the signaling proteins.
This relationship has functional implications for complex formation,
coupling specificity and signal transduction. First, we make the case
that the ICL3 in rhodopsin is more dynamic than apparent from crys-
tal structures. We complement spectroscopic experimental data with
MD simulations to elucidate the role of the G protein in stabilizing
ICL3. Next, we investigate the dynamic TM6 behavior in active β2AR
and its role for G protein coupling specificity. Finally, we turn to the
G α5-helix and its mechanistic role in signal transduction from recep-
tor to G protein.
To obtain data on the protein dynamics, we perform molecular dy-
namics simulations to augment the experimentally determined but
static picture of well-ordered protein structures. MD simulations
have been successfully applied to membrane proteins and especially
to GPCRs (Section 1.2.2) to gain insights into their dynamics. Our sim-
ulations run in the order of 200ns. In this time-scale, it is expected to
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observe structural changes like hinge-bending and loop motions that
arise from the removal of stabilizing interactions [118].
1.3.1 Role of ICL3 in complex formation
Structures of rhodopsin obtained by X-ray crystallography, show the
ICL3 loop of rhodopsin and its apoprotein opsin resolved. There,
ICL3 exhibits an ordered conformation in both inactive and active
receptor states and regardless of whether a GαtCT peptide is bound
or not [39, 30, 31].
Employing MD simulations, we find that the ICL3 becomes un-
structured in active and inactive Opsin, only adopting a structured
conformation upon binding of GαtCT. These findings corroborate a
FTIR study and allow structural interpretation of the spectroscopic
data.
It will be proposed and discussed that a mutual structuring of the
rhodopsin receptor (ICL3) and transducin G protein can provide a
fast and precise signal transfer from rhodopsin to transducin. That
the coupling mechanism needs these attributes is implied by the
perfect switching where rhodopsin activity increases by more than
one billion fold from essentially zero activity after activation by light
through photon capturing.
1.3.2 Role of TM6 in coupling specificity
A number of GPCRs can activate multiple distinct G proteins [13].
The β2-adrenoceptor is one of them, coupling to both Gs and Gi [4].
Ligands are known, which can bias the receptors coupling to the G
protein and/or the subsequent activation of the G protein [27, 25, 26].
However, the (structural) mechanism by which the active β2AR* can
distinguish between Gs or Gi is unknown.
We employ MD simulations of active β2AR* with and without Gs
or Gi derived binding partners to investigate the dynamics of TM6 —
one of the key structural elements of the receptor’s G protein bind-
ing crevice. In MD simulations, we find that GαiCT19 can stabilize
the TM6 of β2AR* in a RhR*-like conformation. With umbrella sam-
pling calculation, we obtain information about the energy barrier that
retards formation of the RhR*-like conformation of β2AR*.
Comparison with MD simulations of RhR* and RhR*•GαCT sug-
gests a structural mechanism by which GPCRs can distinguish be-
tween Gs and Gαi/t. The extent of TM6 outward tilt changes the
size of the receptor binding crevice. Depending on the TM6 outward
tilt, the binding crevice is not accessible by bulkier Gs C-terminus
but the slimmer Gαi/t C-terminus can still bind. Conceivably, this
mechanism could be used by ligands that selectively stabilize one of
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the TM6 conformations and thus bias the signal towards Gs or Gi in
β2AR*.
1.3.3 Role of α5 in signal transduction
The intermediary R*•G[GDP] complex is the first complex of receptor
and G protein during receptor triggered G protein activation [44, 78,
83]. The C-terminus of the α5-helix in the Gα subunit has been iden-
tified as the main interaction site with R* [70, 71, 72, 73, 74]. During
nucleotide exchange in R*•G signaling complexes, the α5-helix of the
Gα subunit is displaced by rotation and translation [80, 78, 32]. Here
we investigate the role of α5 during transition from the intermediary
R*•G[GDP] to the nucleotide-free R*•G[empty] complex.
After modeling the interaction of GαCTwith R* in the intermediary
R*•G[GDP] complex, we perform MD simulations to test if the α5-
helix alone can rotate at the receptor G protein coupling interface.
We apply this protocol, using the C-terminus of α5 in lieu of the
complete G protein, to two GPCRs and their endogenous G protein:
rhodopsin with its G protein transducin and β2-adrenoceptor with
Gs.
The MD simulations of GαCT show switching of the α5-helix as a
result of interactions at the R* interface alone. We propose that the α5-
helix rotates at the coupling interface of the holocomplex during the
transition from the intermediary R*•G[GDP] to the nucleotide-free
R*•G[empty] complex. The intermediate R*•G[GDP] complex pro-
vides a structural scaffold in which the α5-helix can rotate while the
receptor and the G protein stay fixed so that the rotation maximally
effect the GDP binding pocket, triggering GDP release.
2
METHODS
2.1 molecular dynamics simulations
At a basic level, the dynamics of proteins arise from atoms that
change their position over time through interactions with other atoms.
Thus, molecular dynamics (MD) simulations obtain the movement of
N interacting atoms at position r over time t by solving Newton’s
equations of motion simultaneously for each atom ri (Equation 1).
mi
B2ri
Bt2
= Fi
Equation 1: Newton’s equation of motion over time t for an atom at position
ri with mass mi and force Fi.
The force acting on each atom ri is derived from a potential en-
ergy function U that includes all interactions in which the atom at
position ri takes part in, as well as constraints defined for the atom
(Equation 2).
Fi = ´
BU
Bri
Equation 2: Force Fi acting on atom ri derived from the potential energy U.
The movement of the atoms can be followed over time using this
framework. Additional effort is needed to ensure that temperature
and pressure of the system stay constant or in relevant ranges as
required (e. g. by coupling the system to temperature and pressure
baths). Since the system is finite, the boundaries of it require special
treatment (e. g. by employing periodic boundary conditions) to en-
sure meaningful results. However, when everything is taken care of,
the end result of a MD simulation is a trajectory of atomic positions
with very high spatial and temporal resolution.
Biological systems
Biologically relevant systems consisting of, for example, proteins and
solvent molecules, easily contain in the order of 104 to 106 atoms.
Many biological processes, like signal transduction or protein-protein
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binding, occur on timescales ranging from nanoseconds to millisec-
onds. In order to observe these processes, the system need to be
simulated for that long, or longer to get statistically robust data [118].
Generally, simulation times are sought that can be compared to ex-
perimental data [52, 104]. Another area where MD simulations have
proven useful, often on shorter timescales, is structural modeling and
evaluation of general dynamic capabilities of a system [119, 120].
In general, there is a strong tendency that the longer the timescale
or the larger the biological systems, the more interesting the simula-
tion results potentially are. The basic equations that drive MD simula-
tions are — not without coincidence — neither complicated nor com-
putationally expensive as such. However, the challenge lies in scaling
the computations to work on actual hardware for long timescales and
large systems. For that, efficient distributable algorithms and fast im-
plementations for specific processors are required, which immensely
complicates performing actual MD simulations. Most simulations
run on commodity hardware, but to be able to tackle more computa-
tionally demanding problems, there have been efforts to create spe-
cialized hardware solely for running MD simulations [121, 122]. The
most recent of such projects is the Anton machine that also optimizes
the distributed hardware architecture for the algorithms needed to
perform the simulations [123, 124, 106, 54, 125].
In the following section we will give an overview on how program
packages like GROMACS work to perform MD simulations. There
are many parameters to be set before a simulation can be started and
a basic understanding of the inner workings of a simulation pack-
age helps to avoid errors when using it to perform simulations and
interpreting the resulting trajectories.
2.1.1 Simulation algorithm
Every simulation has to start from somewhere (i. e. an initial setup),
so an essential part of setting up a simulation is obtaining rele-
vant starting positions for the biological question at hand. Usually,
these are positions of the various molecules the simulation system
is comprised of, which are biological macromolecules like proteins
or DNA/RNA, solvent molecules (often water), ions, lipids and lig-
and molecules. For these particles, the topology of each molecule
is needed in the form of geometric constraints that define what
molecule they are. These constraints consist of bonds length, bond
angles and dihedral angles. Additionally, the elemental composition
of the molecules is required as well as charge, vdW radius and neu-
tral interaction parameters for each atom. Such parameters are usu-
ally supplied by so called force fields that in turn derive them from
(and fit them to) experimental data. Together, the starting position
and the system topology provide the initial conditions, i. e. the input
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for the simulation algorithm (Scheme 2). If necessary, initial velocities
can also be input, otherwise they are generated, for example, from a
Boltzmann distribution at a specific temperature.
• Initial conditions input
• Simulation loop
– Force calculation
– Position & velocity update
– Constraints inclusion
– Data (positions) output
• Resulting trajectory analysis
Scheme 2: Generic MD simulation algorithm
Given the initial conditions, the system is simulated following
Newton’s equations of motion in the simulation loop while at the
same time considering constraints derived from the system topology
(Scheme 2). The simulation loop generally consists of three steps:
force calculation, position & velocity update and constraint inclusion.
Importantly, the atom positions and other data are written out during
the simulation loop, too.
The first step, the force calculation, derives the force fi acting
on each atom ri from a potential energy function U (Equation 2).
Non-bonded interactions consist of interactions between neutral and
charged pairs of atoms. These interactions are modeled with the
Lenard-Jones (Equation 4) and the Coulomb (Equation 5) potential
respectively. Intra-molecular, bonded interactions are represented
by bond-stretching, angle-bending and dihedral-torsion potentials be-
tween pairs, triples and quadruples of atom positions r, respectively
(Equation 6). For the second step, based on the forces acting on each
atom, the updated positions and velocities can be directly calculated,
for example, by using the velocity Verlet algorithm (See Equation 3
and Listing 1). During this step, temperature coupling (to a virtual
temperature bath) can be achieved by globally rescaling the velocities
of each atom so that the total kinetic energy corresponds to a target
temperature.
The inclusion of distance constraints is the third step and used
to ensure that the simulated molecules retain their initial topology.
MD simulations are only an approximation and for performance rea-
sons it is desirable to increase the simulation time-step as much as
possible (to cover more simulated time per unit of computing time).
However, bonds, for example, have very high vibrational frequencies
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pi(t+
1
2
Bt) = pi(t) +
1
2
Btfi(t)
ri(t+ Bt) = ri(t) + Btpi(t+
1
2
Bt)/mi
pi(t+ Bt) = pi(t+
1
2
Bt) +
1
2
Btfi(t+ Bt)
Equation 3: Velocity Verlet algorithm at time t, with the momentum p = mv
as the product of mass m and velocity v, the atoms position ri, force fi
and time step Bt. See Listing 1 for a pseudo code implementation of the
algorithm.
loop{
p = p + 0.5 * dt * f
r = r + dt * p / m
f = force(r)
p = p + 0.5 * dt * f
}
Listing 1: Velocity Verlet pseudo code. The momentum p = mv as the
product of mass m and velocity v, the atoms position r, force f, time step
dt and a function force(r) to caclulate the force acting on r.
and would require very small time-steps to faithfully represent their
dynamics. Therefore, algorithms like LINCS [126] and SETTLE [127]
have been developed which can guarantee that constraints on bond
length in particular and atom to atom distances in general are ful-
filled at the end of a simulation time-step. Also performed at this
step is pressure coupling (to a virtual pressure bath), often by scaling
the simulation box and the atom positions so that the system con-
forms to a target pressure. Pressure and temperature coupling are
needed to simulate an NPT ensemble where the number of atoms
(N), the pressure (P) and temperature (T) are constant. Finally, the
atoms position are written out to create the trajectories that are later
used for analysis.
2.1.2 Force contributions and constraints
MD simulations must consider a number of non-bonded and bonded
(intra-molecular) interactions to sufficiently approximate the dynamic
behavior of the simulated atoms over time. However, apart from
describing the forces that act on an atom, being able to compute them
fast and efficiently is a prime objective when choosing the equation
and models to calculate them.
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Figure 6: The Lennard-Jones potential (left) is plotted for a carbon-carbon
interaction with parameters from the amber99sb-ildn force-field [129]. The
Coulomb interaction (right) shows the potential for particles with equal ele-
mentary charges (blue) and with the inverse sign (red).
Non-bonded interactions
The Lennard-Jones potential describes the neutral (uncharged) inter-
action between a pair of atoms as a function of their distance. It
consists of a weakly attractive term dominant at larger distances and
a strongly repulsive term that becomes dominant when the atoms ap-
proach each other (Equation 4, Figure 6). The attractive long-range
term represents the van der Waals force and the short-range repul-
sive term approximates the Pauli-repulsion created by overlapping
electron orbitals. The Lennard-Jones potential has two parameters, ε
and σ, which are specific for the type of interacting atoms. These
parameters are created by fits to experimental data and provided
by force-fields. Other potentials for describing neutral atom interac-
tions, the Buckingham potential or the Stockmayer potential, provide
a more realistic description but are more expensive to compute than
the Lennard-Jones potential [128].
vLJ(ri, rj) = 4ε

σ
dij
12
´

σ
dij
6
Equation 4: The Lennard-Jones potential is used to model the neutral inter-
action between a pair of atoms. The parameters ε and σ are specific for the
types of the interacting atoms ri and rj.
The Coulomb potential describes the interaction between a pair of
atoms resulting from electrical charges as a function of the distance
between the atoms. All atoms in charged or uncharged molecules
have individual partial charges resulting in an attractive potential for
charges with opposing signs and a repulsive potential for atoms with
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the same signs (Equation 5, Figure 6). The parameters Qi and Qj are
the partial charges of the interacting atoms and are usually calculated
for force-fields by solving quantum mechanical equations for smaller
parts of whole molecules.
vCoulomb(ri, rj) =
QiQj
4πϵ0dij
Equation 5: The Coulomb potential is a pair potential between point charges
in vacuum with a permittivity of ϵ0. The parameters Qi and Qj are the
charges of the interacting atoms ri and rj; dij is their distance from each
other.
The non-bonded interactions must be evaluated for all pairs of
atoms when applied strictly (Equation 6), which is computationally
very expensive as there are 12N(N´ 1) such interactions in a system
with N atoms. However, a closer look at the interaction potentials
suggests that not all atom pairs need to be considered all the time.
At increasing distance, the forces exerted by the non-bonded inter-
actions quickly get smaller. The Lennard-Jones potential approaches
zero at an exponential rate in the order of d12ij and the Coulomb po-
tential falls off quadratically with respect to the inter-atom distance.
To exploit this rapid decline in interaction strength the neighbor-list
data structure has been developed. Such a data structure is created
for each atom (central atom) and includes all atoms that may inter-
act with the central atom for a given time span. During that time,
only the atoms in the neighbor-list are used when calculating the
non-bonded interactions for the central atom. After the given time
span, the neighbor-list is updated.
Unon-bonded =
atom
pairsÿ
i,j
vLJ(ri, rj) + vCoulomb(ri, rj)
Equation 6: The non-bonded interaction potential is the sum of the Coulomb
vCoulomb and Lenard-Jones vLJ potentials between all pairs of atoms i, j.
Intra-molecular, bonded interactions
In addition to non-bonded interactions, there are a number of
bonded interactions, that characterize the topology of the simulated
molecules. These intra-molecular interactions are described by bond-
stretching, angle-bending and dihedral-torsion potentials between
pairs, triples and quadruples of atom positions, respectively (Equa-
tion 7). The actual constraining is performed during the simulation
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Figure 7: Schematic display of bonded interactions for (A) bond-stretching
between pairs of atoms, (B) angle-bending in atom triples and (C) dihedral-
torsion in atom quadruples.
loop by algorithms like LINCS [126] for general molecules and by
SETTLE [127] optimized for water molecules. They change the atom
positions to guarantee that constrained atom to atom distances are
fulfilled at the end of a simulation time-step. Using these distance
constraints, the bond length can be constraint but also bond and di-
hedral angles by expressing the angular constraints with multiple
distance constraints.
Uintra-molecular =
bondsÿ
i,j
vbond-stretching(ri, rj)
+
bond
anglesÿ
i,j,k
vangle-bending(ri, rj, rk)
+
dihedral
anglesÿ
i,j,k,l
vdihedral-torsion(ri, rj, rk, rl)
Equation 7: The intra-molecular, bonded interactions are calculated be-
tween pairs, triples and quadruples of atom positions r representing bond-
stretching, angle-bending and dihedral-torsion potentials respectively (Fig-
ure 7).
2.1.3 State of the art
With enough raw computational power, long timescales become ac-
cessible to MD simulations and more complete samplings can be
obtained without the need to introduce a bias or sacrifice precision.
Progress is fueled by enhancements of hardware and software. The
current generation of MD software packages can utilize the massively
parallel architecture in graphics processing units (GPUs) [130]. Some
effort was made to build special purpose hardware for MD simula-
tions [121, 122], of which the Anton machine is probably the most
successful achievement [123, 124, 106, 54, 125]. Also, the ubiquitous
cloud-based computing has been recently leveraged for MD simula-
tions by performing a large number of short, independent simula-
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tions in parallel and combining their results with Markov state mod-
els [116].
Also progressing is the development of algorithms that exhibit bet-
ter scaling behavior on massively parallel computers for the calcu-
lation of long range electrostatic interactions than the particle-mesh
Ewald (PME) method. Multilevel summation method (MSM) and fast
multipole method (FMM) have been shown to be applicable to MD
simulations with promising results [131, 132].
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2.2 structure preparations
Before protein structures, for example, from the protein data bank
(PDB), can be used in a MD simulations, some refinement steps need
to be performed to create a coherent structure. The (raw) structural
data from the PDB may be present in a crystallographic or biologi-
cal assembly that is not correct for the context you want to perform
the simulations in. For example, membrane protein structures re-
solved by X-ray crystallography are not embedded in a lipid bilayer
but surrounded by a layer of detergent molecules. Further, the (raw)
structure file may contain — apart from detergent molecules — a
shell of ions and water molecules that are not particularly relevant
for the simulations as they are artificial, owing to the experimental
conditions under which the structure was determined, or easily re-
produced during the creation of the whole simulation system.
2.2.1 Protonation states and internal water molecules
When performing classical MD simulations, correct assignment of the
residues protonation state(s) is especially important. For reasons of
computational efficiency, protonation state changes are not allowed
during the simulation, as the topology of the system cannot change
(see Section 2.1). The protonation status of individual residues gener-
ally cannot be inferred from the (raw) structural data as its resolution
is not high enough to show single hydrogen atoms. But for most of
the residues one can assign the protonation status according to their
pKa and the pH at which the simulation will be performed. Here,
the GROMACS tool pdb2gmx was used to automatically assign a de-
fault protonation at physiological pH to most residues. However, for
some residues there exists experimental evidence that their immedi-
ate environment has a different microscopic pH that induces another
protonation state. In the following section, such cases are discussed
and properly treated. Additionally, the C-termini of the receptor, pep-
tide and G protein molecules are deprotonated (COO´), whereas the
N-termini are fully protonated (NH+3 ).
Internal water molecules are often not resolved due to lack of res-
olution. Especially membrane proteins are mostly only resolved at
modest resolution so that structural details, such as the placement
of internal water molecules, are often not adequately inferable. To
fill internal empty polar cavities with water molecules we employed
the program DOWSER [133]. By calculating the interaction energies
of internal water molecules with their surrounding atoms, DOWSER
assess if a water molecule makes a significant energetic contribution
to the structural stability. In addition to water molecule positions re-
solved from (raw) structural data, DOWSER tests all positions where
a spherical probe, the size of a water molecule, makes contact with in-
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ternal protein surfaces. Here we used DOWSER to obtain the internal
hydration sites to prepare structure for simulations.
2.2.2 Receptors and peptides
Experimental structure determination often requires modifications
made to the specimen to make obtaining data possible or to enhance
the quality (or resolution) of the results. Such modifications may
range from single point mutations over the truncation of N- and C-
termini to the replacement of whole specimen regions. For example,
to solve the structure of GPCRs by X-ray crystallography, the flexible
third intracellular loop (ICL3) is often replaced with a T4-lysozyme
to obtain a more rigid structure with potentially more stabilizing con-
tact in the crystal lattice [59]. Still, some regions within the specimen
may not be resolved due to high flexibility which results in missing
atoms or residues in the structural data. These regions need to be
adapted or modeled to get structures suitable for MD simulations.
RhR receptor
MD simulations of inactive rhodopsin (RhR) were based on the struc-
ture of chain A in PDB entry 1U19. The two palmitoyl chains attached
to the residues C322 and C323 were used as well as the retinal lig-
and covalently attached to K296. All other non-protein atoms were
removed from the structure. In inactive rhodopsin, D8 [134] and
E122 [134] are likely protonated.
RhR* receptor
For all MD simulations of active rhodopsin (RhR*) based on PDB en-
try 3PQR, two palmitoyl chains were attached to the residues C322 and
C323. The covalently attached retinal (to K296) was kept, whereas
all other non-protein atoms were removed from the structure. In
RhR*, diverging protonation states were suggested for D83 [135, 134]
and two residues in the proximity of the Schiff-base, E113 [136] and
E122 [134] as well as E134 [137]. All of these are thus set protonated.
The structures of active RhR* lack a large part of the C-terminus
(residues 327 to 348, UniProt entry P02699), which is not resolved
in any other structure but inactive RhR (PDB entry 1U19). However,
because removal of this region has been reported not to affect activa-
tion of rhodopsin’s natural binding partner, the transducin G protein
Gt [138], we did not model this part of active RhR*.
Ops* receptor
Opsin is characterized by a ligand-free binding pocket and the struc-
ture of active opsin (Ops*, PDB entries 3CAP and 3DQB) shows
empty space within the retinal binding pocket. However, it is highly
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Figure 8: Ops* ligand cavity filled with water. Panel (A) shows Ops* (green)
completely embedded in water with no membrane to allow free influx of
water through two openings that also allow retinal integration and removal
through the lipid bilayer under native conditions [45]. For comparison,
the RhR* (orange) ligand binding pocket with covalently attached retinal
is shown (B) along a detailed view of the water filled Ops* ligand cavity (C).
unlikely that there is a void inside Ops* as this would lead to a col-
lapse of the receptor. Hence, the retinal binding pocket of Ops* was
filled with bulk waters. For that purpose, Ops* was completely em-
bedded in water molecules, and the amino acid side chains and wa-
ter molecules were allowed to equilibrate during a 60ns simulation,
while the protein backbone atoms were restrained to their initial po-
sitions. With this setup, water entered through the two openings that
also allow retinal entry and release through the lipid bilayer under
native conditions [45]. The steady state was reached after about 20ns,
with approximately 27 water molecules in the (ligand-free) binding
pocket and the rest of the protein interior (Figure 8).
As described above for RhR*, the residues D83 [135, 134],
E113 [136], E122 [134] and E134 [137] were protonated. Also, the
receptor C-terminus is treated as described above for RhR*, that is,
not modeled.
RhR*•GαtCT11/19 and Ops*•GαtCT11/19 complexes
The receptors (RhR*, Ops*) in the complexes (RhR*•GαtCT11/19,
Ops*•GαtCT11/19) were prepared the same as the receptors alone.
For RhR*•GαtCT11, the coordinates from the double high-affinity
L341, V347 11-mer GαtCT peptide variant in complex with RhR*
(PDB entry 3PQR) were used. However, the peptide mutations were
changed back to their wild-type forms K341 and C347. These muta-
tions were used to aid crystallogenesis by enhancing the interaction
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between peptide and receptor. But for the simulations we do not need
that stabilizing effect and are more interested in the native contacts.
Similarly, for Ops*•GαtCT11, the coordinates from the high-affinity
L341 peptide variant in complex with RhR* (PDB entry 3PQR) were
used. However, the point mutation in the peptide was changed back
to its wild-type form K341, to obtain the native form. Therefore, the
same 11-mer GαtCT (G340–F350) peptide was used for the RhR*•
GαtCT 11 and Ops*•GαtCT 11 complexes.
For simulations of both receptors — RhR* and Ops*, in complex
with 19-mer GαtCT (332–350) — the 11-mer GαtCT was extended N-
terminally by 8 amino acids using the geometries of an ideal α-helix.
β2AR* receptor
The starting conformations for simulating of active β2-adrenocep-
tor (β2AR*) were prepared based on the agonist-bound X-ray struc-
tures from co-crystals of β2AR*•Gαsβγ (PDB entry 3SN6) [32]. First,
the Gαsβγ was removed from the complex along with the Nb35
nanobody. Non-protein atoms were also removed with the excep-
tion of the receptor-bound agonist. The far C-termini of the β2AR*
structure (342–413, UniProt entry P07550), not resolved in these com-
plexes, were not modeled as removal of this region has been reported
not to affect adenylate cyclase activation [139].
Also — for the simulations of β2AR*— the T4-lysozyme was re-
moved from the N-terminus and a palmitoyl chain was ligated to C341
of β2AR*. Unresolved atoms from the side chains of residues 63,
97–99, 101, 149, 175, 192–195, 267, 269–272, 299, 301–302, 304, 306
and 333 were added applying the standard geometries from the Dun-
brack 2002 library [140]. Three stabilizing mutants (M96T, M98T and
N187E) in β2AR* were changed back to their respective wild-type
form, to obtain the native sequence. The coordinates for the missing
residues of extra-cellular loop (ECL) 2 (176–178) were taken from the
β2AR*-structure (PDB entry 3P0G) where ECL2 is resolved [60]. The
conformation of residues 240 to 264 from ICL3, which are not critical
to receptor function [141], were modeled with help of the fragment-
based loop modeling program SuperLooper [142].
In β2AR*, E122 was set protonated because it is in close contact
with the hydrophobic lipid tails in the middle of the lipid bilayer (as
suggested by Dror et al. [54]).
β2AR*•Gαsβγ and β2AR*•GαsCT11/19 complexes
The structure of the active β2AR* receptor in the β2AR*•Gαsβγ and
β2AR*•GαsCT11/19 complexes was prepared the same as for the
simulations of the receptor alone.
Gαsβγ was prepared as follows. The missing Gαs N-terminal
residues 1–8 were modeled using standard geometries before a palmi-
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toyl chain was ligated to residues C3 and G2, each [143]. A geranylger-
anyl chain was ligated to residue 68 of the Gsγ-subunit [144], after the
missing residues 1–4 of the N-terminus and residues 63–68 of the C-
terminus were added. The mutated residues G72S in Gαs and M1Q
in the Gsβ were changed back to the wild-type form. Unresolved
atoms from the side chains of residues 24, 35, 58, 59, 94, 118, 136, 139,
188, 189, 191, 194, 195, 201, 216, 240, 300, 322, 369 in Gαs, 1, 42, 129,
130, 172 in Gsβ and 62 in Gsγ were added using standard geometries
from the Dunbrack 2002 library [140]. The conformation of the miss-
ing residues 60–70, 85–87, 203–204 and 256–262 in Gαs were again
modeled with SuperLooper [142].
For simulations of 11-mer GαsCT (residues 384–394) and 19-mer
GαsCT (residues 376–394), the coordinates from the β2AR*•Gαsβγ
complex were used by truncating the Gαs subunit N-terminally.
β2AR*•GαiCT complex
An initial β2AR*•GαiCT19 complex was created from MD simu-
lations based on the crystal structure complexes of β2AR*•Gαsβγ
(PDB entry 3SN6) and RhR*•GαtCT (PDB entry 3PQR). First, a
GαiCT19 starting position within the β2AR* binding crevice was ob-
tained that resembles GαtCT11 bound to RhR*. To this end, β2AR*
was superposed with the RhR*•GαtCT complex without employing
the flexible TM6. Thus, the superposition was guided by a sequence
alignment of β2AR* and RhR* and employed the Cα atoms from
TM1–5 and TM7. The position of GαtCT in this superposition was
then taken as the starting position of GαiCT, which was created from
GαtCT by changing I338 to V. In this starting position, no contacts are
formed between TM6 and GαiCT. The peptide is initially attached to
ICL2 and TM5 but can move freely within the β2AR* binding crevice.
RhR*•GαsCT complex
The GαsCT starting position for the RhR*•GαsCT complex was ob-
tained following the same sequence alignment and superposition pro-
tocol as for β2AR*•GαiCT but with RhR* as the receptor and GαsCT
as the peptide target. Thus, resulting in a complex composed of the
RhR* structure and a GαsCT peptide bound in a way resembling
GαsCT bound to β2AR* in the β2AR*•Gαsβγ complex.
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Figure 9: Simulation system with proteins, lipids and water. A rhodopsin
molecule (orange cartoon) is embedded in a lipid bilayer surrounded by
water molecules (space-filling atoms colored by element, carbon: turquoise,
oxygen: red, nitrogen: blue, phosphorus: olive, hydrogen: white). For
clarity, lipids and water molecules that would be occluding the view of the
receptor are not shown.
2.3 performing molecular dynamics simulations
To perform the intended classical molecular dynamics simulations
of our membrane proteins, the prepared structures (see Section 2.2)
need to be put into a suitable water/lipid environment to create a
simulation system to be used with the GROMACS simulation pack-
age. Further, topology definitions of the prepared structures need
to be created with the GROMACS tool pdb2gmx. For that, force-field
parameters are required that adequately describe the topology and
the potential interactions (see Section 2.1). With all the necessary
simulation inputs in-place, a preparatory multi-step protocol tries to
minimizes the occurrence of artifacts due to the (initially) composed
nature of the created simulation system (Figure 9).
32 methods
2.3.1 System preparation
System preparation and subsequent minimization and equilibra-
tion were performed with the GROMACS suite (version 4.5) [145].
The prepared (see Section 2.2) receptor and GαCT structures
and their complexes were inserted into an equilibrated bilayer of
dimyristoylphosphatidylcholine (DMPC) using the GROMACS g_membed
tool [146].1
Parameters for the DMPC lipids were derived from Berger
et al. [147]. For water, the SPC/E model [148] was used. A salt con-
centration of 0.15mol/L was obtained by adding Na+ and Cl´ ions to
the system with the GROMACS tool genion. The AMBER99SB-ILDN
force field [129] was used for proteins and ions. Ligand parameters
for the agonist 5-hydroxy-4H-benzo[1,4]oxazin-3-one (a.k.a. BI-167107)
of β2AR* were created with the PRODRG2 web-server [149]. Parame-
ters for the 11-cis retinal in RhR where adapted from Kandt, Schlitter,
and Gerwert [150], and parameters for the deprotonated all-trans reti-
nal in RhR* were adapted from Mertz, Lu, Brown, and Feller [151].1
2.3.2 Simulation protocol
To obtain clash-free structures suitable for MD simulations, an
energy minimization was performed in GROMACS using the
steepest descent algorithm until the maximum force went below
1000 kJ/mol/nm. In the following equilibration step, the energy min-
imized structure was simulated for 20ns with all protein backbone
atoms restrained to their initial positions. This allows for relaxation at
the protein-membrane, protein-water and the membrane-water inter-
faces so that voids are filled and side chain packing is optimized. For
the production MD simulations, the position restraints were lifted.1
Based on the equilibrated systems, the production runs were
started with different initial velocities obtained from Boltzmann dis-
tributions at 320K. For equilibration and production runs, all bonds
were constrained using the LINCS algorithm [126], with the excep-
tion of water bonds, which were constrained by the SETTLE algo-
rithm [127]. The temperature was kept constant by coupling the sys-
tem to a temperature bath of 320K, which is high enough to keep the
DMPC membrane from entering the gel phase. The temperature cou-
pling was performed using the velocity-rescaling thermostat of Bussi
et al. [152] with a time constant of 0.2ps. Long range electrostatics
were calculated with the PME method [153]. Berendsen pressure cou-
pling was performed with a time constant of 2.0ps and semi-isotropic
scaling, separating scaling in the membrane plane directions from the
1 paragraph adapted from [56] and/or [101]
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z-direction (i.e the membrane plane normal). The integration time
step used for all simulations was 0.002ps.1
2.3.3 Umbrella sampling calculations
Umbrella sampling (US) facilitates sampling of the conformational
space by applying a restraining potential along a transition coordi-
nate. By employing umbrella sampling over a series of windows,
ranges on the transition coordinate can be sampled, which would be
inaccessible to direct sampling due to energy barriers of the transition
coordinate. The resulting series of histograms contains the biased
distribution along the transition coordinate. The weighted histogram
analysis method (WHAM) is employed to unbias and combine the
histograms [154]. From the resulting distribution, the potential of
mean force (PMF) can be calculated at temperature T as
PMF(c) = ´kBT ¨ lnp(c)
for the probability p of the transition coordinate c and with the Boltz-
mann constant kB [154].1
Here, the transition coordinate for the free energy calculations of
TM6 inward movement and β2AR* GαiCT interaction was selected
from the trajectories of a series of β2AR*•GαiCT19 MD simulations
(Figure A2, simulation 8). Along the selected trajectory, umbrella
sampling MD simulations were performed with respect to the TM6
inward transition by applying the umbrella potential to the upper
part of TM6, namely to the backbone atoms of residues 265 to 277.
We simulated 36 US windows for 200ns each. WHAM was then em-
ployed to obtain the PMFs from the last 100ns from each US window
and the error was estimated by the standard deviation of a block-wise
(three equally sized blocks) analysis.1
1 paragraph adapted from [56] and/or [101]
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2.4 analyses of md simulations
The primary result of MD simulations are atom trajectories which pro-
vide the position of each atom in space and time. Using molecular
visualization tools, the trajectories can be interactively viewed accord-
ing to the topology of the simulated system, that is, which atoms are
connected/bonded to form molecules. Such visual exploration and
analysis immediately gives an overview of the general behavior of the
simulated molecules. However, to obtain summarizing descriptions
of the systems behavior and intrinsic properties that do not become
apparent from the atom positions alone, dedicated calculations are
performed.
2.4.1 Secondary structure assignment
During MD simulations, the secondary structure of the simulated pro-
teins may change. Most of the simulated systems are based on crystal
structures where parts of the proteins are stabilized by crystal lattice
contacts or by crystallization helper molecules. Therefore an accurate
secondary structure assignment cannot be obtained from the crystal
structure but must be obtained dynamically from the simulation data.
In our secondary structure analyses, we focused on the α-helicity of
the ICL3, TM6 and the GαCT. The ICL3 and TM6 show extended
crystal lattice contacts (RhR*) or are only partially resolved (β2AR*).
The GαCT peptides are derived by N-terminal truncation from longer
α-helical structures and may show increased N-terminal flexibility.
In this study, we use the DSSP [155] tool together with the GRO-
MACS script do_dssp to calculate the secondary structure of each
residue over time. DSSP differentiates between eight structural types
and assigns each residue a single type. The structural types can be
classified into three helical types (α-helix, π-helix and 310 helix), two
strand types (β-sheet and β-bridge) and three unordered types (turn,
coil and bend).
2.4.2 RMSD and RMSF calculations
MD simulation data provides a position for every atom at any time.
First steps to summarize this wealth of data are measures that sub-
sume the positional data either over all atoms or over time by calculat-
ing the root mean square deviation (RMSD) or root mean square fluc-
tuation (RMSF) respectively. GROMACS provides g_rms and g_rmsf
tools to efficiently calculate RMSD and RMSF values.
The RMSD is a measure for the average distance between pairs of
atoms (Equation 8). By calculating the RMSD between, for example,
the starting structure of a simulation (or any other reference struc-
ture) and the structure at any given time frame, the deviation from
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the starting (reference) structure can be plotted over time. To focus
on the overall structural changes, the RMSD is usually calculated for
Cα or backbone atoms, thus ignoring the side-chain fluctuations. Ad-
ditionally, before comparing the structures by applying the RMSD
formula, the structures are superposed so that the RMSD reflects the
internal differences and not the global rotation or translation.
RMSD(x,y) =
gffe 1
N
Nÿ
i=1
|xi ´ yi|2
Equation 8: RMSD equation. N is the number of atom positions in each x
and y.
The RMSF is the standard deviation of atomic positions over the
simulation time (Equation 9). By calculating the RMSF for each atom,
flexible and structured regions become easily distinguishable. As
with the RMSD, a preceding superposition is generally necessary. The
RMSF provides a structure-wide summary of the atom’s dynamic be-
havior over time. As such, it is well suited to be mapped on a depic-
tion of a (representative) structure to show its dynamic behavior over
time in a structural context.
RMSF(xi) =
gffe 1
T
Tÿ
j=1
|xi(tj)´ xi|2
Equation 9: RMSF equation. T is the number of timesteps, xi(tj) is the
position of atom xi at time tj and xi is the time averaged position of xi.
2.4.3 Structural superposition
Most structural measures for analyzing simulation data are intended
to provide internal changes and not global rotations or translations.
For example, a membrane protein moving in the lipid bilayer may
provide interesting diffusional characteristics, but when analyzing
the tilt of a TM helix within its helix bundle such motions are all-
consuming noise. Therefore, a superposition should be performed
beforehand minimizing the RMSD between two structures, or more
explicitly between pairs of atoms. The fitting procedure first removes
the translational differences by aligning the two structures and then
finds the optimal rotation. Two equivalent solutions for finding the
optimal rotation have been described [156, 157].
Most of the GROMACS analysis tools provide the option to per-
form a superposition step before the actual analysis and accept a
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group of atoms to fit. Unless otherwise stated, the analyses described
here were performed on structures superposed to the initial structure
of the respective simulation. Specifically, by superposing the back-
bone atoms of the transmembrane helices 1–7.
2.4.4 TM6 position/tilt
In GPCR activation, the release of TM6 from the 7-TM bundle is a
defining moment that leads to the formation of an open intracellular
binding crevice. This outward tilt of TM6 can be measured as the
distance between the tip of TM6 and the tip of either TM2 or TM3 at
the opposing side of the helical bundle. Here we chose TM2, because
RMSD calculations of the tips of TM2 and TM3 have shown that TM2
generally moves fluctuates less. So the distance between TM2 and 6
(dTM2–6) was used as an indicator of the TM6 tilt. Specifically, it is
measured as the distance between the geometric centers for intracel-
lular sections of TM2 and TM6. For TM2, we used the backbone atom
positions of the residues 71–75 (RhR*) and 67–71 (β2AR*); for TM6
residues 244–248 and 265–269, respectively.
2.4.5 MD cluster analysis
The structural variability of ICL3 (residues 224–251) in RhR, RhR*
and RhR*•GαtCT was measured by cluster analyses performed with
the GROMACS tool g_cluster. The MD trajectories were prepared
by a superposition to align all frames on the backbone atoms of the
transmembrane helix segments for the inactive and the active recep-
tor with or without GαCT peptide. Cluster analyses were then per-
formed on the aligned trajectories using the gromosmethod [158] and
a 2Å root mean square deviation (RMSD) cut-off to decide when two
structures (e. g. ICL3 backbone atoms at two points in time) are neigh-
bors. Shortly, the gromos clustering method starts by counting how
many neighbors each structure has that satisfy the RMSD threshold.
The structure with the most neighbors is taken — including its neigh-
bors — to form the largest cluster. Then, this process is repeated,
ignoring all structures that are already in a cluster, until no more
structures are left. This results in a series of distinct clusters of struc-
tures where each cluster tends to be centered around a representative
structure.
2.4.6 Calculation of peptide helix axis, tilt and rotation
The first turn of both peptides from the Gα C-terminus (GαCT) is
highly dynamic because of the absence of N- terminal intra-helical
hydrogen-bonding partners stabilizing this part of the α-helix in
α5 (Figure A9). The overall stability of the α-helical conformation
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of residues 3–8 and of the turn structure of residues 9–11 was as-
sessed by secondary structure content (Figure A9) using the program
DSSP [155]. Based on the α-helical residues, the representative helix
axes for the two GαCT peptides can be determined and thus varia-
tions in tilt and rotation of the helices (Figure A13). The rotation and
tilt movements of GαtCT and GαsCT were calculated from the local
axis of their α-helical sections as implemented in the GROMACS tool
g_helixorient. The program calculates the local rotation and tilt for
groups of four consecutive Cα atoms. We calculated these values for
all α-helical sections and subsumed the local tilt and rotation respec-
tively to get an overall measure of the rotation and tilt movement.
The tilt angle between GαCT and the membrane plane is subsumed
analogously as the angle between the local helix axis and its projec-
tion onto the membrane plane. The membrane plane was defined
from the position of the active receptors (R*) relative to the initial
lipid bilayer into which R* was inserted and was thus not dynami-
cally recalculated during the MD simulations. Sample calculations of
the membrane planes as the best fitting (least square) planes through
all lipid head group phosphates confirmed that the orientation of R*
within the lipid bilayer does not change much.1
2.4.7 Calculation of GαCT RMSD and lateral motion within the binding
cavity of R*
Two different types of backbone RMSDwere calculated with the GRO-
MACS tool g_rms. The binding cavity RMSD describes the structural
integrity of the binding cavity and was calculated as the RMSD of
the backbone atoms from the binding cavity after a least-square su-
perposition of the backbone atoms of the binding cavity to the back-
bone atoms of the binding cavity from the equilibrated system. The
binding cavity was defined as all residues of R* that are in contact
(atoms within 4Å) with residues from the C-terminal reverse turn of
GαsCT (residues 391–393) and GαtCT (348–350). The peptide RMSD
describes the movement of GαCT relative to its position in the crys-
tal structure. It was calculated as the RMSD of the backbone atoms
from GαCT after the same superposition was used to determine the
binding cavity RMSD. Because the N-terminal turn of GαsCT is very
flexible (for DSSP analysis see Figure A9), the first two residues at
the N-terminus were omitted for RMSD calculations. The lateral (XY)
motion of the C-terminal reverse turn within the membrane plane
was calculated from the geometric center of the backbone atoms of
the last seven C-terminal residues of GαCT.1
1 paragraph adapted from [56] and/or [101]
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2.4.8 Calculation of hydrogen bond and cation-π interaction energies
Potential hydrogen bonds between R1353.50 of RhR*/Ops* and
C347.O of GαCT were monitored as a function of the distance be-
tween the acceptor atom C347.O and the hydrogen atoms: HE, HH11,
HH12, HH21 and HH22 of R1353.50 (as named in the AMBER99SB-
ILDN force field). The hydrogen bond energies were calculated ac-
cording to the formula of Espinosa, Molins, and Lecomte [159] as a
function of the distance between the acceptor atom and the hydrogen
of the donor atom:
´0.5 ¨ (50 ¨ 1.1 ¨ 103 ¨ e´36 ¨ d),
where d is the distance between acceptor and hydrogen.1
The hydrogen bond interaction energy was calculated as the sum
of the hydrogen bonding energies of all acceptor-donor pairs. The
hydrogen bonds that include the atoms HE and HH21 of R1353.50
contribute most to the total energy. Cation-π interactions between
R1313.50 of β2AR* and Y391 of GαsCT were detected with the pro-
gram CaPTURE [160]. This program also reports an electrostatic in-
teraction energy estimate that agrees qualitatively with ab initio cal-
culations at the HF/6–31G** level, but underestimates the magnitude
by roughly a factor of two which is about the same as the van der
Waals interaction energy that is also reported by this program [160].
Here we use the electrostatic interaction energy as reported by CaP-
TURE to qualitatively capture the trend of the cation-π interaction in
the MD simulations.1
2.4.9 Solvent accessible surface, interaction area and water contacts
The interface between receptor and GαCT was investigated to mon-
itor the expulsion of water molecules from the interface and to
measure the resulting formation of a hydrophobic patch between
ICL3/TM6 and GαCT. The solvent accessible surface area (SAS) can
be calculated for complete molecular complexes or parts of them with
the GROMACS tool g_sas. Additionally, for MD simulations that in-
clude explicit water molecules, the water accessibility can be obtained
directly by counting contacts between specific residues and the en-
tirety of water molecules (i. e. the solvent).
The interaction area between two molecules (i. e. binding partner
A and B) can be calculated as the combination of multiple SAS. First,
the SAS of the complex (SASAB) and the SAS of binding partner B
(SASB) are calculated separately. The difference between the area con-
tribution of B to SASAB and SASB constitutes the interaction area.
Further, the fraction between the interaction area and SASB can also
1 paragraph adapted from [56] and/or [101]
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be calculated. A fraction of one means a binding partner B is com-
pletely accessible, whereas a completely buried binding partner has
a fraction of zero.
2.5 cluster analysis of docking calculations
To detect feasible interactions between GαsCT and the β2AR* cyto-
plasmic crevice, docking calculations were performed by P. Hilde-
brand following the flexible docking protocol as described in his pre-
vious analysis [78] and implemented in the GOLD package [161].
To group similar docking poses from results of 11 independent
docking runs of GOLD, an RMSD based cluster analysis were per-
formed. To realize this analysis we applied the single-linkage cluster-
ing method with a cut-off of 1.5Å as implemented in the GROMACS
tool g_cluster.
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2.6 analysis automation strategies
To facilitate analysis of a large number of different simulated systems,
each with many individual simulations (Section 2.2, Table A1), a flex-
ible analysis automation strategy was devised. A number of observa-
tions made during initial/previous analyses provided necessary in-
sights to create a flexible protocol. Analyses like “what are the hydro-
gen bonds between receptor and peptide” need to be performed on
many different systems that contain a receptor and a peptide. Gener-
alized, this means applying a tool to various different systems. While
doing so, tool-specific parameters like the “maximum hydrogen bond
length” do not get changed, but system-specific parameters like the
“trajectory input file” do change. Moreover, to comprehensively ana-
lyze even a single system, for example MIIb•GαtCT (MIIb_GtaCT11),
many different tools may be used. Following the (just introduced)
notion of tool- and system-specific parameters, it is clear that system-
specific parameters are fixed while tool-specific parameters change
with every tool used.
Now, it would be advantageous to exploit the distinguishing prop-
erty of tool- and system-specific parameters, that is the observation
that they are independent. For that, a structured project definition (Sec-
tion 2.6.1, Listing 2) was created, where tool and system-specific pa-
rameters are saved independently from each other. Given such a clear
separation, the idea is to flexibly apply tools to systems using their
respective parameters. To do so, a common tool interface (Section 2.6.2,
Listing 3) is needed that understands the tool- and system-specific
parameters regardless of what specific calculation an underlying tool
performs.
2.6.1 Structured project definition
The structured project definition is written in the JavaScript object no-
tation (JSON) format and aims to provide a succinct description of
all required tool- and system-specific parameters. A simplified ex-
cerpt of a structured project definition file is given in Listing 2 and
the line numbers in this section refer to that listing. Mainly, it is a
loosely hierarchical format in which data at lower levels of the hi-
erarchy try to utilize data from the higher levels whenever possible.
For example, to get the trajectory file name in line 15, the values
of the __dir__ entries in lines 3, 7 and 14 are concatenated to yield
/home/arose/projects/rho/3pqr/GaCT/all/md_all.xtc. This helps
to minimize repetition of file name parameters.
1 {
2 "project" : {
3 "__dir__" : "/home/arose/projects" // directory
4 } ,
5 "systems" : {
6 "MIIb_GtaCT11" : {
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7 "__dir__" : "rho/3pqr/GaCT/" , // directory
8 "__variables__" : {
9 // data commonly needed as tool input
10 // e.g. residue or atom selections
11 } ,
12 "__sub__" : {
13 "all" : { // concatenated simulations
14 "__dir__" : "all/" ,
15 "traj_file" : "md_all.xtc" ,
16 "part_length" : [ 200 , 200 , 200 , 200 , 200 ]
17 } ,
18 "md01" : { // individual simulation
19 "__dir__" : "md01/analysis/" ,
20 "traj_file" : "md01_mc_fit_protein.xtc"
21 } ,
22 // ... 4 more simulations
23 }
24 }
25 } ,
26 "tools" : {
27 "hbond_peptide_receptor" : {
28 "__doc__" : "Calculate a receptor’s internal hbonds" ,
29 "__name__" : "mdkit.hbond.Hbond" ,
30 "radius" : 0 .3 6 , // max hbond distance
31 "output_dir" : "hbond/intra_receptor/" ,
32 "ndx_group1" : "Receptor" , // resdiue selection 1
33 "ndx_group2" : "Peptide" // resdiue selection 2
34 }
35 } ,
36 "defaults" : {
37 "gro_file" : "md01_protein.gro" , // common input files
38 "ndx_file" : "index2.ndx" ,
39 "figsize" : [ 8 , 4 ] , // default plot size
40 }
41 }
Listing 2: Simplified excerpt of a structured project definition (see the running
text for a description of its content). The structured project definition uses the
JSON format1 to save its content. The JSON format knows a succinct set of
values. These are objects (key value pairs seperated by commas enclosed in
curly brackets, e. g. {"key1": value1, "key2": value2}), arrays (values
seperated by commas and enclosed by square brackets, e. g. [value1,
value2]), strings (enclosed by quotation-marks e. g. "string1"), numbers
(e. g. 1.23) or booleans (true or false). Here we additionally use // to
denote comments.
The top level of the format consists of the four entries project,
systems, tools and defaults. The project entry contains general
data on the project such as its base path (line 2). The systems entry
lists all different simulated MD systems and their specific parameters,
for example the MIIb_GtaCT11 starting in line 6. Each system entry
has a __sub__ entry containing parameters relevant for any trajectory
file that may need to be analyzed. Essential for this is the traj_file
entry (line 15) and for concatenated trajectory files the length of the
individual parts is often useful (line 16). All tools eventually required
for analysis are held in the tools entry. The example starting at line
27 is the hbond_peptide_receptor tool used to “Calculate a receptor’s
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internal hbonds”, as stated in its documentation string (__doc__, line
28). The __name__ entry (line 29) directly refers to the tool class Hbond
(Listing 3), contained in the hbond module within the mdkit package
comprising all tools. The next entries specify the maximum distance
between hydrogen bond partners (line 30), the path where the out-
put files are written to (line 31) and the two residue groups between
which hydrogen bonds are to be analyzed (line 32–33).
Flexible analysis framework
The top level organization of the structured project definition immedi-
ately reflects the separation of the system- and tool-specific param-
eters that spurred the creation of the format. Moreover, the way
of referring to the code class to be executed (__name__, line 29), is
identical to the module organization of the Python language, which
was used to implement the tool framework. Therefore the structured
project definition can be seen as a data-driven (or parameter-driven) exten-
sion of the Python language, providing domain specific functionality.
In other words, the structured project definition is as a configuration file
for a flexible analysis framework.
2.6.2 Common tool interface
This is mostly a broad overview of the analysis framework built upon
the structured project definition and the common tool interface. The frame-
work is implemented in the Python programming language. To start,
some detailed information is appropriate to help illustrate how the
Hbond class example (Listing 3) fits into the context of the framework.
The heart of the common tool interface is the Tool class, which imple-
ments the always required boiler-plate code. This makes it possible
to easily start new tools like a hydrogen bond analysis tool by simply
creating an Hbond class that inherits from the Tool class (Listing 3).
Similar code reuse is achieved by means of the supplemental classes
GromacsMixin and PlotMixin, which provide basic support for work-
ing with GROMACS command line tools and for graphical outputs,
respectively.
Input & output. Essential when implementing tools following the
common tool interface definition is setting the args & out properties
and implementing the calculate & analyzemethods. The args prop-
erty defines all parameters that may be set by data from a structured
project definition. When creating a new class it is initially filled with
common args from the base classes the new class inherits from, for
instance, the Tool, GromacsMixin or PlotMixin classes. The out prop-
erty lists all the files a tool may create. This is useful when the tools
are programmatically used and nested; that is, when one tool calls
another tool. By clearly defining the input and output of the tools,
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1 class Hbond( Tool, GromacsMixin, PlotMixin ):
2 args = [
3 # input files and parameters
4 # special to the Hbond tool
5 ]
6 out = [
7 # output files generated by the Hbond tool
8 ]
9 def calculate( self ):
10 # code neccessary to calculate hydrogen bonds
11 def analyze( self ):
12 # creation of plots and lists
Listing 3: The stub of the Hbond class conforming to the common tool interface.
The definition in line 1 shows that the Hbond class inherits common methods
from the Tool, the GromacsMixin and the PlotMixin class. By inheriting
from the Tool class, setting the args & out properties (line 2 & 6) and
implementing the calculate & analyze methods (line 9 & 11), the Hbond
class conforms to the common tool interface.
there is no need to know their internal functioning to be able to inter-
operate with them as modular components.
Computation. The tool’s actual functionality needs to be imple-
mented in the calculate & analyze methods. Both methods may
produce the output files expected of the tool. Separation of the meth-
ods into two is founded in the type of data processed. To analyze
MD simulations, the tools mainly deal with atom coordinate trajecto-
ries. The common processing scheme is to first calculate some mea-
sure from the trajectory data and then analyze the extracted values.
This process is reflected by the calculate and the analyze methods.
For the Hbond tool, the former method calculates potential hydro-
gen bonds and records the time and position of the involved atoms.
The analyze method then, for instance, filters out very infrequent hy-
drogen bonds, groups the remaining hydrogen bonds by residue and
plots their occurrences over time.
Conclusion
The described common tool interface makes creation of new tools very
easy, with hardly any need for (repetitive) boiler-plate code. This ren-
ders it feasible to write simple wrapper tools around the command
line tools supplied by GROMACS itself, for example around g_hbond
to create the Hbond tool. These wrapper tools then re-use highly
efficient functionality but adhere to the common tool interface so they
can be used in conjunction with the structured project definition. All
the analyses described in Section 2.4 were performed with similarly
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created tools that augment existing programs with project-specific
post-processing and visualization steps. Hence, the analyses of the
MD simulations were automated utilizing the common tool interface
and beyond that the structured project definition.

3
RESULTS
3.1 role of icl3 in complex formation of rhr*
GPCR structures obtained by X-ray crystallography show the ICL3
loop of opsin/rhodopsin in an well-ordered conformation in both in-
active and active receptor states and regardless of being bound to a
GαtCT peptide or not. To characterize the dynamics of ICL3 in RhR,
Ops* and Ops*•GαtCT (as well as in RhR* and RhR*•GαtCT), we
performed MD simulations of the receptors in a lipid/water environ-
ment that is more natural than the crystal lattice in which the struc-
tures were resolved. Accounting for the experimental conditions is
especially important for ICL3, which is involved in crystal lattice con-
tacts that stabilize a well defined conformation that may be artificial.
Additionally, we specified the effect GαtCT on the ICL3 structure by
removing GαtCT from the receptor. The observed ICL3 flexibility is
then investigated by RMSD, RMSF and cluster analyses of the sim-
ulation data. In the discussion, these MD results will complement
data from spectroscopic experiments on the G protein peptide’s role
in stabilizing ICL3.
3.1.1 MD Simulation of RhR, Ops* and Ops*•GαtCT states
The MD simulations of inactive RhR [39], active Ops* and Ops*•
GαtCT [31] show how the ICL3 structure behaves when taken out
of the crystal lattice and embedded into a lipid bilayer within a wa-
ter/ion solution. By looking at the backbone RMSD values of the
ICL3 and the other intracellular loops ICL1 and ICL2, we can estab-
lish how much the loops diverge from their initial structure during
the simulation. A larger RMSD value indicates either a more flexible
structure or that a new stable conformation is adopted and bearing
the latter in mind the RMSD can thus be used as a first proxy for
flexibility. The analysis shows that in all RhR, Ops* and Ops*•GαtCT
states, the ICL3 is considerably more flexible than ICL1 and ICL2
(Figure 10), suggesting that regardless of receptor activation ICL3 be-
haves differently from the two other intracellular loops.
RMSD & Cluster analysis
The RMSD analysis (Section 2.4.2) by itself can not detect whether
a new conformation is adopted and can not tell if these are fre-
quently occupied and for how long, in other words whether they
form distinct conformational sub-states. Frequently occupied confor-
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Figure 10: Conformational flexibility of ICL3 in RhR, Ops* and Ops*•GαtCT
analyzed by MD simulations. (A) Inactive RhR, (B) active Ops*, and (C) ac-
tive Ops* in complex with GαtCT. The bottom row shows for each system
the respective X-ray structure (gray) and three representative conformations
(red, orange, yellow) obtained by cluster analysis. The tube thickness di-
rectly relates to fluctuations of each residue (RMSF) within a given cluster.
The occurrences of depicted cluster conformations are given in the middle
row. The top row depicts the RMSD for the transmembrane helices (or-
ange), ICL1 (red), ICL2 (blue), and ICL3 (black). (A) The three most oc-
cupied conformations (clusters 1–3) are shown, indicating a highly flexible
ICL3. (B) Depicted are three metastable conformations (clusters 4, 6 and 7)
which are adopted after leaving the initial conformation given by the X-ray
structure. It is observed that these conformations vary significantly among
each other and with respect to the starting structure. (C) The three most
occupied conformations (clusters 1–3) are very similar to the initial confor-
mation taken from the crystal structure. See Figure 11 for the full cluster
analysis. The figure and legend are reproduced from [56]
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mations of ICL3 over the course of all simulations were therefore
identified by a cluster analysis of ICL3, namely the residues 224–251
(Figure 11). Here we use representative structures of the three most
occupied ICL3 conformations for each of the RhR, Ops* and Ops*•
GαtCT based simulations to assess the structural heterogeneity of
ICL3 (Figure 10). Comparing representative ICL3 structures from the
cluster analysis with the respective crystal structures shows whether
the ICL3 structure diverged in the MD simulations (Figure 10).
Cluster analysis of the simulations of inactive RhR shows a high
ICL3 flexibility (Figure 10A) which fits well to the high B-factor val-
ues found in the crystal structures of inactive RhR (e. g. 1U19, 1GZM).
Moreover, while the loop is flexible during the simulations, the TM6
still retains its solvent exposed helical extension as seen in the crystal
structures. The RMSD also gives a first indication of a different ICL3
flexibility in the active receptor Ops* compared to Ops*•GαtCT, (i. e.
the ICL3 flexibility depends on the presence of the GαtCT peptide.
In active Ops*, the ICL3 departs from its initially structured confor-
mation and becomes highly flexible and more and more disordered
after ą 200ns (Figure 10B). Also note that the various disordered con-
formations have lifetimes of about ~10´8 s (as estimated from the
time-lines in Figure 11) and are populated for less than 10% of the
respective simulations.
Cluster and RMSD analysis of the simulations of the Ops*•GαtCT
complex reveal a rigid ICL3 with its secondary structure preserved
(Figure 10C). The largest cluster contains almost 95% of all observed
ICL3 conformations (Figure 11C). this cluster shows some minor flex-
ibility, but fluctuates tightly around the mostly α-helical conforma-
tion resolved in the crystal structure (Figure 10C, gray). Analyzing
the interaction area between receptor and peptide in comparable sim-
ulations of the RhR*•GαtCT complex, we observe that the peptide
residues L344, C347, G348 and L349 are buried within the receptors
intracellular crevice (Figure A8B). In conjunction with L226, V230,
V250 and V254 from ICL3, a hydrophobic patch is formed, stabiliz-
ing ICL3 in a α-helical conformation. Additionally, hydrogen bonds
from K341 in GαtCT to T242 and T243 in the receptor are observed
(Figure 17C,F).
RMSF analysis
To obtain a more fine-grained description of the ICL3 flexibility, we
calculated the RMSF from the MD trajectory for each amino acid (Sec-
tion 2.4.2). The RMSD gives a time-resolved description of the whole
structure or of individual parts such as the ICL3. Similarly, the clus-
ter analysis is limited to the whole structure or individual parts. In
contrast, the RMSF summarizes the flexibility during the complete
trajectory in a single value. To compare the ICL3 flexibility of the
RhR and Ops* simulations with those of Ops*•GαtCT, we calculated
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Figure 11: Cluster membership time-line and RMSF plots for (A) inactive
RhR, (B) the active conformation Ops* and (C) the active conformation Ops*
complexed with GαtCT peptide. For each system, one 400ns (#1) and two
200ns simulations (#2 and #3) were run. The cluster membership at each
simulation time frame (green) for the 10 biggest clusters of each system
is shown in the top row. Each cluster is labeled with its ID, the average
backbone RMSD among the cluster members and the percentage of frames
within the cluster. The bottom row shows the backbone RMSF of residues
224 to 251. The figure and legend are mostly reproduced from [56]
Figure 12: RMSF change between dark state and active conformation (A)
and between active conformation with and without GαtCT peptide (B).
For comparison, a detailed view of ICL3 in the crystal structures of RhR
(C, green, 1U19) and RhR*•GαtCT (D, orange, 3DQB) is shown. Selected
residues are labeled at the height of their Cα atom (gray spheres). The
GαtCT peptide is colored violet. The panels (A), (B) and their legends are repro-
duced from [56]
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how much the RMSF changes (Figure 12). A comparison of RhR and
Ops* shows that activation leads to a loss of flexibility particularly in
TM5 around A233 but a gain of flexibility in TM6 around K248. The
binding of the GαtCT peptide strongly restrains the ICL3 residues
as apparent from the comparison of Ops* and Ops*•GαtCT RMSF
values (Figure 12). Taken together, these analyses of the simulation
data suggest that the ICL3 is an intrinsically unstructured region that
becomes structured and more defined when GαtCT binds.
ICL3 dynamics characterization & comparison with experimental data
To summarize, ICL3 is the only of the three intracellular loops (Fig-
ure 11, top row) that departs much from the starting conformations
taken from the crystal structures as indicated by the large RMSD in-
crease of 5Å to 10Å. ICL1 and ICL2 remain near their starting confor-
mations. The addition of the GαtCT peptide, however, dramatically
reduces the flexibility of ICL3, which remains structured in all simu-
lations of Ops*•GαtCT.
The ICL3 conformations observed in the simulations of RhR and
Ops* built up an ensemble of fluctuations between similar states
with lifetimes of 10ns to 100ns as seen in the cluster time-series (Fig-
ure 11A, B). Cluster 1 in Figure 11B is comprised of ICL3 conforma-
tions very similar to the one found in the crystal structure. After
about 200ns (simulation #1) or earlier (#2, #3), no return of the ICL3
loop to its initial structure is observed, further corroborating that the
ICL3 conformation in the respective crystal structures strongly de-
pends on the contacts with the crystal lattice.
The RMSF plots show which residues are most flexible (Figure 11,
bottom row) and how this changes from RhR to Ops* Figure 12. In
RhR, the fluctuations suggest an approximate loop length of 8–10
residues with the residues around 236 fluctuating the most, which
means the flexibility is shifted to the TM5 side. Altenbach et al. re-
ported EPR measurements of individually spin-labeled amino acids
within the ICL3 with the same results [162], the same shift in flexi-
bility. Specifically, in Ops*, i. e. after activation, the TM5 side around
residue K231 fluctuates less, whereas on the TM6 side the region
around residue K248 shows increased flexibility. Finally, with bound
GαtCT, the whole ICL3 region fluctuates only half as much as in
Ops*, with RMSF values peaking at 4Å instead of 8Å.
3.1.2 MD Simulation of RhR* and RhR*•GαtCT states
At the start of the project, only the structures of the apoprotein Ops*
and Ops*•GαtCTwere determined, but not with covalently bound all-
trans retinal. However, while we performed the simulations with the
apoprotein, the structures of RhR* and RhR*•GαtCT were solved [66].
When parameters for the deprotonated all-trans retinal in RhR* [151]
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became available, we took the opportunity and tried to verify the
results obtained with Ops* and Ops*•GαtCT. And indeed, the TM6
tilts in simulations of RhR*•GαtCT (Figure A2D) exhibit distinctly
narrower fluctuations than in simulations of RhR* alone (Figure A2F).
This shows that in RhR*, too, the GαtCT has an ordering effect on the
intracellular tip of TM6 and thereby on ICL3.
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3.2 dynamics of tm6 in β2ar* and rhr*
The β2-adrenoceptor can activate multiple, distinct G proteins, cou-
pling to both Gs and Gi [4]. While there are known ligands which can
bias the receptors to couple to either [163], the structural mechanism
by which the active β2AR* can distinguish between Gs or Gi is un-
known. Here we thus investigate the dynamics of TM6 as the source
of the β2AR* feature to bind to (and distinguish between) different
G proteins. For that, we start by comparing available crystal struc-
tures of active GPCRs to see what structural differences there are and
what might be the reason for them. We identify the TM6 tilt as the
main difference and the bulkiness/slimness of the interaction partner
as the likely cause. In MD simulations of uncomplexed β2AR*, we
observe different TM6 conformations in addition to a very flexible
ICL3. This is in contrast to Ops* or RhR*, where there is considerable
ICL3 flexibility but no TM6 conformation with a larger outward tilt
(see Section 3.1, Figure A2F). Observing these different TM6 confor-
mations (of which one looks very similar to the TM6 conformation
of the crystal structures of RhR*•GαtCT) in β2AR* raises the ques-
tion if the different G proteins β2AR is capable to bind can stabilize
distinct TM6 conformations.
Peptides as surrogates
However, before performing MD simulations that directly address
the question of TM6 conformations, we establish the use of peptides
in MD simulations as a surrogate for the G protein holocomplex. The
rationale behind this is twofold. First, it allows comparison with the
available structural data of RhR*•GαtCT. Secondly, using peptides
instead of the G protein holocomplex immensely lowers the compu-
tational load and allows performing computational analyses which
otherwise would take prohibitive amounts of computing time. Our
data suggests that peptides of sufficient length adequately mimic the
coupling interface on the G protein side.
3.2.1 Binding modes and space requirements of GαCT
The crystal structures of β2AR*•Gαsβγ [32] and of RhR*•GαtCT [31,
66, 67] are the only complexes reported so far that show the interac-
tion of the GαCT and the R* binding crevice. Although the RhR*•
GαtCT complex does not contain the G holoprotein, the structure
and interaction of GαtCT agrees remarkably well with the GαsCT in
β2AR*•Gαsβγ. Moreover, GαCT is a key determinant of R* G cou-
pling specificity, which in case of rhodopsin and GαtCT stabilizes the
same active MIIbH+ receptor conformation as Gt [100], corroborating
the use of GαCT peptides as surrogates of the holoprotein. Both Gα
C-termini adopt an α-helical conformation terminated by a reverse
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Figure 13: Alignment of GαCT19 sequences colored by similarity and
residue type using the clustelx color scheme. Alignment columns are col-
ored according to the majority consensus discerning hydrophobic (blue),
basic (red), acidic (magenta), polar (green) and small (white) residue types.
A non-unanimous consensus is colored lighter with non fitting outliers in
white. Tyrosine is always colored turquoise. The figure and legend are adapted
from [101]
Figure 14: Cytoplasmic crevice of β2AR* (blue) and RhR* (orange) from
complexes with Gs [32] and GαtCT [31], respectively. (A-C) Side view: The
outward-tilted TM6 of β2AR* allocates space for the bulky GαsCT (outlined,
translucent surface) that would clash (indicated by the red outline in C)
with the more inward-tilted TM6 position of RhR* (orange) in complex with
GαtCT (translucent surface). R3.50 from the base of the cytoplasmic crevice
and Y391/C347 from the tip of Gαs/tCT are shown as sticks. (D) Schematic
representations of the two crystal structure interactions in A-C. The figure
and legends are reproduced from [101]
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turn, whose tip binds to R3.50 from the E(D)RY motif that forms the
base of R* binding crevice. A sequence alignment shows bulkier side
chains in the reverse turn of GαsCT than in GαtCT or its close ho-
mologue GαiCT (Figure 13). Specifically, these are Y391 in GαsCT
vs R135 in GαtCT or GαiCT. The β2AR*•Gαsβγ complex structure
then shows a cation-π interaction between Y391 and R1313.50 (Fig-
ure 14A). Whereas, in RhR*•GαtCT, a hydrogen bond between the
carbonyl oxygen of C347 and the guanidinium group of R1353.50 con-
nects the Gα reverse turn with receptor-binding crevice (Figure 14B).
In addition to the cation-π interaction, the β2AR*•Gαsβγ complex
features a 5Å to 6Å larger outward tilt of TM6 as RhR*•GαtCT. Su-
perposition of GαsCT onto the position of GαtCT in RhR* results in
clashes between GαsCT and TM6, suggesting that GαsCT requires
a larger outward tilt than GαtCT or GαiCT (Figure 14C). We thus
propose that different space requirements for the key interactions of
GαtCT and GαsCT with R* determine distinct TM6 outward tilts in
the corresponding complexes (Figure 14D).
3.2.2 Flexible TM6 behavior in uncomplexed β2AR
The crystal structure of the β2AR*•Gαsβγ complex shows a TM6 con-
formation of β2AR* tilted further outward than in RhR*•GαtCT. To
find out whether β2AR* can exists in a RhR*-like conformation, we
removed the constraining Gαsβγ. We then hypothesized that GαiCT
might be able to stabilize the TM6 of β2AR* in a conformation simi-
lar to that in RhR*•GαtCT. Using the receptor coordinates from the
β2AR*•Gs complex [32], we started a series of MD simulations of the
uncomplexed β2AR*. For that we reconstituted β2AR* in-silico into
a DMPC lipid bilayer solvated in water and carried out five indepen-
dent 200ns to 400ns MD simulations.
With the cytoplasmic binding partner absent, we observe a broad
distribution of TM6 tilts (Figure 15A,D), which is in accordance with
earlier experimental [55] and computational analyses [54]. The TM2
to TM6 distance (dTM2–6, see Section 2.4.4) peaking at 28Å reflects the
presence of the Gs-coupled state in the uncomplexed β2AR*. How-
ever, at around 23Å, another peak arises, defining another population
of TM6 tilts in β2AR* (Figure A1A). The smaller dTM2–6 in that popu-
lation renders it similar to the more closed RhR*•GαtCT state. Dur-
ing the simulations, we observe TM6 moving back and forth between
the states of both populations, while the cytoplasmic end of TM6 un-
dergoes pronounced order-to-disorder transitions (Figure A1B). Such
flexibility of R* has been previously shown by spectroscopic studies
applying NMR on β2AR* [164] or FTIR [43] on RhR*.
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Figure 15: Conformations of the cytoplasmic crevice of β2AR* observed in
MD simulations (A,D) alone, (B,E) with GαsCT19, and (C,F) with GαiCT19.
Panels A-C show the time traces of the TM6 tilts (dTM2–6) with resulting
distributions and observed probabilities p. Panels D-F schematically depict
the Gs-coupled state (blue) and the RhR*-like state of β2AR* (red) defined
by representative TM2 and TM6 conformations. (C) In 3 of 21 simulations
(100ns to 600ns), β2AR* adopts a RhR*-like conformation with GαiCT19.
Crystal structures of R and R* exhibit the following TM6 tilts: inactive β2AR
(PDB entry 2RH1), 18.2Å; β2AR*•Gs (3SN6), 29.7Å; inactive RhR (1U19),
16.4Å; and RhR*•GαtCT (3PQR), 23.2Å. The figure and legend are reproduced
from [101]
3.2.3 Using GaCT peptides as a surrogate of G
GαCT peptides have been successfully used as surrogates for G to
stabilize the active receptor conformation [76]. Recently, Gαs/iCT
peptide based FRET sensors have been used to detect a β2AR* lig-
and that selectively activate Gi over Gs [163]. The β2AR*•Gαsβγ
complex gives us the opportunity to identify the minimum length a
GαsCT peptide needs to sufficiently mimic complex stabilization by
Gs so that it can be used as a surrogate of Gs. For that, we performed
a series of β2AR* MD simulations with Gs truncated to GαsCT 19-
mer (GαsCT19, 376FNDCRDIIQRMHLRQYELL394) and 11-mer pep-
tides. The effect of the peptides on TM6 in these simulations was
then compared to simulations of the full β2AR*•Gαsβγ complex.
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The 19-mer peptide remains in its starting conformation during all
simulations (Figure A3) and keeps TM6 at its initial position (Fig-
ure 15B,E) through the same specific interactions as with Gs (Fig-
ures A4B and A5B). However, with the further truncated 11-mer
peptide, we observe a higher positional variability of GαsCT11 (Fig-
ure A3) and TM6 (Figure A2) stemming from a reduction of specific
contacts between β2AR* and GαsCT11 (Figures A4C and A5C).
The higher positional variability of GαsCT 11 compared to GαsCT
19 and an analysis of the specific contact between GαsCT and β2AR*
suggest that 15 C-terminal residues of Gα are required to form the
binding interface for Gs coupling to β2AR* (see Figures 17A, A4A-C,
and A5A-C). These 15 residues can form a scaffold between ICL2 and
TM5/6 that alone sufficiently stabilizes the more open cytoplasmic
crevice of β2AR* coupled to Gs. But the initially helical N-terminus
of the GαsCT11 peptide exhibits some unwinding, too. To account
for that unwinding, we will use GαCT19 peptides, not 15-mer pep-
tides, as surrogates of G to investigate the coupling to β2AR* and in
particular the stabilization of specific TM6 conformations.
3.2.4 Stabilization of a RhR*-like conformation of β2AR* by GαiCT
Given the observation of a RhR*-like conformation in the ensemble
of uncomplexed β2AR* conformations, we addressed the question
of whether the RhR*-like conformation can be stabilized by a Gαi
C-terminal 19-mer (GαiCT19). Finding that β2AR* can accommo-
date GαiCT with a RhR*-like conformation would corroborate the
proposed role of TM6 in distinguishing between GαsCT and GαiCT.
To address this question, we extrapolated a starting position for
GαiCT19 (336FDAVTDVIIKNNLKDCGLF354) from the crystal struc-
ture complex of GαtCT19 (332FDAVTDIIIKENLKDCGLF350) with
RhR* [31] (see Section 2.2.2). The receptor coordinates were taken
from the β2AR*•Gs crystal structure complex [32] to form a β2AR*•
GαiCT complex suitable for starting MD simulations where GαiCT19
initially does not have any contact with TM6. In 18 of the 21 indepen-
dent simulations started with that complex, TM6 tends to persist in
its initial position for the first hundreds of nanoseconds (Figure A2E).
This TM6 behavior is similar to what we observed in the simulations
of uncomplexed β2AR* (Figure 15A, D). However, the initial receptor
conformation is left and TM6 spontaneously tilts inward by 6Å (Fig-
ure 15C,F) in 3 simulations. In those simulations, a β2AR*•GαiCT
complex with a dTM2–6 = 23Å is formed.
β2AR*•GαiCT with a Gs-like TM6 conformation
The 18 remaining simulations exhibit no departure from the initial,
crystal structure conformation of the receptor. There TM6 stays in an
outward-tilted conformation, but the GαiCT peptide changes. Leav-
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Figure 16: Umbrella sampling run along the coordinates of the TM6 inward
movement during transition from the starting state using the receptor co-
ordinates from the β2AR*•Gs complex to the β2AR*•GαiCT 19 complex
(see Figure 15). (A) potential of mean force (PMF) energy profile (black line)
and error estimation (gray area). Arrows indicate the positions of the ini-
tial (Gs coupling state, blue) and the final β2AR* conformation (red) on the
transition coordinate (Section 2.3.3). An energy barrier of (3.0˘ 2.3)kT is at
2.3nm on the transition coordinate, which corresponds to dTM2–6 « 28.6Å.
(B) Increase of the β2AR* GαiCT19 interaction surface accompanying the
TM6 inward movement. (C) Schematic depiction of the TM6 inward move-
ment and corresponding (D) view of the the intracellular binding crevice,
using the actual receptor coordinates from the simulation. Panel (A), (B) and
their legend are reproduced from [101]
ing its initial position, GαiCT gains contact with TM6 by adopting
a GαsCT-like conformation. After GαiCT is wedged that way in the
binding crevice, we unsurprisingly do not observe TM6 tilting inward
as it is now stabilized by the peptide. Presumably, this conforma-
tion is heavily biased by the initial crystal structure conformations, of
the receptor from which the simulation starts. Nevertheless, GαiCT
seems to be able to bind in two different conformation depending on
the TM6 position. While this raises the question why there may be
two different GαiCT binding modes, it does not affect the observation
that GαsCT exhibits only one binding mode.
Umbrella sampling
Observing the TM6 inward motion in just a fraction of the performed
simulation, points to an substantial energy barrier that retards forma-
tion of the more closed β2AR* state that binds GαiCT. To characterize
that energy barrier, we performed umbrella sampling (US) MD sim-
ulations along one of the trajectories that lead to a β2AR*•GαiCT
complex. For this trajectory, we calculated the PMF (Figure 16A). The
PMFs firstly confirm the existence of such an energy barrier which
probably arises from the reorganization of interactions that is ob-
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Figure 17: Contacts observed in MD simulations of various R*•GαCT19
complexes. (A-C) Recurring polar contacts involving side chains (dashed
boxes), backbone carbonyl (dotted boxes), or cation-π interactions (solid
boxes) between peptides (circles) and receptors (boxes) depicted as inter-
action schemes. Buried residues are colored green; accessible residues are
blue (see also Figure A8). (D-E) Top view from the intracellular side on the
different R*•GαCT19 complexes. Hydrogen bonds between residues (sticks)
of peptides (gray) and R* (colored) are indicated as dotted lines. For clarity,
only the C-terminal 11 residues of the GαCT19 peptides are shown in pan-
els D-F, but in panels A-C, the full set of interactions is described. The figure
and legend are reproduced from [101]
served between TM5/6 (Figure A6B). Secondly, the PMFs show a
continuous downhill reaction for the TM6 inward movement after
the barrier is overcome.
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While GαiCT19 remains at its starting position and forms the
key interaction between C351 and R1313.50, the interaction surface
between β2AR* and GαiCT19 increases (Figure 16B). Additional
specific interaction in form of hydrogen bonds between N347 and
P1383.57 from the second intracellular loop (ICL2) and from D341
and K345 to ICL3 are also observed. Notably, these interactions re-
flect the hydrogen bond network that is observed in MD simulations
of GαtCT with RhR* (Figures 17C and A5E). As a result, β2AR* can
form a complex with GαiCT that shows remarkable similarity to the
crystallographically determined RhR*•GαtCT complex (Figure A7C).
The TM6 is tilted inwards, closing the cytoplasmic crevice and form-
ing a tight interaction with GαiCT (Figure 16B). The resulting com-
plex of the extrapolation of GαiCT to Gi (based on β2AR*•Gs) has no
clashes with the membrane nor within the complex itself (Figure A7).
Comparison of R*•GαCT19 complexes
Including the RhR*-like β2AR*•GαiCT complex in addition to the
β2AR*•GαsCT and the RhR*•GαtCT complex, we have now ob-
tained simulation data on three distinct receptor GαCT complexes.
To describe the observed differences of their respective coupling in-
terface, we analyzed the hydrogen bonding pattern, cation-π interac-
tions (Figure A5) and the interaction area (Figure A8) between recep-
tor and peptide. The results are summarized in Figure 17. Apart
from the already described interaction to R3.50, all complexes show
multiple hydrogen bonds from the peptide TM5/6 and ICL2. We find
hydrogen bonds to H8 in β2AR*•GαsCT and RhR*•GαtCT but not
in β2AR*•GαiCT, which in turn exhibits hydrogen bonds to ICL1 ex-
clusively. With 4 buried and 4 exposed residues, the GαsCT peptide
is less enclosed in our simulations as GαiCT (5 buried, 4 exposed)
and GαtCT (6 buried, 6 exposed). This clear-cut distinction between
buried and exposed residues in RhR*•GαtCT suggest a very specific
coupling interface.
3.2.5 Control MD simulations of RhR* with and without GαsCT
Having established that β2AR* is capable of accommodating both
GαsCT and GαiCT peptides, we wondered whether RhR* can do it
too, that is form a well-defined complex with GαsCT in addition to
RhR*•GαtCT for which crystal structures exist. While it has been
shown that RhR* does not form functional complexes with Gs [165],
investigating a putative binding mode of GαsCT with RhR* is still
of interest. In the beginning of this section, we propose that the dy-
namics of TM6 are the crucial feature of β2AR* for distinguishing
between different G proteins. Finding that RhR* lacks similar TM6
dynamics and fails to accommodate GαsCT would serve as a control
of this hypothesis, corroborating the role of TM6. To this end we
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performed a series of MD simulations with RhR* and (modeled) pu-
tative RhR*•GαsCT complexes. In this RhR*•GαsCT model, GαsCT
is bound in a way resembling GαsCT bound to β2AR* in the β2AR*•
Gαsβγ complex (Section 2.2.2).
First, we do not observe larger TM6 outward tilts corresponding
to the β2AR*•Gs conformation in MD simulations of uncomplexed
RhR* (Figure A2F). But for β2AR* we did observe RhR*•GαtCT-like
conformations of TM6. Secondly, in simulations of a putative RhR*•
GαsCT peptide complex (see Section 2.2.2), the characteristic cation-
π interaction between Y391 and R3.50 (here R135) does not form as
with β2AR*•GαsCT (A4). Taken together, these results suggests that
TM6 tilts in RhR* are limited and that RhR* can not accommodate
GαsCT. This is in accordance with RhR*’s failure to activate Gs [165]
and the absence of a Gs signaling pathway in the visual rhodopsin
system [12].
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3.3 role of r* in g α5 displacement
The intermediary R*•G[GDP] is the first stable/specific complex of
receptor and G protein in the sequence of events during receptor-
triggered G protein activation (Figure 5). R*•G[GDP] accumulates
under excess of GDP while GTP is absent [44, 83], likely involving
the α5 helix for coupling [83]. Here we investigate how the tran-
sition from the intermediary R*•G[GDP] to the nucleotide-free R*•
G[empty] complex causes nucleotide release. Specifically, what the
role of the α5 helix at the receptor G protein coupling interface is.
We propose that the α5 helix rotates at/within the coupling interface
during the transition leading to the nucleotide release as described
in [78].
Due to the lack of structural data on the intermediary R*•G[GDP],
we first create a model of that complex based on flexible docking cal-
culations and requirements deduced from experimental data on the
R*•G[GDP] and R*•G[empty] complexes and their transition. Start-
ing from the intermediary R*•G[GDP] model, we employ MD simu-
lations to test if the α5 helix alone (without the rest of the G protein)
can perform its proposed role at the receptor G protein coupling in-
terface.
3.3.1 Prerequisites of a R*•G[GDP] complex
The intermediary R*•G[GDP] complex should meet a number of re-
quirements deduced from experimental data and sterical constraints
placed on the G orientation by the membrane environment, the pre-
ceding and the following G conformations.
The G protein in the uncomplexed Gα[GDP] and in the R*•G com-
plex differ in a number of places as revealed by X-ray structure and
HDX as well as EPR analyses [80, 32, 81, 82, 83]. The α5 helix
switches (i. e. rotates and translates with respect to the Gα Ras do-
main) and the all-helical (AH) domain is displaced. Directly contact-
ing the GDP nucleotide and forming its binding pocket, the loop at
the N-terminal end of the α5 helix and the AH domain are crucial for
GDP stabilization. To maintain a stable GDP binding pocket it is thus
reasonable that in the nucleotide-bound R*•G[GDP] intermediate the
structure known from uncomplexed Gα[GDP] is preserved, i. e. the
α5 helix is not switched (and the all-helical domain is not displaced).
For the β2AR* Gαs system, HDX experiments suggest that Gαs
with GDP bound couples to β2AR* mainly through contact with
GαsCT [83]. After adding GDP to a nucleotide-free preparation that
stabilized the empty site complex, the exchange rates do only slightly
increase at the α5 C-terminus. These exchange rates show differences
between GDP-bound and nucleotide-free complexes. Low exchange
rates indicate structured elements, which suggests that α-helical con-
64 results
formation of GαsCT in GDP-bound Gαs that is stabilized through in-
teractions with β2AR*. In contrast, adding a non-hydrolyzable GTP
analog uncouples Gs from β2AR*•Gs and results in high exchange
rates of the α5 C-terminus [83].
Superposing the crystal structures of uncomplexed G, Gαs[GTPγS]
or Gαi[GDP] with R*•GαCT shows major clashes with the membrane
(see Fig. 5 of ref. [31]). Meeting the requirement of a not switched α5
helix to preserve the structure of uncomplexed Gα[GDP] and main-
tain a stable GDP binding pocket, the C-terminus of GDP bound Gα
must thus bind with a different orientation to β2AR* in the GDP-
bound as in the empty site complex. Of note, rotating the complete G
protein by the amount the α5 helix turns in the helix switch, a clash
free model of the R*•Gs[GDP] complex can be obtained as shown
previously for RhR*•Gt [78].
3.3.2 R*•G[GDP] complexes identified by flexible docking and modeling
With the aim of modeling R*•G[GDP] complexes, docking calcula-
tions were performed to detect feasible GαsCT interactions with the
β2AR* cytoplasmic crevice. To this end, P. Hildebrand applied the
flexible docking protocol as previously described [78], using a fixed
α-helical backbone geometry but flexible side chains. The thus ob-
tained docking poses were then analyzed by clustering as described
in Section 2.5.
Previously, docking of GαtCT 15- and 19-mer peptides recovered
the position of the RhR*•GαtCT X-ray structure, which is likely the
position α5 would adopt in the RhR*•Gt empty site complex. In ad-
dition, a second position featuring different interactions was found
and assigned to reflect the intermediary RhR*•Gt[GDP] complex [78].
Now, in a flexible docking analysis of 15-mer GαsCT to β2AR*,
we find an analogous pair of states for the β2AR* Gs system (Fig-
ures 19, 18).
GαsCT docking states
The flexible docking yields multiple states, of which the highest scor-
ing conforms to the position and orientation of GαsCT seen in the
co-crystal of β2AR*•Gs (Figure 18), thus confirming the applicability
of the docking approach. Moreover, this state shows the characteristic
cation-π interaction between Y391 and R1313.50 (Figure 19B). A num-
ber of contacts from the N-terminus of 15- mer GαsCT to ICL2 and
3 of β2AR* are also formed as in the β2AR*•Gs complex. Notably,
hydrogen bonds of Q384 with the main chain carbonyl group of I135
from the conserved P1383.57 C-terminal cap of TM3 (Figure 19D) are
observed. A second docking state of GαsCT has fitting properties for
a β2AR*•Gs[GDP] model. There, a rotation around the helix axis (i. e.
compared to the first docking state) results in a shift of the reverse
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Figure 18: Clusters of peptide positions obtained by flexible docking of 15-
mer GαsCT to β2AR*. The largest cluster (orange) coincides with the po-
sition and orientation of GαsCT in the X-ray structure. However, in agree-
ment with the MD simulations of β2AR*•GαsCT (A10) GαsCT is shifted
away from TM3 as compared to its position in the β2AR*•Gs[empty] com-
plex. In the blue cluster (third largest cluster), GαsCT is rotated by 70°
compared to the X-ray state and represents the position in a putative R*•
G[GDP] intermediate. The inset shows the view along the helix axis, high-
lighting the difference between both states. The orientation of GαsCT from
the second largest cluster (representative structure shown in red in the inset)
is neither compatible with the X-ray state nor with the R*•G[GDP] interme-
diate because it over-twists the rotation of GαsCT. Hypothetically, this posi-
tion refers to one of the intermediate dissociation states observed by single
particle EM of the β2AR*•Gs complex [82].
turn of GαsCT by one residue relative to R1313.50. The cation-π inter-
action with Y391 is replaced by a hydrogen bond R1313.50 forms with
E392 (Figure 19A, B). In lieu of a hydrogen bond to Q384 at the N-
terminus, a potential hydrogen bond between the backbone oxygen
of I135 from the P1383.57 cap and R385 forms (Figure 19C, D).
In the described docking states, the same conserved structural mo-
tifs of β2AR* are employed by GαsCT for binding. However, com-
parison of both states shows that the shift of the interacting residues
of GαsCT by one position goes along with a clockwise rotation of
GαsCT by 60° and a translation of 1.5Å. Given that the α5 helix
within Gs is rotated in the opposite direction by the same magni-
tude between the uncomplexed Gα[GDP] and the R*•G complex, the
nucleotide-bound states of Gs or Gi can be superposed with GαsCT
of the second docking state to create a very similar complex configu-
ration as in the β2AR*•Gs complex, however, with α5 rotated by 60°
(Figure 19E, F). As in the previous analysis of the RhR* Gt interac-
tion [78], the such created complex does not cause any major protein-
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Figure 19: Comparison of (left panel) the β2AR*•Gs[GDP] model and (right
panel) the β2AR*•Gs X-ray structure. Potential hydrogen bonds to the cyto-
plasmic crevice (cyan cartoon) from (A, B) the C-terminal reverse turn and
(C, D) the N-terminus of GαsCT in (A, C) the intermediate position obtained
from flexible docking (yellow cartoon) and (B, D) in the empty site complex
(magenta cartoon), respectively. Residue labels from β2AR* are colored in
black, residues from GαsCT are red. Potential hydrogen bonds are denoted
as black dashed lines. (E) Complete model of the β2AR*•Gs[GDP] interme-
diate compared to (F) the β2AR*•Gs X-ray structure (PDB entry 3SN6). R*•
G[GDP] was obtained by superposition of Gαs[GTPγS] (PDB entry 1AZT),
with the intermediary β2AR*•GαsCT complex obtained from flexible dock-
ing analysis by common backbone atoms. Gsβ- and Gsγ of PDB entry 3SN6
were superimposed to Gαs to obtain a complete model. The figure and legend
are reproduced from [166]
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protein/protein-membrane clashes or distortions. Since in that com-
plex α5 is also structured and the Gs is not altered, especially at the
the GDP binding pocket, it fulfills the above-listed requirements and
was assigned to the β2AR*•Gs[GDP] complex.
3.3.3 Observation of GαCT switches at the R* G protein interface
The rotation of α5 within the cytoplasmic crevice of the R*•G[GDP]
complex is the distinguishing feature that separates the GDP-bound
from the nucleotide-free state. With the R*•G[GDP] complex at hand,
we now want to test whether the rotation of α5 can result from inter-
actions of GαCT and the cytoplasmic crevice alone, that is without
requiring the G holoprotein to be present. To perform the test, we
started 30 MD simulations from the R*•GαCT complexes from the
intermediary GαCT positions obtained by flexible docking of both
systems — the β2AR* GαsCT as well as the RhR* GαtCT system.
Since we work with the peptides here and not the holoprotein, only
the interactions between GαCT (i. e. α5) and R* can influence the test
as desired. Additionally, we performed the simulations with 11-mer
GαCT peptides which are the largest common structure of GαCT in
the available experimental data [66, 167, 68, 69, 32, 31, 67]. However,
as a test, we also evaluated the effect of the peptide length by per-
forming 10 more MD simulations with 19-mer GαCT peptides. In
general, all simulations were unbiased with GαCT neither restricted
to its starting conformation nor in its mobility.
R*•G[GDP] simulation with GαCT
We performed a total of 60 MD simulations, 30 each for the β2AR*
and the RhR* systems, of which 18 feature a GαCT helix switch, 8
for GαsCT and 10 for GαtCT. Analysis of the MD simulations shows
that the 11-mer GαCT adopts in about one third of the simulations
a conformation maintained for the remainder of the simulation (Fig-
ures A22–A31). Formation of the maintained binding modes occurs
quickly, i. e. within 50ns for GαsCT and within 3ns for GαtCT. With
the exception of two simulations, we observe a switch-like transition
of GαCT from its starting position to its position seen in the X-ray
structures in all of them. The transitions are monitored by the param-
eters backbone RMSD and peptide rotation (Figures 20, A22, A23).
Despite the fact that two different receptors and peptides were sim-
ulated, the GαCT peptides undergo similar screwing motions to re-
establish the key interaction with R3.50 as in the nucleotide-free state.
The formation of that interaction becomes apparent in time-resolved
analyses of distance and energy (Figures 20E-F, A24, A25). During the
GαCT helix switch, the secondary structure of GαCT persists (Fig-
ures A26, A27) while a number of water molecules are displaced
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Figure 20: Switch of GαsCT (left) and GαtCT (right) at the R* interface ob-
served in MD simulations. Background panel: GαsCT switches with the cy-
toplasmic crevice of β2AR* from the intermediary (red) to the empty site po-
sition (blue). The transition is schematically indicated by semi-transparent
colored cartoons. GαsCT is rotated around its helix axis (red and blue ar-
rows) by about 60°, which eventually leads to GDP release from the nu-
cleotide binding pocket of the Gs holoprotein (gray, flat-shaded). In addi-
tion, a tilt motion of GαsCT parallel to the membrane plane is observed. The
surface of the receptor (gray) is cut at the position of R3.50 (orange patch)
located at the floor of the cytoplasmic crevice. TM helices are drawn as
cylinders. For clarity, H8 and TM6 of β2AR* are omitted. Backbone-RMSD
of (A) GαsCT or (B) GαtCT relative to their position in the X-ray struc-
ture. Change in rotation of (C) GαsCT or (D) GαtCT around its helix axis.
Distance between (E) the center of the phenyl ring of Y391 of GαsCT and
R1313.50 or (F) between the carbonyl oxygen of C347 of GαtCT and R1353.50.
Gray bars indicate the mobility of GαCT in MD simulations of (left) β2AR*•
Gs or (right) RhR*•GαtCT (see Figures A10, A11 and A13). The mobility of
switched GαsCT (after about 100ns) is only slightly increased when com-
pared to the mobility of the corresponding section in β2AR*•Gs (gray bar).
The time series data are drawn on top of the raw data as a running aver-
age. The plots are linear for the first 10ns and logarithmic for the remaining
time (gray dashed lines). The four representative simulations (black, red,
blue, green) of GαsCT (Figure A22, simulations 8, 9, 21 and 23) and of
GαtCT (Figure A23, simulations 9, 16, 21 and 30) were picked from 8 and
10 simulations where a switch was observed (Figures A22 and A23). The
figure and legend are reproduced from [166]
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from the coupling interface in favor of the formation of a hydrophobic
patch between GαCT and ICL3 of R* (Figures A19, A28–A31).
In simulations where no single conformation is maintained, GαCT
diffuses away and unfolds or fluctuates between different orienta-
tions and positions. The only additional maintained binding mode
of GαCT is observed in simulations 11 and 12 in the RhR* GαtCT
system (Figures A22B–A31B). There, the helix axis of GαtCT is tilted
10° steeper toward the membrane plane.
19-mer GαCT simulations
The additional simulations of 19-mer GαCT performed to the eval-
uate the effect of peptide length show very similar dynamics as ob-
served with the shorter 11-mer peptides, including two helix switch
events for each system respectively (Figure A18). Due to the lack of
stabilizing contacts with R*, the N-terminal portion of 19-mer GαCT
is highly mobile (Figure A18A). In contrast, the mobility of the C-
terminal reverse turn of switched GαCT is low, as with the 11-mer
peptides and comparable to the mobility of the corresponding sec-
tion in β2AR*•Gs (Figure 20A, C, E, gray bars).

4
DISCUSS ION
4.1 disordered regions and rhr*•gαtct formation
Active rhodopsin (RhR*) can activate up to 103 G proteins (G, Gαβγ)
per second and more [44], while at the same time exhibiting virtually
no constitutive activity. To elucidate the structural determinants that
allow such a perfect switching behavior (i. e. unparalleled speed and
fidelity), we investigated intrinsically unstructured regions in both
binding partners. In the G protein the Gα C-terminus (GαCT) be-
comes structured upon binding to RhR* [68, 31, 32]. For the recep-
tor, the third intracellular loop (ICL3) is a candidate for an intrin-
sically unstructured region, as ICL3 is often unstructured in other
GPCRs and sequence analysis, too, suggests it is intrinsically unstruc-
tured [61]. However, structures of rhodopsin obtained by X-ray crys-
tallography show the ICL3 of rhodopsin and its apoprotein opsin
resolved in both inactive and active receptor states and regardless of
being bound to a GαtCT peptide or not [39, 30, 31].
4.1.1 ICL3 structure and effect of GαtCT observed in MD simulations
The molecular dynamics (MD) simulations of rhodopsin show the
fluctuations of the receptor structures in the first few hundred
nanoseconds after removal from the crystal lattice and placement in
a membrane-water environment (Figure 21). Within that timespan,
the ICL3 of the receptor is generally observed to be flexible unless
constrained by a GαtCT peptide. In simulations of RhR, the flexibil-
ity reflects the high B-factors seen in the respective crystal structures.
In contrast, the simulations of RhR* without a GαtCT peptide show
high ICL3 flexibility despite moderate B-factors in the respective crys-
tal structures. However, in the crystal structures of RhR*, the ICL3 is
stabilized by a number of contacts within the crystal lattice: the sym-
metry mates contact ICL3 with ICL2 and helix 8 (H8, Figure 21). The
lack of those constraints (resulting from the experimental conditions)
in the MD simulations fits to the differing ICL3 behavior in the simu-
lations.
Interpretation of the observations from the MD simulations should
be done with respect to the ensemble of ICL3 conformations at sta-
tistically robust timescales. For that, we compare the MD data with
Fourier transform infrared spectroscopy (FTIR) results on the confor-
mational diversity of RhR*. The FTIR experiments provide informa-
tion on the ensemble of ICL3 conformations for the receptor states
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Figure 21: Comparison of RhR* ICL3 crystal lattice contacts and flexibil-
ity observed in MD simulations. (A) Crystal contacts in RhR* (PDB entry
3PXO) involving ICL3 are shown as gray patches between a central receptor
molecule (red) and its symmetry mates (green). The symmetry mates con-
tact ICL3 with ICL2 and H8 as well as TM6 with H8 (italic labels). (B) Flex-
ibility of ICL3 observed in MD simulations of RhR* embedded in a lipid
bilayer-water environment. Shown are the crystal structure (gray), which is
also the starting conformation, and three representative conformations (red,
orange, yellow) obtained by cluster analysis.
that populate each of the active receptor’s conformations. However,
assigning the distinctive FITR markers to structural changes is not
readily possible, especially at atomic resolution. By combining the
FTIR data on well-defined molecular ensembles with the atomistic
MD data of single molecules, a more complete view of the ICL3 be-
havior in RhR* is provided [56].
4.1.2 FTIR spectroscopy links stabilizing effect of GαtCT to ICL3
Using FTIR spectroscopy, the metarhodopsin states of light-induced
retinal-bound receptors can be distinguished (for an in depth investi-
gation of rhodopsin with FTIR see Elgeti [168]). Within milliseconds
of illumination, rhodopsin leaves the dark state conformation and
enters the multi-step equilibrium scheme of metarhodopsin states
(Scheme 3). The exact distribution of metarhodopsin states across
the equilibrium can be controlled by experimental conditions, i. e. by
pH and temperature. By analyzing pH titration curves of specific
FTIR difference bands using Scheme 3, the fractions of the individual
metarhodopsin states can be deduced [169, 56]. At high pH (ą 9) and
a temperature of 30 ˝C, MI, MIIa, and MIIb are found to be each pop-
ulating a fraction of approximately one-third. However, at low pH,
the titration curves converge with an apparent pKa of 7.5, indicat-
ing stabilization of the protonated MIIbH+ receptor state. In the pH
range of 5 to 6, the MIIbH+ receptor state is selectively stabilized by
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facilitating proton uptake to E134 and thus destabilizes the inactive
state [170].
MIéMIIaéMIIbéMIIbH+
Scheme 3: Equilibrium scheme of metarhodopsin states. Adapted from [56].
By adding GαtCT peptides to the spectroscopic titration assay, sta-
bilizing interactions between peptides and specific metarhodopsin
states can be investigated [56]. Following Scheme 4, the pH-
dependent distribution of the metarhodopsin states was described.
Addition of 10mM peptide shifted the apparent pKa to 9.1. A se-
lective stabilization of the protonated MIIbH+•GαtCT complex was
found, extending over a much broader pH range of 5 to 9 than with-
out GαtCT [56].
To investigate the effect of the GαtCT peptide binding on the re-
ceptor structure, a peptide binding spectrum (PBS) was devised [56]:
Two difference spectra measured in the presence and absence of the
GαtCT peptide are obtained; by subtracting one from the other, a
double difference is calculated that defines the PBS. The subtrac-
tion cancels out the vibrational changes of the unbound receptor
molecules, leaving the conformational changes to receptor and pep-
tide upon complex formation [171, 172, 173]. Strong bands in the
structurally sensitive amide II region of the GαtCT PBS indicate
changes to the secondary structure of receptor and peptide [56].
MI é MIIa é MIIb é MIIbH+
ê ê
MIIb•GαtCT é MIIbH+•GαtCT
Scheme 4: Equilibrium scheme of metarhodopsin states extended by GαtCT.
Adapted from [56].
The crystal structures of RhR* and RhR*•GαtCT show a hydrogen
bond network in ICL3 that links TM5 and TM6. It is comprised of the
residues K231ICL3, E2476.30 and T2516.34 and has been suggested as
a determinant of the active conformation [1]. K231ICL3 is also part
of the conserved Y5.58(x)7K(R)ICL3 motif. The role of K231ICL3 was
previously investigated in a metadynamics simulation study [113].
There, the K231A mutant was used to prevent participation of this
residue in hydrogen bonds and thus (potentially) weakening the link
between TM5 and TM6. Moreover, energetic analysis of the metady-
namics simulations suggests that the K231A mutation considerably
affects the distribution of activated receptor conformations [113].
The FTIR spectroscopic study therefore obtained a difference
spectrum of the K231A rhodopsin mutant and of wild-type (WT)
rhodopsin at MIIbH+-favoring conditions [56]. A double difference
spectrum K231A minus WT was calculated to highlight the effect of
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the K231A mutation. Remarkably, that double difference closely re-
sembles the inverted GαtCT PBS. As the spectra describe conforma-
tional changes, their similarity suggests that the receptor conforma-
tion that is stabilized by GαtCT is in turn destabilized by the K231A
mutation. This implies that the conformation stabilized by GαtCT
is also present as a significant fraction in the ensemble of receptor
conformations in the absence of GαtCT [56].
4.1.3 Hierarchy of conformational states in RhR*
By employing FTIR spectroscopy and MD simulations of membrane
embedded rhodopsin, the static view provided by X-ray crystal struc-
tures could be revised with the help of complementary dynamic in-
formation. Both, the FTIR and the MD analysis, suggest that without
GαtCT the active receptor exists in an ensemble of states. The MD
analysis indicates a flexible ICL3 that adopts many different confor-
mations. The spectroscopic study established the receptor’s confor-
mational diversity and analysis of the K231A mutant could link that
diversity to ICL3.
To discuss the role of the intrinsically unstructured regions, we will
integrate the results on ICL3 and GαtCT dynamics into the concept
of protein dynamics developed by Frauenfelder and co-workers [174,
175]. The concept establishes a hierarchy of three conformational
states by distinguishing between the exchange rates. The top tier
(tier 0) consists of protein states that exchange on the microsecond
timescale. For RhR* the equilibrium of metarhodopsin states MI,
MIIa, MIIb and MIIbH+ builds up tier 0 (Scheme 3). The protein
states in turn are each an ensemble of taxonomic sub-states of tier 1
exchanging with nanosecond lifetimes. Further sub-division of the
taxonomic sub-states yields the statistical sub-states of tier 2 describ-
ing fluctuations that change on the picosecond timescale [176]. These
relatively fast conversions imply energy barriers of less than 1 kT,
which results in fluctuating behavior at physiological temperatures
that can be readily observed in MD simulations. Cluster analysis
of RhR and Ops* simulations shows ICL3 conformations exchanging
with lifetimes of 10ns to 100ns, indicating fluctuations within taxo-
nomic sub-states (Figure 11A, B). Within a single taxonomic sub-state,
the backbone RMSF describes its statistical sub-states, e. g. for ICL3
in simulations of RhR* stabilized by GαtCT (Figure 11C).
A salient insight from the hierarchy of conformational states is that
transitions within a lower tier can facilitate transitions within a higher
tier and, especially, that taxonomic transitions allow for fast protein
state transitions [52], which will be important for a functional inter-
pretation of the FTIR and MD results.
4.1 disordered regions and rhr*•gαtct formation 75
4.1.4 GαtCT binding stabilizes a single sub-state of RhR*
The extreme C-terminus of the Gα subunit becomes structured upon
binding RhR*. In X-ray crystallography structures of nucleotide
bound Gαi/tβγ [64], Gαiβγ [177] (close homologue of Gt) or
Gαs [65], the GαCT is not resolved. Solution NMR structures show
that the GαtCT peptide forms a capped α-helix when bound to ac-
tive rhodopsin [68, 69]. Upon binding of the peptide, the structure
of RhR* also exhibits changes as shown by FTIR spectroscopy [173].
However, crystal structures of RhR* do not show major differences
between structures with or without peptide [31, 30, 66]. This dis-
crepancy likely stems from the constraints imposed by the crystalliza-
tion conditions, in particular by the crystal lattice. All structures of
RhR* feature extensive crystal contacts of ICL3 regardless of binding
partner or lack thereof [30, 31, 67, 66, 167, 178, 179, 75]. Note that
the intrinsic flexibility of ICL3 is a major obstacle to successful struc-
ture determination of GPCRs in general and many structures were
resolved with a fused T4-lysozyme in place of the ICL3 [180].
Our MD simulations support the notion that RhR* features an en-
semble of ICL3 conformations, exhibiting much more flexibility than
the other intracellular loops and helix 8 (Figure 10). As the simula-
tions were based on protonated R*H+ (MIIbH+ or Ops*H+) struc-
tures, the observed fluctuations showing different bent and helical
conformations of ICL3 can be assigned to the R*H+ protein state.
Furthermore, the conformations within the ICL3 ensemble exchange
on timescales of 10´8 s (Figure 11B), which puts them in the realm
of taxonomic sub-states (tier 1). Our analysis agrees with an EPR
analysis on the α-helical content of ICL3 notably in the aspect that
flexibility of ICL3 is shifted to the TM5 side [162]. Also, the FTIR
study complementing the MD simulations finds features in the dif-
ference spectra after hydrogen/deuterium exchange, which suggest
backbone structuring after GαtCT peptide binding [56].
The spectroscopic and in silico data strongly suggest that ICL3 con-
stitutes an intrinsically unstructured region that populates the taxo-
nomic sub-states in the R*H+ protein state. Adding a GαtCT peptide
drastically changes the structure of ICL3 by altering the underlying
conformational energy landscape from a rugged but relatively flat
shape into a rather deep well (Figure 22) that corresponds to a largely
α-helical ICL3 conformation (Figure 10C). This stabilization of one
specific taxonomic sub-state of R*H+ is apparent from distinct fea-
tures in the peptide-binding spectrum [56]. The involvement of ICL3
in the peptide binding can be deduced from the destabilizing effect of
the K231A mutation as shown by the FTIR analysis [56]. ICL3 struc-
turing or decrease in solvent accessibility upon complex formation
was also suggested by a hydrogen-deuterium exchange study [84].
Notably, it had been proposed based on sequence analysis of GPCRs
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that ICL3 forms an intrinsically unstructured region that gets struc-
tured through complex formation of receptor and G protein [61].
Figure 22: Mutual structuring of the receptor G protein coupling interface.
GαtCT specifically binds to the protonated active rhodopsin state (MIIbH+,
Ops*H+), thereby stabilizing a single taxonomic sub-state. (A) Upon RhR*•
GαtCT complex formation, both GαtCT (bottom) and ICL3 (top) become
structured (red cartoons) through mutual adjustment of the initially un-
structured binding partners (black cartoon). Shown are the the unstruc-
tured ICL3 from RhR (1U19), the structured ICL3 from RhR* (3PXO), an
unstructured GαtCT (obtained by a MD simulation of GαtCT in water)
and the structured GαtCT found in co-crystals of RhR* and GαtCT (3PQR).
(B) Schematic display of the mutual structuring of GαtCT and ICL3 along a
reaction coordinate describing ICL3 flexibility from unstructured (left) to
structured (right). In the absence of GαtCT, ICL3 is more likely to be
unstructured than structured (back energy landscape). Upon addition of
GαtCT, the energy landscape is stepwise adjusted by interactions between
GαtCT and ICL3 until the final complex is formed. Structuring of GαtCT
at the coupling interface gradually makes a structured ICL3 conformation
more favorable (red arrows and red energy landscape). Note that the in-
dividual energy levels and energy barriers are only schematic and do not
represent experimentally obtained values. The figure and legend are adapted
from [56]
4.1.5 Binding of GαtCT to the active receptor by mutual adjustment
In both binding partners, receptor and G protein, a main part of their
coupling interface is disordered until complex formation. The recep-
tor exhibits a flexible ICL3 and the GαCT is unstructured [68, 64].
Given their disordered property, complex formation purely by con-
formational selection would be statistically improbable and thus ex-
tremely slow: Consider the multitude of taxonomic sub-states in a
disordered region and how likely it would be to select the correct
sub-state by chance. However, since active rhodopsin can activate up
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to 103 G proteins per second and more under optimal conditions [44],
we propose (based on the data produced in this study) a mutual ad-
justment coupling mechanism that starts after receptor and GαCT are
in proximity.
Formation of an encounter complex [181] between activated recep-
tor and GαCT is likely facilitated by the long-range charge potential
(~1/r) of R1353.50 and other charged amino acids exposed at the re-
ceptor binding crevice ( Figure 17F). The encounter complex changes
the local environment of both GαtCT and ICL3 by bringing them
together such that short-range hydrophobic interactions (~1/r6) may
build up. This would promote helix formation in GαCT and ICL3
through the associated expulsion of water molecules.
To conclude, we propose the following mutual structuring scheme
as a mechanism allowing a fast and precise signal transduction from
receptor to G protein. Once in contact, the ensembles of GαCT and
ICL3 conformations become coupled. Then, a mechanism of stepwise
complex formation takes over, comprising several stages of mutual
adjustment [103] that shift the population of taxonomic sub-states
towards the final complex. This shift corresponds to moving along
a reaction coordinate in an energy landscape that is gradually al-
tered as a result of the ongoing interactions between GαCT and ICL3
(Figure 22). With each step towards the final complex, more spe-
cific conformations along the reaction coordinate are selected. This
stepwise progression works by transient population of distinct taxo-
nomic sub-states exchanging within nanoseconds. The resulting bind-
ing funnel [182] has a large opening, accommodating a multitude
of encounter complexes to start the formation of the final complex.
By initially requiring only a structurally rather unspecific encounter-
complex, formation of the final complex becomes more probable than
in a purely conformational selection scheme.
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4.2 tm6 position and β2ar* g protein coupling
The β2-adrenoceptor can couple to the G protein families Gs and
Gi [4]. Moreover, the receptor must be able to distinguish between
Gs and Gi, as there are known ligands, which can bias the recep-
tor to prefer coupling to one G protein family [163]. The structural
mechanism by which β2AR* specifically selects Gs or Gi is unknown.
However, spectroscopic studies have linked the dynamics of TM6 to
G protein versus arrestin selectivity [27, 26].
In this study, we explored the dynamics of TM6 in active β2AR*,
employing MD simulations to address the issue of Gs versus Gi se-
lectivity. Motivated by the differing TM6 conformations found in
β2AR*•Gs and RhR*•GαtCT, we investigated the TM6 behavior af-
ter removal of the constraining binding partner (i. e. Gs or GαtCT,
respectively). We find that the TM6 in β2AR* populates a larger
conformational space than suggested by the β2AR*•Gs crystal struc-
ture. One of the observed TM6 conformations looks very similar to
the TM6 conformation of the crystal structures of RhR*•GαtCT. Ex-
tensive simulations and energy calculations then indeed suggest that
GαiCT can stabilize β2AR*•GαiCT complex that again looks very
similar to the RhR*•GαtCT crystal structure.
Additional simulations indicate that a RhR*•GαsCT complex is not
feasible. This is in line with a structural comparison of the β2AR*•
Gs and RhR*•GαtCT crystal structures, indicating that specific inter-
action of the bulkier GαsCT with R3 .50 requires a larger TM6 out-
ward tilt than the slimmer GαtCT. In Section 4.1, we already studied
the flexibility of ICL3, the loop connecting TM5 with TM6, in the
rhodopsin system. The different roles of TM6 and ICL3 in receptor
activation and G protein coupling will be discussed.
4.2.1 Conformational heterogeneity of TM6 in active β2AR*
In MD simulations, we observe a strong structural heterogeneity for
the active GPCR β2AR* with bound agonist and in the absence of
intracellular interaction partners. We find different TM6 tilts broadly
distributed, creating a conformational space of the active β2AR*. The
TM6 tilt distributions exhibit two maxima, one at 23Å and the other
at 28Å. The Gs coupled state [32] is well represented by the pro-
nounced maximum at 28Å. The maximum at 23Å, however, does
not correspond to any structurally resolved β2AR conformation. But
it indicates a second β2AR* conformation with a TM6 tilt, very simi-
lar to the 23.2Å observed in the X-ray structure of the RhR*•GαtCT
complex [31].
Our observations of structural heterogeneity are in accordance with
recent studies that provide experimental evidence of structural het-
erogeneity in active β2AR*. Two major conformational states of TM6
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and TM7 in β2AR* were observed in an NMR study with site-specific
cysteine labels and different ligands [27]. Similarly, different con-
formational states of β2AR* depending on ligand and intracellular
binding partner were found in a study combining NMR spectroscopy
with methionine labels and µs timescale MD simulations [55]. An-
other NMR study with a cysteine label on the intracellular side of
TM6 observed multiple β2AR conformations depending on the type
of ligand and the presence of a G protein mimetic nanobody [164].
Moreover, we find the α-helical content of TM6 decreasing after
removal of Gs and increasing upon complex formation (Figure A6A)
with GαiCT. In simulations of β2AR*•Gs, the α-helical content of
TM6 remains unchanged. These observation for the β2AR* system
are very similar to our finding for the RhR* system, where we fo-
cused on the ICL3, linking TM5 and TM6. The similarity of α-helical
content of TM6 in β2AR* and RhR* is also remarkable insofar as
TM6 in β2-adrenoceptor is much less restricted by its ICL3 than in
rhodopsin with a much shorter ICL3. In our combined FTIR and MD
study, we find that in RhR* the ICL3 exists in an disordered ensemble
and upon G protein binding adopts a single ordered conformation
(see Section 4.1 and [56]). Both systems seem to go from disordered,
more flexible conformations to a single specific conformation in the
final complex. In Section 4.1, we argue that such an ordering process
allows for fast and precise binding events.
4.2.2 Stabilization of a more closed β2AR* conformation by GαiCT
In MD simulations of β2AR* with GαiCT, a close homologue of
GαtCT, we observe a defined β2AR*•GαiCT complex that is very
similar to the RhR*•GαtCT complex determined by X-ray crystallog-
raphy (Figure A7C). This β2AR*•GαiCT complex exhibits a more
inward tilted TM6 than the β2AR*•Gs complex (Figure 15). As we
find this more inward tilted TM6 already present in the conforma-
tional space of the active β2AR*, it is likely that the GαiCT peptide
selects it from the equilibrium and stabilizes it. In contrast, we did
not observe a β2AR*•Gs or β2AR*•GαsCT complex with an inward
tilted TM6 in our simulations. Additionally, simulations of a putative
RhR*•GαsCT peptide complex proved unstable (Figure A2F), which
is in line with Gs not coupling with RhR* [165] and the absence of a
Gs signaling pathway in the RhR system [12].
Since the difference in TM6 outward tilt is the major structural dif-
ference between β2AR*•Gs and β2AR*•GαiCT or RhR*•GαtCT, we
assume that TM6 plays a significant role in determining whether a
receptor or receptor conformation can or can not bind to Gs or Gαi/t.
Our structural comparison of the binding crevice in β2AR*•Gαsβγ
and in RhR*•GαtCT (Section 3.2) suggests that specific interaction
of the bulkier GαsCT with R3.50 needs a larger outward-tilted TM6,
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resulting in a more open binding crevice. The MD simulations cor-
roborate this interpretation of the complex structures. Taken together,
our observations suggest that Gs and Gαi/t stabilize different recep-
tor conformations. An analysis of the interactions between GαCT
and receptor finds the two binding modes governed by different sets
of specific interactions by which the GαCT imprint their own shape
onto the receptor binding crevice (Figure 17).
Moreover, our analysis of Gi vs Gs interactions with the active
receptors β2AR* and RhR* provides a structural explanation of pre-
vious mutational studies. A chimera of Gαs and Gαt with only 11
C-terminal residues from Gαt could successfully bind to RhR*, result-
ing in potent activation [73]. Alanine mutants at the GαCT identified
C347 and G348 as essential for activation by RhR*. The corresponding
positions in Gi and Gs are Y391, E392 and C351, G352. The impor-
tance of the positions is reflected in the differential interactions of Gs
and Gi we observe in the simulations. These are Y391 to R3.50, E392
to TM6/H8 for Gs (Figure 17A) or N347 with ICL2, C351 with R3.50,
and D350 with ICL1 for Gi (Figure 17B).
β2AR*•GαiCT complex formation
To characterize the observed β2AR*•GαiCT complex formation in
terms of energy differences (∆G), we performed umbrella sampling
calculations. We find while β2AR*•GαiCT complex formation is re-
tarded by an energy barrier, once this is overcome, TM6 inward move-
ment commences in a continuous downhill reaction. Crossing over
the energy barrier seems to correlate with the increase of the β2AR*
GαiCT19 interaction surface accompanying the TM6 inward move-
ment (Figure 16A,B). This suggests that the corresponding water dis-
placement plays an important role in β2AR*•GαiCT complex forma-
tion, indicating an entropic contribution to the binding energy [183].
4.2.3 Extrapolation of β2AR*•GαiCT to a β2AR*•Gαiβγ model
The β2AR*•Gs complex [32] shows the arrangement of β2AR* with
an activated Gs. Defining features of Gs in this complex are a rotated
and translated α-helix in Gαs together with a displacement of the
Gαs all-helical domain. By employing the Gs from β2AR*•Gs com-
plex to extrapolate from the GαiCT 19 peptide to the Gi holoprotein,
the defining features of an active G could be retained in a putative
β2AR*•Gαiβγ complex. Moreover, the such modeled β2AR*•Gαiβγ
complex yields a feasible arrangement of β2AR* and Gi without in-
ternal clashes (Figure A7A) or unexpected membrane contacts/inser-
tions.
In the context of G protein activation, GDP release is mainly trig-
gered (apart from intrinsic activity, if any) by complex formation
with an active GPCR. In Section 4.3, we propose a mechanistic role
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of the α5 helix displacement for GDP release in the β2AR*•Gs and
RhR*•Gt systems. Also, the model of β2RhR*•Gαiβγ by Alexan-
der, Preininger, Kaya, Stein, Hamm, and Meiler [87] features the
same general GαiCT binding mode as in our β2AR*•GαiCT com-
plex. Given the high degree of similarity between the β2AR*•GαiCT
and the RhR*•GαtCT complexes, the proposed helix switch should
be applicable to the β2AR*•Gi system as well.
4.2.4 TM6 tilts, ICL3 flexibility and G protein binding modes
The GPCR structures resolved so far show the same overall 7-TM fold,
even in distantly related receptors from different families [34]. A no-
table difference with regard to the TM bundle is the position of TM6.
Generally the TM6 positions fall into two clusters, one that is asso-
ciated with the inactive receptor state and another representing the
active receptor, capable of binding a G protein. In the inactive recep-
tor, the intracellular part of TM6 is buried within the TM bundle and
directly contacting TM3 [36, 37, 38]. Upon receptor activation, TM6
tilts outward, increasing the distance between TM3 and the intracel-
lular part of TM6 by more than 6Å. This hallmark event of GPCR
activation creates a binding crevice at the intracellular side to which
a G protein can bind [1].
While there are now structures of inactive receptors for most GPCR
families, structural data on active receptors is still sparse [2, 3]. How-
ever, beginning with TM3-TM6 distance measurements by a SDSL
EPR study comparing inactive to active rhodopsin, experimental ev-
idence was provided for a substantial TM6 movement upon activa-
tion [28, 29]. Later, structures of RhR*, β2AR* and M2* resolved
by X-ray crystallography showed the active receptors in full atom-
istic detail [30, 32, 33]. These structures also exhibit a range of TM6
positions, that depend on the system, the interaction partner or the
experimental conditions [33, 3]. Still, all these TM6 positions create
an intracellular binding crevice, thus suggesting an ensemble of TM6
conformations in active GPCRs.
Investigating the role and the source of the ensemble of TM6 confor-
mations in active GPCRs and their complexes with intracellular bind-
ing partners is an ongoing research effort. Initially, it had was pro-
posed that the β2AR*•Gs structure [60] shows the productive signal-
ing complex, whereas the RhR*•GαtCT structure [31] depicts part of
the signaling complex in an earlier state, closer to the first encounter
of receptor and G protein [184, 60]. However, this interpretation ig-
nores that the two structures are complexes derived from different
receptors and different G proteins. The β2AR*•Gs structure shows
a cation-π interaction between Y391 and R3.50, whereas in RhR*•
GαtCT a backbone hydrogen bond between C347 and R3.50 connects
the Gα reverse turn with receptor binding crevice (Figure 14A,B). The
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cation-π interaction is not possible for the Gαi/t family as it lacks
a tyrosine in the Gα reverse turn. Numerous spectroscopic studies
have now shown the influence of binding partners and ligands on
the β2AR* conformations, especially on the TM6 conformation [27,
55, 164]. In Section 4.2.1, we propose that β2AR* employs different
TM6 positions to accommodate the two different G proteins Gs and
Gi β2AR* is capable of binding and activating. A crystal structure of
a β2AR*•Gi or RhR*•Gt holocomplex would go a long way tracking
down differences in Gs versus Gαi/t binding modes and explaining
how GPCRs accommodate different G proteins.
ICL3 flexibility
Closely related to the issue of TM6 conformations is the structure and
flexibility of the ICL3 linking TM5 and TM6. In Section 4.1 we dis-
cussed the ICL3 behavior in the RhR Gt system. There we provide
evidence that the ICL3 is a disordered region that becomes structured
upon binding to GαtCT. The intracellular ends of TM5 and TM6 ex-
hibit order to disorder transitions, blurring the exact start and end
of the ICL3. We further propose that the binding is driven by a mu-
tual structuring process involving ICL3 and GαtCT, allowing for fast
and precise signaling. In the β2AR system investigated in this sec-
tion, the ICL3 is much longer than in RhR and not resolved in the
available crystal structures [40, 60, 32]. The lack of structural data
on β2AR ICL3 suggests it is disordered, which corroborates similar
observations in our simulations of β2AR* and β2AR*•Gs. The intra-
cellular domains of GPCRs, especially ICL3, are generally predicted
to contain intrinsically disordered regions for all GPCR classes, not
just for members of class A as investigated here, and are implicated in
fine-tuning receptor activity and mediating interactions with their ef-
fector proteins, for example G proteins [61, 62]. When we focused our
analysis on the intracellular end of TM6 instead of the full ICL3, we
made similar observations as in our RhR ICL3 study. Without the Gs
protein, some disordering can be observed at the intracellular TM6
end of β2AR* (Figure A1). Notably, in one simulation of β2AR*•
GαiCT where TM6 moves inward, the full ICL3 adopts an ordered
conformation that it maintains for the remainder of the simulation
(Figure A6).
4.2.5 Structural mechanism of G protein selection by β2AR*
We investigated how Gi might bind to β2AR* and what the differ-
ences are compared to Gs binding. For this purpose, we performed
MD simulations of β2AR* with GαiCT and Gs/GαsCT. Our results
add to the recent findings suggesting that GPCR signaling is based
on an ensemble of active receptor conformations [27, 55, 164] which
are influenced by a variety of extracellular ligands and intracellular
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Figure 23: β2AR and RhR specificity scheme. Upon binding of GαCT
(+GαCT), a single receptor conformation is adopted. The equilibrium of
active receptor states includes in the case of β2AR* conformations selective
for GαsCT and GαiCT. In RhR*, the conformational space is more special-
ized and tuned to support binding only to GαtCT. Notably, the binding
modes of β2AR*•GαiCT and RhR*•GαtCT are very similar, presumably
due the very high sequence similarity of GαiCT and GαtCT.
proteins [26, 185, 186]. Ligands specifically shift the equilibrium of
receptor conformations — and not just towards the inactive or active
state (i. e. as inverse agonists or agonists do respectively) but also
towards active receptor conformations favoring specific effector pro-
teins [163].
In this study, we employed the Gα C-termini of Gs or Gi to inves-
tigate the interactions with the active β2AR*. GαCT is known to be a
main interaction site with the GPCR governing coupling fidelity and
specificity [70, 71, 72, 73, 74]. Thus, GαsCT and GαiCT represent key
sites for interactions with the active β2AR*, and our MD simulations
indeed show them stabilizing distinct active receptor conformations.
In the simulations, GαsCT maintains the β2AR* conformation from
the X-ray structure β2AR*•Gs complex, which is also maintained in
simulations with Gs. Moreover, simulations of β2AR* show an en-
semble of conformations from which GαiCT can stabilize a β2AR* re-
ceptor conformation resembling RhR* (Figure 15). More precisely, the
active receptor exhibits intrinsic TM6 flexibility spanning a conforma-
tional space from which the G protein selects a specific conformation
for productive interaction and signal transfer. The Gα C-terminus is
often sufficient to control the binding specificity by presenting just a
small number of crucial residues (Figure 17 and ref [73]).
Structural analyses of β2AR*•Gs and RhR as well as simulations
of RhR*•GαsCT together with the putative β2AR*•GαiCT complex
suggest β2AR* can adopt a RhR*-like conformation that excludes Gs
from binding and being activated. Thus, by inducing a RhR*-like
conformation of β2AR*, ligands may switch β2AR* to a receptor con-
formation that only activates Gi but not Gs [163]. To summarize, the
ensemble of specific R* conformations constitutes a control mecha-
nism for adjust which signaling pathway prevails in the intracellular
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network. In addition to the availability and affinity of different G
proteins, shifts within the ensemble of active receptor conformations
may favor or abolish productive interaction and alter signal efficiency.
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4.3 role of r* in g α5 displacement
Signal transfer from GPCRs to G proteins has to bridge a distance
of 30Å to get from the receptor binding crevice to the GDP binding
pocket. The α5 helix from the Gα subunit provides a direct con-
nection between the GDP binding pocket and the coupling interface
between receptor and G protein [32] which has been linked to GDP
release [87]. Upon R*•G complex formation, the α5 is displaced, par-
ticularly rotated [80, 32]. Here we investigated the role of α5 and its
displacement to elucidate the events leading to GDP release and thus
to signal transduction.
For signal transfer, a series of intermediate states is occupied by re-
ceptors and G proteins reflecting an intricate interaction network that
governs the complex formation required for GDP release. In these in-
termediates, participation of a number of protein domains is required
in a sequential manner for the stepwise adoption of a productive com-
plex [83, 48, 43, 56, 1, 187, 170, 188, 65, 82] (Figure 24). A number of
crystal structures of the inactive and active forms of receptors [34] as
well as G proteins and their complexes [76, 32] are available. Given
the experimental condition in which they were resolved, these struc-
tures reflect stable states at fixed points in their series of intermediates
and likely states at endpoints. A clear example of such a state is the
β2AR*•Gs complex, a GDP free state exhibiting the defining features
of an active receptor G protein complex.
Considering the central position of the α5 helix during complex for-
mation, we wanted to learn more about how and when the rotation
of α5 of the α-subunit of Gs and Gt occurs within the binding crevice
of β2AR* and RhR*. For that, we created a model of the R*•G[GDP]
intermediate, employing flexible docking analysis and validated it
against available structural data (Figure 24). By starting MD simu-
lations from this R*•G[GDP] intermediate, we obtained a dynamic
view describing the effect the receptor has on the α5 helix. To keep
the computations feasible, we studied the dynamics of GαsCT and
GαtCT, derived from the far C- terminus of α5, in lieu of the com-
plete G protein. With this setup, we tested whether the α5 helix can
rotate given only the interactions of GαCT with R*.
4.3.1 Characterization of the R*•G[GDP] intermediate
First experimental evidence for a R*•G[GDP] intermediate was pro-
vided by a study on the kinetics of Gt activation in disc mem-
branes [44, 78]. The R*•G[GDP] intermediate’s defining features is
that GDP is still bound in the nucleotide binding site of the Gα sub-
unit after complex formation with the active receptor. Intermediates
are generally seen as stable states linked by transition states, showing
transitory or partial features of the final complex to which their reor-
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Figure 24: Role of the α5 helix in the interaction between R* and G that
leads to nucleotide exchange. From left to right. (A) Membrane anchored
Gαβγ[GDP] with an unstructured α5 C-terminus encounters R* with a par-
tially unstructured cytoplasmic crevice. (B) Intermediate R*•Gαβγ[GDP]
complex formed through mutual structuring of the α5 C-terminus and the
R* cytoplasmic crevice. The α5 helix has not rotated compared to free R*•
Gαβγ[GDP]. (C) Rotation of α5 has lowered the energy barrier separat-
ing R*•Gαβγ[GDP] from R*•Gαβγ[empty], resulting in GDP release. (D)
Uptake of GTP completes the nucleotide exchange reaction accompanied
by Gαβγ[GTP] uncoupling from R*. The figure and legend are reproduced
from [166]
ganization eventually leads [189]. In the context of protein dynamics
developed by Frauenfelder and co-workers [174, 175], intermediate
states are considered protein states with microsecond, i. e. finite, life-
times. Here we are interested in an intermediate complex formed
by R* G[GDP] featuring a folded GαCT and ICL3 (or just the intra-
cellular parts of TM5 and TM6 in case of a long ICL3). As argued
in Section 4.1 and ref [56] for the signal transfer from RhR* to Gt,
such an intermediate is formed as the result of a mutual structuring
process by stepwise reduction of the conformational space.
By means of a flexible docking analysis, we obtained models of
the R*•G[GDP] intermediate for the β2AR* Gs and the RhR* Gt sys-
tem. These intermediates show a double sandwich structure com-
prising αN/β2-β3 loop, ICL2, α5 and ICL3 (Figure 19A, for GαtCT
see [78]), which is also seen in the β2AR*•Gs complex, and exhibit
the C-terminal reverse turn and a structured ICL3. In contrast to the
β2AR*•Gs complex, however, the α5 is not rotated/displaced in the
intermediate.
Regarding the interaction of GαtCT with RhR* (see SI of [78]), we
find a hydrogen bond in our intermediate from GαtCT to the con-
served P1383.57 cap interconnecting TM3 with ICL2. Mutations of
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the ICL2 including the P1383.57 have previously been used to create
a RhR*•Gt complex that forms but is not productive [57]. Whether
such an unproductive complex has GDP still bound is not clear, but
interactions with the ICL2 seem to be crucial for successful signaling.
For the β2AR* Gs system, Sunahara and co-workers recently pro-
vided data that suggest GDP-bound Gαs couples to β2AR* mainly
through GαsCT [83]. In our intermediate GαsCT binds to β2AR* by
a hydrogen bond between E392 and R1313.50 of TM3 employing the
E(D)RY motif. Additional hydrogen bonds are found from GαsCT to
ICL2 and 3 (Figure 19A, C).
Neither GαsCT nor GαtCT exhibit extended hydrophobic interac-
tions in our intermediate states. As the full desolvation potential is
not exploited, the absence of such interaction generally may be in-
dicative of intermediate states. Here it also specifically reflects the
weak coupling of GDP-bound Gαs to β2AR* [83]. Accordingly, we
observe in our MD simulations, a highly dynamic behavior of espe-
cially GαsCT but also of GαtCT in the intermediate position. As
described in the next section, the GαCT peptides either unfold and
diffuse away or switch very quickly to the position seen in the crystal
structures of β2AR*•Gs or RhR*•GαtCT, respectively. However, note
that the very fast switching we observe is likely exaggerated due to
our use of peptides in lieu of the complete G protein. We expect the
intermediate to be stable for longer in the context of the full G protein
with more restricting interactions when the GαCT is part of the Gα
subunit and has no free N-terminus as with the GαtCT peptides.
4.3.2 Switching of the α5 helix at the R* interface
We performed 30 MD simulations each of the β2AR* and of the RhR*
systems. In both systems, about one third of the simulations feature a
GαCT helix switch. Analysis of these simulations shows that the ori-
entation and the key interactions present in the X-ray structures are
eventually restored as a result of the GαCT helix switch (Figure 20).
In the case of RhR* and GαtCT, our simulations can essentially repro-
duce the X-ray structure of RhR* with 11-mer GαtCT [31]. However,
for β2AR* and GαsCT, the available structural data is on the full
β2AR*•Gs complex, showing additional constraints on the GαsCT
position as part of the whole Gα subunit. Still, we observe GαsCT
restoring the orientation and key interactions seen in the crystal struc-
ture of the β2AR*•Gs complex [32].
These observations show that GαsCT and GαtCT can transition
from their intermediary position to the position and orientation rep-
resenting the GDP-free complexes (Figure 20) without applying addi-
tional forces. Specifically, the interactions of the far C-terminus of α5
with the intracellular crevice of R* and the solvent are the only appar-
ent forces we observe in the simulations. Thus, the ability of the α5
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helix to switch at the R* interface seems to be an intrinsic feature of
the coupling interface comprising GαCT and the intracellular crevice
of R*. Following the theory of complex formation, transition from
intermediate states to the final complex is accompanied by a reorga-
nization of electrostatic interactions and desolvation of hydrophobic
patches [189]. Accordingly, we observe changes in the hydrogen bond
network (Figures 19A-D, A24, A25) and an expulsion of water lead-
ing to the formation of a hydrophobic contact patch at the binding
interface of GαCT and ICL3 of R* (Figures A19, A28, A29).
In our proposed structural models, transitioning from the interme-
diate GDP-bound to the final GDP-free state, the rotation of the α5
helix inherently exposes two adjacent sites of the α5 helix to the intra-
cellular binding crevice of R*. Thereby two different (but not distinct)
interaction networks are involved during R*•G[GDP] formation and
its transition to the GDP-free complex. Conceivably, these networks
function to independently verify R* Gα C-terminus complementarity,
that is they allow R*•G[empty] formation only after successful R*•
G[GDP] formation. The initial interaction network for R*•G[GDP]
would not require altering the position of α5. We propose (see next
section) that rotation of the α5 helix triggers GDP release with for-
mation of the second interaction network, yielding the R*•G[empty].
Thus the initial interaction network would be uncoupled from GDP
release. Such a nuanced role of GαCT would be in line with and
add to the already described complex role of GαCT in determining
coupling specificity and efficiency [70, 74, 76].
Involvement of the highly conserved motifs at R3.50 and at the
P3.57 cap of TM3 (Figures 19, A16, A17) in the hydrogen bond net-
work between GαCT and R* indicates that the observed mechanism
is applicable in similar form to other GPCR/G protein systems.
4.3.3 Role of the α5 helix switch for GDP release
The present study describes a structural mechanism by which the α5
helix switch could occur and lead to the release of GDP from the
nucleotide binding pocket (Figure 24). An α5 helix displacement is
known to happen upon R*•G[empty] complex formation and is thus
coupled to GDP release. Interconnecting the R* cytoplasmic crevice
with the G nucleotide binding pocket, the α5 helix is a prime suspect
for bridging that distance and transducing a signal [87, 80, 32, 78].
Here we propose that the intermediate R*•G[GDP] complex pro-
vides a structural scaffold in which the α5 helix can rotate while the
receptor and the G protein (especially the Gα subunit) stay fixed [78].
The structural scaffold is composed of the elements of the double
sandwich structure from Gα and R*: αN-β1 or β2-β3 loop, ICL2, α5,
ICL3 and the membrane anchors. Given such a fixed frame, the α5
helix can propagate the signal to the GDP binding pocket by rotating
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within the intracellular crevice of R*. In MD simulations of GαCT, we
observe that the α5 helix switches resulting from interactions with at
the R* interface alone, indicating the feasibility of the scaffold mecha-
nism.
Signal propagation by α5 rotation presumably works through
destabilization of the GDP binding pocket. Specifically, changes of
the α5-β5 loop have been identified as one of the key elements in the
course of GDP release [87]. While GDP is bound, the α5-β5 loop of
the G protein is highly constrained, forming a short structural ele-
ment with strong polar interactions to GDP. Due to the counter clock-
wise rotation of α5, the α5-β5 loop is eventually elongated as seen
in the the X-ray structure of the β2AR*•Gs complex. Moreover data
from HDX experiments strongly suggest that this loop becomes more
flexible in the β2AR*•Gs complex [83]. Therefore, the α5 helix switch
may facilitate GDP release by releasing the constraints on the α5-β5
loop and thus playing an integral part in the mechanism of receptor
G protein coupling.

5
CONCLUS ION AND PERSPECT IVE
5.1 dynamic coupling interface of gpcrs
The results presented here show that the GPCR coupling interface
features highly dynamic regions that adapt to accommodate different
intracellular binding partners or the same binding partner in differ-
ent and highly specific conformations. However, before the receptor
forms a productive signaling complex with its binding partner, an ag-
onist needs to activate the receptor [1, 2, 3]. In case of rhodopsin, the
covalently linked 11-cis retinal acts as an inverse agonist which is iso-
merized by light absorption to the agonist all-trans retinal [1]. Other
GPCRs — like the β2-adrenoceptor— show considerable constitutive
activity [47], without a bound agonist. Additionally, GPCR activation
depends on pH [50, 169, 23] and lipid composition [24], emphasizing
the importance of experimental conditions. Eventually, the active re-
ceptor presents itself as an equilibrium of active conformations that
share major rearrangements of the transmembrane helix bundle com-
pared to the inactive receptor state [28, 29]. The exact distribution of
the active conformations is governed by specific agonists which may
shift the equilibrium of active conformations towards specific confor-
mations [18, 27] and thus ultimately regulate which cellular signaling
pathway is activated [13].
But first, to form a signaling complex, the receptor and its intra-
cellular binding partners need to find each other and form loosely
coupled encounter complexes [181]. Electrostatic interactions are
known to facilitate the formation of such encounter complexes [190].
The exposure of R3.50 (from its buried state) during receptor acti-
vation, along with other positively charged residues at the intracel-
lular receptor interface, may thus help to facilitate encounter. For
rhodopsin, a sequential fit mechanism has been suggested based on
the observation that the C-terminus of the γ-subunit (GγCT) can in-
teract with earlier rhodopsin intermediates than the main interaction
site GαCT [187, 191]. In the sequential fit mechanism, GγCT may
help to form earlier encounter complexes that allow for faster forma-
tion of the signaling complexes. Arrestin, on the other hand, needs a
phosphorylated receptor C-terminus in addition to an active receptor
conformation [192]. Interaction between the p44 splice-variant of ar-
restin and the receptor’s C-terminus is also observed with the inactive
receptor, allowing for some form of pre-complexes [193]. A general
effect on complex formation would come from superstructures pro-
posed for rhodopsin where receptor molecules form large ordered
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structures [194, 195]. For G proteins, this suggests that encountering
one receptor in the superstructure may speed up subsequent encoun-
ters of receptors due to the spatial proximity [196, 197].
Mutual structuring of ICL3 and GαCT
We propose that, following the creation of an encounter complex, a
mutual structuring process leads to the formation of a specific com-
plex. Both the receptor and its intracellular binding partners include
an intrinsically unstructured region at sites known to be crucial for
signaling complex formation [162, 68, 84]. The ICL3 of the receptor is
known to be flexible and has often been replaced to facilitate crystallo-
genesis [180]. In the case of rhodopsin the ICL3 is so short that crystal
contacts stabilize it in the available crystal structures of active con-
formations [31]. However, in this combined study employing FTIR
spectroscopy and MD simulations we were able to describe the intrin-
sically disordered nature of ICL3 on a structural level [56]. Moreover,
we identified MIIbH+ as the specific receptor conformation to which
GαtCT binds and in which the ICL3 becomes structured (Section 4.1).
While the ICL3 from the receptor becomes structured, the counterpart
at the intracellular binding partner becomes structured too. GαCT
forms a continuous α-helix capped by a reverse turn motif only when
bound to an active receptor [68]. The “finger loop” in arrestin is more
flexible, exhibiting different conformations [198, 199]. A peptide de-
rived from the “finger loop” (ArrFL) becomes structured similarly to
GαtCT and binds to the same intracellular receptor as GαCT [75].
In MD simulations, we were able to observe destructuring events
of ICL3, GαCT and ArrFL. But the reverse process remains to be elu-
cidated. To observe the destructuring, it was sufficient to remove the
respective binding partner. For the reverse process, i. e. the structur-
ing, a more elaborate approach is needed. A suitable encounter com-
plex (or better yet, an ensemble of encounter complexes) would be
required to start simulations from — with the aim to observe struc-
turing. Given the large degree of freedom within such encounter
complexes [200], it is likely necessary to bias or simplify the simu-
lation to increase the chance of observing structuring with adequate
computational resources. One avenue could be to have one of the
binding partners already structured, for example the ICL3, and then
focus on GαCT folding within the receptor binding crevice environ-
ment. Another approach would be to start the simulations with the
binding partners in ways that limit their degree of freedom and thus
allowing extensive sampling.
In reality, mutual structuring will eventually take place, regardless
of whether it is intractable for MD simulations or not, and lead to
the formation of a specific complex [103]. In the case of the interac-
tion between receptor and G protein, the first specific complex will be
the R*•G[GDP] intermediate [44, 78]. As described earlier, however,
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whether a productive signaling complex can be efficiently formed de-
pends on the specific distribution of conformations in the equilibrium
of active receptor conformations.
TM6 conformations and biased signaling
The intracellular binding partners of GPCRs may show different bind-
ing strength or no binding at all with respect to specific active re-
ceptor conformations [18, 27]. Thus the stabilization of specific ac-
tive receptor conformations, by different agonists, can enhance (or in-
hibit) the formation of signaling complexes and through that provide
a structural mechanism explaining the biased signaling capabilities of
ligands [25]. Several spectroscopic studies have found TM6 exhibiting
multiple conformations in β2AR*, linked to the presence of different
ligands and/or intracellular binding partners [27, 55, 164]. Here we
employed MD simulations, after a detailed structural comparison, to
find a putative β2AR*•GαiCT complex with a TM6 conformation dis-
tinct from β2AR*•Gs but similar to RhR*•GαtCT. Given the close re-
lationship between Gi and Gt, the β2AR*•GαiCT complex suggests
that the TM6 conformation in R* depends on which G protein type it
is bound to: a small outward tilt of TM6 is sufficient for Gαi/t, but
a large TM6 outward tilt is required for Gs. This interdependence
of G protein and TM6 conformation readily provides an explanation
for the disparity of TM6 outward tilts in the crystal structures of the
β2AR*•Gs and RhR*•GαtCT complexes [31, 32].
Now, assuming that there are two active receptor conformations
with respect to TM6, one for Gi and on for Gs, implications for biased
signaling are apparent. The β2-adrenoceptor can activate both the
stimulatory Gs and the inhibitory Gi protein signaling pathway [4].
Moreover, a β2AR ligand is known that can selectively activate the Gi
while silencing the Gs pathway [163]. In light of our β2AR*•GαiCT
complex with its specific TM6 conformation prohibiting Gs binding,
we suggest that Gi selective ligands shift the equilibrium of active
receptor states towards this Gi specific TM6 conformation. Thus, lig-
ands may utilize TM6 to allow the receptor to distinguish between
different G proteins. Similar mechanisms are directly conceivable for
other structural elements in the receptor that undergo major struc-
tural rearrangements during activation like TM5 or ICL2 [53].
The structural link between ligands and changes at the intracellular
binding crevice is only poorly understood. TM6 plays a major role
in both receptor activation and in the equilibrium of active receptor
states [29, 55]. Thus, it is conceivable that the connector (I1213.40
and F2826.44 in β2AR) proposed by Dror, Arlow, Maragakis, Mildorf,
Pan, Xu, Borhani, and Shaw [54] for receptor activation is also impor-
tant for modifying the conformational equilibrium of active receptor
states through biased ligands. Initial MD simulation studies show a
ligand dependence for the receptor activation pathway [116] and the
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subsequent conformational equilibrium of active receptor states [201].
Given that TM6 and its large movements are so crucial, it would be
valuable to make TM6 the center of a MD simulations study: by sam-
pling the conformational space of TM6 in the equilibrium of active
receptors, the boundaries of TM6 movement could be described and
involved residues inferred. Moreover, performing such a study with
different ligands would yield insights into the mechanism by which
ligands act on the conformational space of TM6.
α5-helix rotation during GDP release
Once the receptor is activated, a complex with an intracellular bind-
ing partner can be formed, depending on the equilibrium of active
receptor conformations. Eventually, a productive signaling complex
will be formed that relays the signal to downstream effectors [6, 13].
However, for the interaction between receptor and G protein, the first
specific complex will be — presumably via a mutual structuring pro-
cess — the R*•G[GDP] intermediate. In this study, we focused on
the next step of GDP release, to which the displacement of the α5-
helix is central [80, 78, 83]. The α5 helix bridges the distance of 30Å
between receptor nucleotide binding pocket, allowing allosteric sig-
nal transmission. Upon formation of the R*•G[GDP] intermediate
and the following transition to the nucleotide-free R*•Gαβγ[empty]
complex, the α5-helix from the Gα-subunit is displaced. Then, the nu-
cleotide exchange (GTP for GDP) is completed by proceeding through
R*•Gαβγ[empty] and the following separation of Gαβγ[GTP] from
R* [76].
Given its place as the first specific complex during nucleotide ex-
change, we suggest that the R*•G[GDP] intermediate provides a struc-
tural scaffold in which the displacement of the α5-helix can occur.
Since the α5-helix provides an — at least allosteric, if not direct —
connection between receptor and GDP binding pocket, its rotation is
likely involved in GDP release [80, 88, 89, 90, 78]. Here we propose
that the rotation of the α5-helix proceeds after formation of the R*•
G[GDP] intermediate, in a fixed frame provided by additional inter-
action between receptor and G protein. In MD simulations of GαsCT
and GαtCT peptides, we observed intrinsic switching of the α5 he-
lix at the interface of β2AR* and RhR*, respectively, indicating the
feasibility of the scaffold-based mechanism. Starting from our R*•
G[GDP] intermediate and employing sufficient computing resources,
we could extend the GαCT peptide-approach to the full G protein.
This will allow us to directly investigate the effect the rotation of the
α5-helix within the R*•G[GDP]-provided scaffold has on the GDP
binding pocket.
A
APPENDIX
System Simulations Length
RhR 1ˆ 400ns, 2ˆ 200ns 0.8µs
RhR* 1ˆ 400ns, 4ˆ 200ns 1.2µs
RhR*•GαtCT19 5ˆ 200ns 1.0µs
RhR*•GαtCT11 1ˆ 400ns, 4ˆ 200ns 1.2µs
RhR*•GαtCT11 intermediate 30ˆ 100ns 3.0µs
RhR*•GαsCT19 5ˆ 200ns 1.0µs
RhR*•GαsCT19 intermediate 1ˆ 400ns, 3ˆ 200ns 1.0µs
Ops* 1ˆ 400ns, 4ˆ 200ns 1.2µs
Ops*•GαtCT11 3ˆ 400ns, 7ˆ 200ns 2.6µs
β2AR* 1ˆ 400ns, 4ˆ 200ns 1.2µs
β2AR*•Gαsβγ 5ˆ 200ns 1.0µs
β2AR*•GαsCT19 1ˆ 400ns, 4ˆ 200ns 1.2µs
β2AR*•GαsCT11 10ˆ 500ns 5.0µs
β2AR*•GαsCT11
intermediate
30ˆ 200ns 6.0µs
β2AR*•GαiCT19 3ˆ 600ns, 8ˆ 200ns, 10ˆ
100ns
4.4µs
β2AR*•GαsCT19
intermediate
1ˆ 400ns, 5ˆ 200ns 1.4µs
β2AR*•GαiCT19 umbrella
sampling
36ˆ 200ns 7.2µs
40.4µs
Table A1: Overview of performed MD simulations. Each row lists the sys-
tem, the length and count of simulations, and the overall per system simu-
lation time. The total simulation time is 40.4µs.
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β2AR Conservation Loca-
tion
T66 T 46%, S 16%, N 7%, K 4%, R 4%, E 3%, Q 3%,
A 3%
ICL1
N69 Y 59%, N 15%, D 4%, T 3%, S 2%, F 2%, A 2% ICL1/TM2
R1313.50 R 89%, C 3%, H 2% TM3
P1383.57 P 86%, A 6% TM3
D331 E 30%, D 24%, Q 10%, K 6%, N 5%, T 3%, S
3%, R 3%, H 2%
H8
Table A2: Conservation of residues from the binding cavity of R* impor-
tant for stabilization of the R*•G[GDP] intermediate. Conservation was cal-
culated from the alignment of all sequences from the UniProt data base
(http://www.uniprot.org/, release 2012_07) which belong to the g protein
coupled receptor 1 family and are in the human genome. Sequence align-
ment was performed with the Clustal Omega program. Only amino acids
observed in at least 2% of the aligned sequences are listed. The figure and
legend are reproduced from [166]
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Figure A1: (A) Superposition of the RhR*•GαtCT crystal structure (orange,
PDB entry 3PQR) with a snapshot from the MD simulation of uncomplexed
β2AR* (red). Note the similarity of the TM6 tilt at the intracellular side. The
gray box denotes the part of TM6 analyzed in B. (B) Time series showing the
secondary structure assignment of the intracellular TM6 region of β2AR* as
calculated with DSSP [155]. The observed structure types are α-helix (blue),
310 helix (gray), turn (yellow), coil (white) or bend (green). The black arrow
denotes fromwhich simulation and at what time the β2AR* structure shown
in (A) was taken. The plot shows the data of multiple MD simulations, each
between 200ns and 400ns long. The figure and legend are reproduced from [101]
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Figure A2: TM6 tilt measured as the TM2-TM6 distances of (A) β2AR*•
Gαsβγ, (B) β2AR*•GαsCT 19, (C) RhR*•GαtCT 19, (D) RhR*•GαtCT 11,
(E) β2AR*•GαiCT 19 and (F) RhR*. Shown are the time traces of the TM2-
TM6 distances and the resulting distributions with observed probabilities p.
The lengths of the individual simulations are given in Table A1. Note that N-
terminal truncation to GαsCT 11 leads to higher observed variability of TM6
tilts compared to β2AR*•GαsCT 19 or β2AR*•Gαsβγ, especially within in-
dividual simulations. This effect is less articulate for RhR*•GαtCT11 com-
pared to GαtCT19. The figure and legend are reproduced from [101]
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Figure A3: GαsCT and ICL3 flexibility of various complexes. Shown are the
backbone RMSF changes of GαsCT relative to β2AR*•Gαsβγ of (A) β2AR*•
GαsCT11 or (B) β2AR*•GαsCT19. (C) Tube depiction of β2AR* with
GαsCT 11 (blue), with GαsCT19 (green) or with GαsCT from Gαsβγ (yel-
low). The thickness of the tube corresponds to the RMSF value of the re-
spective amino acids. The RMSF is the standard deviation of atomic po-
sitions over simulation time and was calculated with the GROMACS tool
g_rmsf from the MD simulations of the respective systems as listed in Ta-
ble A1. Before the analysis each frame was superposed with the backbone
atoms of TM1-TM7 of the initial structure. The figure and legend are reproduced
from [101]
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Figure A4: Cation-π interactions between β2AR* and (A) Gαsβγ,
(B) GαsCT19, (C) GαsCT11 and between (D) RhR* and GαsCT19. Each
plot shows the data of multiple MD simulations, each between 200ns and
500ns long. See Table A1 for the lengths of the individual simulations.
The time series show the electrostatic (black) and hydrophobic (red, Lenard-
Jones potential) contributions to the interaction energy as calculated by the
CaPTURE program [160]. Blue lines denote frames where the interaction
energy of cation-π interaction between R3.50 and C391 is significant, which
occurs continuously in the β2AR* simulations with the exceptions of simula-
tion 3 in (B) and simulations 3, 4, 6 in (C). The cation-π interaction between
RhR* and GαsCT19 seen in simulation 3 (D) exhibits no face-to-face orienta-
tion as in β2AR* but rather an edge-to-face orientation. The figure and legend
are reproduced from [101]
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Figure A5: Polar interactions between R* and GαCT. Each plot shows the
data of multiple MD simulation, each between 100ns and 600ns long. The
lengths of the individual simulations are given in Table A1. The time se-
ries denote one (black), two (blue) or three (green) polar interactions be-
tween two residues as observed in the MD simulations of (A) β2AR*•
Gαsβγ, (B) β2AR*•GαsCT19, (C) β2AR*•GαsCT 11, (D) β2AR*•GαiCT19,
(E) RhR*•GαtCT19 and (F) RhR*•GαtCT11. Polar interactions between
GαCT and R* were calculated with the GROMACS tool g_hbond using a
donor-acceptor distance cutoff at 3.6Å and a cutoff angle of 30° for the angle
given by the acceptor-donor-hydrogen atoms. In (D) only those simulations
of β2AR*•GαiCT19 are shown where TM6 changes its starting position and
moves inward. The figure and legend are reproduced from [101]
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Figure A6: (A) Structuring of ICL3 that accompanies TM6 inward movement
(see 15C) in the MD simulation of β2AR*•GαiCT 19 used in the Umbrella
Sampling. (B) Rotation of TM6 around its axis (at residues 273–280, gray
box) observed in the same simulation. The figure and legend are reproduced
from [101]
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Figure A7: (A) Model of β2AR*•Gαiβγ based on the arrangement of
β2AR*•GαiCT19 determined by classical and US MD simulation data and
(B) the crystal structure of β2AR*•Gαsβγ (for comparison). Apparently,
there are no clashes with the membrane (black lines) nor within the com-
plex itself. As in the β2AR*•Gαsβγ complex, the arrangement in β2AR*•
Gαiβγ does not result in any major clashes (as shown with the inactive GDP
bound Gαi/t in [78]). Comparison of both complexes, however, reveals a
difference in the rotational tilt of the GαCT relative to β2AR, resulting in a
slightly different orientation of Gαiβγ relative to the receptor. (C) Compar-
ison of the transmembrane helix arrangements in β2AR*•GαiCT19 (red),
RhR*•GαtCT11 (orange) and β2AR*•Gs (blue). The figure and legend are
reproduced from [101]
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Figure A8: Per residue interaction area fraction of the GαsCT19 peptides
observed in MD simulations of (A) β2AR*•GαsCT19, (B) RhR*•GαtCT19
and (C) β2AR*•GαiCT19. The interaction area fraction is calculated as the
fraction of solvent accessible surface (SAS) (calculated with the GROMACS
tool g_sas) of the R*•GαCT complex and the SAS of the free peptide. A
fraction of one means a residue is completely accessible whereas completely
buried residues have a fraction of zero. Residues with a fraction below
0.35 are denoted buried and those with a fraction above 0.7 are denoted
accessible. In (C) only those simulations of β2AR*•GαiCT 19 are shown
where TM6 changes its starting position and moves inward. The figure and
legend are reproduced from [101]
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Figure A9: Secondary structure analysis of GαCT in (A) β2AR*•GαsCT and
(B) RhR*•GαtCT. Starting from the conformation of the X-ray structures
from the co-crystals, analysis with the program DSSP of ten 200ns simula-
tions shows stable helical core regions (blue), but helix-coil transitions at the
N-terminus (pale orange). The first two residues were accordingly ignored
for calculation of helix axes (Figure A13) and backbone-RMSD (Figure A10).
The C-terminus is defined by two residues forming a stable turn (yellow).
Y391 or C347 (interacting with R3.50 of the binding cavity) are both in po-
sition C, the so defined last residue of the helix [202]. It proceeds E392 or
G348 in position C’ defined as the first turn residue. The last two C-terminal
residues are assigned as coil by DSSP, but are part of the stable C-terminal
reverse turn and thus were included in the analysis of backbone-RMSD.
(C) Superposition of GαsCT and GαtCT. Labeling of the C-terminal reverse
turn according to Aurora & Rose [202]. The figure and legend are reproduced
from [166]
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Figure A10: Mobility of (A) β2AR*•GαsCT and (B) RhR*•GαtCTmonitored
by the backbone-RMSD of GαCT. The GαCT backbone-RMSD describes the
movement of GαCT relative to its position in the X-ray structures. It is
calculated over the complete trajectory of the simulation, after superposition
to the binding cavity from the equilibrated system (also see Section 2.4.7).
The histograms are calculated from ten 200ns simulations each. For analysis
only the last 9 residues were considered (for the explanation see the legend
of Figure A9). The figure and legend are reproduced from [166]
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Figure A11: Distance and interaction energies with R3.50 in β2AR*•GαsCT
and RhR*•GαtCT. Distance between (A) the center of the phenyl ring of
Y391 of GαsCT and R3.50 or (B) between the carbonyl oxygen of C347 of
GαtCT and R3.50. (C) Cation-π interaction energy between Y391 of GαsCT
and R3.50 or (D) hydrogen bond energy between carbonyl oxygen of C348 of
GαtCT and R3.50. For clarity, only energies ă ´4.1kJmol´1 are shown. The
histograms average over the ten 200ns simulations, depicted in Figure A21.
The figure and legend are reproduced from [166]
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Figure A12: Potential hydrogen bonds stabilizing (A) β2AR*•GαsCT and
(B) RhR*•GαtCT. Only those interactions with a donor-acceptor distance
ă 3.5Å and an angle between acceptor-donor-hydrogen ă 30° that persist
for at least 10% of the trajectory of a simulation were considered as potential
hydrogen bonds. The number of potential hydrogen bonds between two
residues at a given point in time is color coded: black indicates one, blue two
and green three hydrogen bonds. Gray bars separate independent 200ns
simulations. The figure and legend are reproduced from [166]
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Figure A13: Mobility of GαCT in β2AR*•GαsCT and RhR*•GαtCT mea-
sured by rotation and tilt. Histogram for the rotation around the helix axis
of (A) GαsCT and (B) GαtCT. Histogram of the helix tilt motion perpendic-
ular to the membrane plane of (C) GαsCT and (D) GαtCT. The analyses are
based on 10ˆ 200ns simulations each (Figure A20). For definition of helix
axis and tilt see Section 2.4.6. The peaks of the tilt angle distribution are
clearly different, although the standard deviations overlap. The figure and
legend are reproduced from [166]
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Figure A14: (A) α5 helix switch in transition from nucleotide bound Gs to
nucleotide free β2AR*•Gs[empty] and (B) rotation/ switch-like movement
of GαsCT in the binding cavity of R*. Comparison of the α5 helix switch
in G with orientations of GαsCT in the binding cavity of R* reveals a very
similar rotation of about 70°. The nucleotide bound Gs (Gαs[GTPγS], PDB
entry 1AZT, colored in light blue) was superimposed to β2AR*•Gs[empty]
(PDB entry 3SN6, colored in red) by the Ras domain, excluding α5. The
unresolved C-terminal reverse turn in Gαs[GTPγS] was modeled from su-
perimposing the α5 helix of β2AR*•Gs[empty] (dark blue). The orientation
of GαsCT in a putative R*•G[GDP] intermediate (colored in light blue) was
obtained from flexible docking analysis (Figure 18, Section 2.5) and its ori-
entation in the X-ray (colored in red) was derived from PDB entry 3SN6.
Superimposition with Gαi[GDP] (PDB entry 1GP2) instead of Gαs[GTPγS]
reveals a very similar rotation of α5. The figure and legend are reproduced
from [166]
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Figure A15: Structure of modeled ICL3 of β2AR*. The protein loop was
modeled with the program SuperLooper [142] which utilizes existing loops
linking transmembrane helices from structures in the PDB (http://www.
rcsb.org). See also Section 2.2 for details on the preparation of active recep-
tor and GαCT structures and complexes. The figure and legend are reproduced
from [166]
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Figure A16: Interactions between β2AR* and GαsCT in the putative R*•
G[GDP] intermediate. Potential hydrogen bonds and van der Waals con-
tacts were analyzed using the programs HBPLUS [203] and LIGPLOT [204].
Residues with closest distances less than 4Å are considered to be in van der
Waals contact. The figure and legend are reproduced from [166]
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Figure A17: Interactions between β2AR* and GαsCT in the position and
orientation observed in the X-ray structures (PDB entry 3SN6). Potential
hydrogen bonds and van der Waals contacts were analyzed using the pro-
grams HBPLUS [203] and LIGPLOT [204]. Residues with closest distances
less than 4Å are considered to be in van der Waals contact. The figure and
legend are reproduced from [166]
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Figure A18: Secondary structure analysis of GαCT 19-mer and transi-
tions from the intermediary to the R*•GαCT19 complex for β2AR*•
GαsCT19 (A, C, E) and RhR*•GαsCT 19 (B, D, E). (A, B) Starting from the in-
termediary GαCT positions obtained by flexible docking, analysis with the
program DSSP of the combined/concatenated GαCT 19-mer simulations
shows stable helical core regions (blue), but helix-coil transitions at the N-
terminus (pale orange). See also Figure A9. The observed rotation and
RMSD of GαCT are given for the individual simulations. (C, D) Change in
rotation of (C) GαsCT or (D) GαtCT around its helix axis. (E, F) Backbone-
RMSD of (E) GαsCT or (F) GαtCT relative to the position in the X-ray struc-
ture. In simulation marked with a *, the helix switch occurred, i. e. a rotation
of about 60° and a decrease in RMSD below 4Å was observed. The figure
and legend are reproduced from [166]
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Figure A19: Water expulsion accompanying the helix switch. In the interme-
diate state of β2AR*•GαsCT (A) and RhR*•GαtCT (C) a number of water
molecules (blue ellipsis) are located between GαCT and TM5 and 6 of R*.
During the helix switch and formation of the final β2AR*•GαsCT (B) and
RhR*•GαtCT (D) complex these water molecules are displaced in favor of
hydrophobic interactions (orange ellipsis) between GαCT and TM5 and 6 of
R*. For time-series data of the water expulsion and the hydrophobic patch
formation see Figure A28–Figure A31. The figure and legend are reproduced
from [166]
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Figure A20: Mobility of GαCT in (A) β2AR*•GαsCT and (B) Ops*•GαtCT
measured by rotation and backbone RMSD. The rotation of GαCT around
its helix axis during ten 200ns simulations, starting from the GαCT position
of the X-ray structure, is depicted in green. The peptide RMSD (red) de-
scribes the movement of GαCT relative to its position in the co-crystal. For
definitions of helix axis, rotation and peptide RMSD see Section 2.4.6. The
plots are linear for the first 10ns and logarithmic for the remaining time.
The figure and legend are reproduced from [166]
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Figure A21: Distance and interaction energy of R3.50 in β2AR*•GαsCT and
Ops*•GαtCT. (A) Distance (yellow) and cation-π interaction energy (blue)
between the center of the phenylring of Y391 in GαsCT and R1313.50 during
ten 200ns simulations, starting from the GαCT position of the X-ray struc-
ture. For clarity, only energies ă ´4.1kJmol´1 are shown. (B) Distance
(yellow) and hydrogen bond energy (blue) between the carbonyl oxygen of
C348 in GαtCT and R1353.50 during ten 200ns simulations. The plots are
linear for the first 10ns and logarithmic for the remaining time. The figure
and legend are reproduced from [166]
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Figure A22: Mobility of GαsCT in β2AR*•GαsCT intermediate and mea-
sured by rotation and backbone-RMSD. The rotation around the helix
axis during thirty 200ns simulations is depicted in green. The peptide
RMSD (red) describes the movement of GαsCT relative to its position in the
crystal structure. For definitions of helix axis, rotation and peptide RMSD
see Section 2.4.6. Simulations in which a switch event occurs are marked
with a star (*) in the upper left corner. The plots are linear for the first 10ns
and logarithmic for the remaining time. The figure and legend are reproduced
from [166]
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Figure A23: Mobility of GαtCT in Ops*•GαtCT intermediate measured by
rotation and backbone-RMSD. The rotation around the helix axis during
thirty 100ns simulations is depicted in green. The peptide RMSD (red)
describes the movement of GαtCT relative to its position in the crystal
structure. For definitions of helix axis, rotation and peptide RMSD see Sec-
tion 2.4.6. Simulations in which a switch event occurs are marked with a
star (*) in the upper left corner. Simulations in which GαtCT adopts a sta-
ble binding mode but does not switch are marked with a tilde (~) in the
upper left corner. The plots are linear for the first 10ns (dashed gray line)
and logarithmic for the remaining time. The figure and legend are reproduced
from [166]
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Figure A24: Distance and interaction energies of R1313.50 in β2AR*•GαsCT
intermediate. Distance (yellow) and cation-π interaction energy (blue) be-
tween the center of the phenylring of Y391 in GαsCT and R1313.50 dur-
ing thirty 200ns simulations. For clarity, only energies ă ´4.1kJmol´1 are
shown. Simulations in which a switch event occurs are marked with a star
(*) in the lower left corner. The plots are linear for the first 10ns (dashed
grey line) and logarithmic for the remaining time. The figure and legend are
reproduced from [166]
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Figure A25: Distance and interaction energies of R1353.50 Ops*•GαtCT in-
termediate. Distance (yellow) and hydrogen bond energy (blue) between
carbonyl oxygen of C348 in GαtCT and R1353.50 during thirty 100ns sim-
ulations. Simulations in which a switch event occurs are marked with a
star (*) in the lower left corner. Simulations in which GαtCT adopts a sta-
ble binding mode but does not switch are marked with a tilde (~) in the
lower left corner. The plots are linear for the first 10ns (dashed gray line)
and logarithmic for the remaining time. The figure and legend are reproduced
from [166]
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Figure A26: Secondary structure analysis of GαsCT in β2AR*•GαsCT in-
termediate. For each GαsCT residue the secondary structure according to
the program DSSP is shown over time (blue: α-helix, 310-helix: gray, turn:
yellow, green: bend, coil: pale orange). Simulations in which a switch event
occurs are marked with a gray star (*) in the upper left corner. The figure and
legend are reproduced from [166]
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Figure A27: Secondary structure analysis of GαtCT in Ops*•GαtCT inter-
mediate. For each GαtCT residue the secondary structure according to the
program DSSP is shown over time (blue: α-helix, 310-helix: gray, turn: yel-
low, green: bend, coil: pale orange). Simulations in which a switch event
occurs are marked with a gray star (*) in the upper left corner. The figure and
legend are reproduced from [166]
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Figure A28: Hydrophobic patch between GαsCT and β2AR* in β2AR*•
GαsCT intermediate. The minimal distances between L393 of GαsCT and
V222 (black), A226 (red), A271 (blue) and L275 (green), respectively, of TM5
and 6 of β2AR* are plotted over time. The plots are linear for the first 10ns
(dashed gray line) and logarithmic for the remaining time. The figure and
legend are reproduced from [166]
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Figure A29: Hydrophobic patch between GαtCT and Ops* in Ops*•GαtCT
intermediate. The minimal distances between L349 of GαtCT and L226
(black), V230 (red), V250 (blue) and V254 (green), respectively, of TM5 and 6
of Ops* are plotted over time. The plots are linear for the first 10ns (dashed
gray line) and logarithmic for the remaining time. The figure and legend are
reproduced from [166]
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Figure A30: Hydration status of the hydrophobic patch of β2AR* at GαsCT
interface in β2AR*•GαsCT intermediate. The number of contacts ă 2.5Å
between any water molecule and V222, A226, A271 and L275 of TM5 and
6 of β2AR* are plotted over time. Simulations in which a switch event
occurs are marked with a gray star (*). The plots are linear for the first 10ns
(dashed gray line) and logarithmic for the remaining time. The figure and
legend are reproduced from [166]
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Figure A31: Hydration status of the hydrophobic patch of Ops* at GαtCT
interface in Ops*•GαtCT intermediate. The number of contacts ă 2.5Å be-
tween any water molecule and L226, V230, V250 and V254 of TM5 and 6 of
Ops* are plotted over time. Simulations in which a switch event occurs are
marked with a gray star (*). The plots are linear for the first 10ns (dashed
gray line) and logarithmic for the remaining time. The figure and legend are
reproduced from [166]
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GLOSSARY
1AZT PDB entry of Gαs complexed with GTPγS; X-ray crystal
structure at 2.3Å resolution. [65]
1GP2 PDB entry of G protein heterotrimer Gαiβγ with GDP
bound; X-ray crystal structure at 2.3Å resolution. [177]
1GZM PDB entry of dark state/inactive rhodopsin; trigonal crys-
tal form; X-ray crystal structure at 2.65Å resolution. [205]
1U19 PDB entry of dark state/inactive rhodopsin; X-ray crystal
structure at 2.2Å resolution. [39]
2RH1 PDB entry of inactive β2AR; X-ray crystal structure at 2.4Å
resolution. [40]
3CAP PDB entry of active opsin; X-ray crystal structure at 2.9Å
resolution. [30]
3DQB PDB entry of active opsin; with bound high affinity
GαtCT; X-ray crystal structure at 3.2Å resolution. [31]
3P0G PDB entry of nanobody stabilized active β2AR; X-ray crys-
tal structure at 3.5Å resolution. [60]
3PQR PDB entry of metarhodopsin II; with bound double high
affinity GαtCT; X-ray crystal structure at 2.85Å resolution.
[66]
3PXO PDB entry of metarhodopsin II, X-ray crystal structure at
3.0Å resolution. [66]
3SN6 PDB entry of β2AR*•Gαsβγ complex; X-ray crystal struc-
ture at 3.2Å resolution. [32]
ABMD adiabatic biased MD
agonist A ligand that increases receptor activity [206].
CaPTURE A software program that detects cation-π interactions in
protein structures by estimating the electrostatic and the
van der Waals interaction energy [160].
DEER double electron-electron resonance
DMPC dimyristoylphosphatidylcholine
DOWSER A software tool that assesses if an internal water molecule
makes a significant energetic contribution to the structural
stability by interacting with their surrounding atoms [133].
DSSP The standard algorithm for defining the secondary struc-
ture of proteins that are available structures at atomic res-
olution. Based on electrostatic interactions and the geom-
etry of the protein backbone, the algorithm assigns eight
types of secondary structure, including α-helices and β-
sheets [155].
ECL extra-cellular loop
EM electron microscopy
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EPR electron paramagnetic resonance
FMM fast multipole method
FTIR Fourier transform infrared spectroscopy
GPCR G protein-coupled receptor
GPU graphics processing unit
GROMACS A popular software package to perform and analyze
molecular dynamics simulations [145].
HDX hydrogen-deuterium exchange
ICL intra-cellular loop
inverse agonist A ligand that reduces receptor activity, e. g. by stabilizing
the inactive receptor state [206].
JSON JavaScript object notation. A lightweight data-interchange
format (http://www.json.org/).
ligand A molecule that alters the activity of a receptor [206].
MD Molecular dynamics (Section 2.1).
MSM multilevel summation method
NMR nuclear magnetic resonance
PME particle-mesh Ewald
PMF potential of mean force
Python A high-level, multi-purpose programming language (http:
//www.python.org).
RMSD Root mean square deviation (Section 2.4.2).
RMSF Root mean square fluctuation (Section 2.4.2).
SAS solvent accessible surface
SDSL site-directed spin labeling
TM trans-membrane helix
US Umbrella sampling (Section 2.3.3).
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